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Methanogens are obligately anaerobic archaea which produce methane as a
byproduct of their respiration. They are found across a wide diversity of environments
and play an important role in cycling carbon in anaerobic spaces and the removal of
harmful fermentation byproducts which would otherwise inhibit other organisms.
Methanogens subsist on low-energy substrates which requires them to utilize a highly
efficient central metabolism which greatly favors respiratory byproducts over biomass.
This metabolic strategy creates high substrate:product conversion ratios which is
industrially relevant for the production of biomethane, but may also allow for the
production of value-added commodities. Particularly of interest are terpene compounds,
as methanogen membranes are composed of isoprenoid lipids resulting in a higher flux
through isoprenoid biosynthetic pathways compared to Eukarya and Bacteria. To assess
the metabolic plasticity of methanogens, our laboratory has engineered the methanogen
Methanosarcina acetivorans to produce the hemiterpene isoprene. We hypothesized that
isoprene producing strains would result in a decreased growth phenotype corresponding
to a depletion of metabolic precursors needed for isoprenoid membrane production. We
found that the engineered methanogens responded well to the modification, directing up
to 4% of total towards isoprene production and increasing overall biomass despite the

additional metabolic burden. Using flux balance analysis and RNA sequencing we
investigated how the engineered strains respond to isoprene production and how
production can be enhanced.
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Chapter 1: The Anaerobic World of Methanogens
Life, in all of its diversity of scale and form, exists within a cycle of composition
and decomposition. Though complex, this cycle can be clearly delineated between life
with and without the presence of oxygen. In the aerobic space, small organic compounds
are assembled into larger compounds of increasing complexity. As life grows larger and
larger it requires exponentially greater amounts of energy and carbon to sustain itself.
Through aerobic respiration, great amounts of energy are generated by the breaking down
of complex molecules [1]. This creates a cycle of complex organisms consuming and
breaking down less complex organisms, ever increasing in size until eventually the large
organism dies. Once these large, complex biomasses expire, they are broken down by
other aerobic organisms as much as possible, though they can only be degraded so far in
an aerobic space. To further decompose complex organic structures to their base
components, anaerobic degradation is necessary. Anaerobically, microbes respire and
ferment organic matter to terminal degradation products, 1- and 2- carbon compounds
which are unusable to the majority of life on Earth [2]. These terminal degradation
products would accumulate ad infinitum, trapped without use, were there not a way to
return them to a state usable for the carbon cycle. Methanogens gain energy not by the
separation of complex compounds into smaller ones, but rather by the bioconversion of 1and 2- carbon compounds into methane [2-6]. This gaseous methane then bubbles back
into the aerobic world where it is consumed by methanotrophic organisms and is returned
to the carbon cycle (Figure 1). Without methanogens the world would be drowned in
simple carbon compounds with no way to rebuild complex life.
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The discovery of methanogens:
The discovery of methanogens was not a simple linear path. As with many
microbes, their effects were recorded before the organisms themselves were observed. In
the late 16th century, physicist and chemist Alessandro Volta recorded observations of
flammable gases which emerged from reservoirs in marshland sediments [2]. When
ignited these gases rapidly combusted into a brilliant blue flame, though the gas itself
could be collected and transported, maintaining its combustive nature. It would not be
until the 17th century that this flammable gas would be properly named by chemist
August von Hofmann as methane. The properties and benefits of methane were
characterized far before it was understood how it was most commonly created. Today we
know methane for primarily two things: its use as a renewable fuel source as natural gas,
and its potent effect as a greenhouse gas. Methane in the atmosphere has a 28 times
greater warming effect than carbon dioxide and is believed to be a major contributing
factor to global climate change [7-9]. Unbeknownst to the early scientists, however, this
flammable gas was created not chemically, but by microorganisms, and those microbes
themselves push the limits of what life is capable.
Before identification of the organism itself was achieved, the conditions by which
microbial methane production could occur were characterized. In the late 1800s it was
known that decaying plant biomass would produce methane though the mechanism was
still unknown. Using similar techniques which Louis Pasteur utilized to prove the
microbial nature of ethyl alcohol, researchers compared the methane produced by
intestinal rumen supplemented with plant biomass with and without sterilization. When
the rumen were sterilized via chemical and thermal means no methane were produced,
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showing that it was not the simple ‘decay’ of the plant biomass which caused the
formation of methane but rather a living biological process [3]. It would not be until 1933
that the organisms responsible for biomethane would be cultured and identified from
river mud [10]. Originally thought to be bacteria, it was identified that these methanogens
were capable of growing in inorganic medium with only simple carbon sources as their
sole source of carbon and energy. These microbes would continue to be a curiosity in the
microbial community and would become the focus of Dr. Carl Woese, who would use the
ribosomal RNA sequence of methanogens as the foundation of archaea as an independent
domain of life [4, 11].
Often called “The Third Domain,” archaea represent life at its most primitive and
diverse. To call archaea the Third domain however is somewhat of a misnomer as these
organisms are some of the most evolutionarily ancient beings still in existence [12].
Methanogenic archaea have been identified in environments spanning the boundaries of
life sustaining conditions, from acidic to alkaline (pH 3.0-10.2), thermophilic to
psychrophilic (-2°C to 110°C), and including both fresh and saline aquatic environments
[13]. Currently methanogens are of most interest due to their production of methane, both
because of their ecological impact as a byproduct of agricultural production in livestock
[14] and rice cultivation [15] and their use as a renewable source of natural gas [16, 17]
as well as a high energy fuel source for rocket engines [18, 19].
Methanogen metabolism:
Despite their diversity of environments, methanogens are united by their unique
central metabolism. All known methanogens are strict obligate anaerobes and produce
methane as the primary byproduct of their central respiration [3]. As mentioned above,
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methanogens grow in these anaerobic environments by the reduction of one carbon (C1)
compounds including carbon dioxide and carbon monoxide, methanol, methylamines,
and methyl sulfides as well as acetate [20-22]. It has also been demonstrated recently that
coal and long-chain alkanes can be utilized as a methanogenic substrates [23-27]. To
grow on these energy poor substrates methanogens have adopted a highly efficient central
respiratory pathway known as the Wolfe Cycle [6]. In the five best characterized versions
of this pathway substrates are reduced to methane while formate, primary and secondary
alcohols, or H2 are oxidized to CO2 with the assistance of the electron carrying molecules
Coenzyme M and Coenzyme B [20, 28]. Cofactors associated with the Wolfe cycle are
regenerated via a transmembrane ion gradient which also serves to produce ATP for the
methanogen via ATP synthase [29, 30]. These reactions yield a very small amount of
energy for the methanogen and as a result the methanogens only obtain between 0.5 and 2
moles of ATP per mole of substrate [20]. A result of this low energy yield is a higher
focus on respiration in methanogens than any other organism with over 99% of the
chemistry within the cell being directly tied to the Wolfe Cycle. This focus on central
respiration makes methanogens an ideal organism for the production of renewable
biofuels as the vast majority of feed substrate is converted efficiently to methane. It
should be noted, however, that while the Wolfe Cycle is highly conserved and
exceedingly efficient, it can also be modified to better serve biotechnological goals
without undermining the proficiency of methanogenic growth. In this dissertation we will
explore the metabolic flexibility of methanogens as well as the potential for their
application in biotechnology. For example, by overexpressing the cytoplasmic enzyme
complex heterodisulfide reductase (HdrABC), methane production in methanogens

5

grown on methanol has been shown to produce 30% extra methane without a detectable
change in growth rate compared with a non-modified strain [31]. Additionally, it is
possible that the regeneration of methanogenic cofactors may be more flexible in their
regeneration than initially thought [32]. If a methanogen were to be engineered to
produce a non-native metabolite where the formation of which allows for the
regeneration of ferredoxin, F420, coenzyme M or coenzyme B then production of that
metabolite has the potential to increase the rate of methanogenesis while also producing
the desired product [32].
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Figures and legends:

Figure 1: The global carbon cycle divided into aerobic and anaerobic segments. Large
macromolecules are developed in the anaerobic portion of the carbon cycle through a
series of methylotrophic and carbon fixing reactions leading to complex organic biomass.
Decomposing organic biomass is fermented into its most basic 1- and 2-carbon forms
anaerobically. 1- and 2- carbon compounds are utilized by methanogens and bioconverted
into gaseous methane which returns to the aerobic segment of the carbon cycle (N. Buan).
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Chapter 2: Insights into the biotechnological potential of
methanogenic archaea
This chapter to be submitted for publication
Abstract
Methanogens are anaerobic archaea which conserve energy by producing
methane. Found in nearly every anaerobic environment on earth, methanogens serve
important roles in ecology as the bedrock of the global carbon cycle and in industry as a
source of renewable biofuels. Environmentally, methanogens play an essential role in the
reintroducing unavailable carbon to the carbon cycle by anaerobically converting lowenergy, terminal metabolic degradation products such as one- and two-carbon molecules
into methane which then returns to the aerobic portion of the carbon cycle. In industry,
methanogens are commonly as an inexpensive source of renewable biofuels as well as
serving as a vital component in the treatment of wastewater though this is only the tip of
the iceberg for their metabolic potential. In this review we will discuss how
methanogens’ efficient central metabolism and isoprenoid membranes open the door to
future biotechnology applications.

Methanogen ecology and diversity
Methanogens are single-celled organisms that conserve energy via the conversion
of substrate carbon compounds into methane gas [1]. This gaseous methane then bubbles
back into the aerobic world where it is consumed by methanotrophic organisms and is
returned to the carbon cycle. Currently the methane produced by methanogens is of

12
interest due to methane’s ecological impact resulting from agricultural production by
livestock [2] and rice cultivation [3] as well as methane’s benefits as a renewable source
of natural gas [4, 5] which is a high energy fuel used for heat, electricity generation, and
for transportation including for rocket engines [6, 7]. Methanogenic archaea have been
identified in environments spanning the boundaries of life sustaining conditions, from
acidic to alkaline (pH 3.0-10.2), thermophilic to psychrophilic (-2°C to 110°C), and
including both fresh and saline aquatic environments [8]. In addition to these
environments, Methanogens are found symbiotically communing in a wide range of
single- and multi-cellular hosts ranging from amoebae [9] and protozoa [10] to the guts of
termites [11, 12], bovine [13], and humans [14, 15]. The ability for methanogens to thrive
in these wildly diverse environments is testament to their metabolic robustness.
Regardless of the environment they inhabit, methanogens share a similar metabolic niche,
the bioconversion of low-energy substrates into biomass and high-energy molecules at a
high degree of efficiency. The average macromolecular composition of a methanogen
includes 63% protein, 0.1% Fatty acid lipids, 5% isoprenoid lipids, 0.5% carbohydrates,
28% nucleic acids, and 4% metabolites and metabolic precursors [16]. The relatively high
abundance of isoprenoid lipids and protein concentration make them am appealing source
of difficult to synthesize lipids and molecules, something which can be further enhanced
through genetic engineering. In this review we discuss how methanogen metabolism
allows them to thrive under strict energetic conditions and how those special metabolic
features can be utilized in biotechnology.
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Expanding the Wolfe Cycle of methanogenesis
Despite a wide diversity of habitats, methanogens are united by their unique
central metabolism. All known methanogens to date are strict obligate anaerobes and
produce methane as an essential byproduct of metabolism [1]. As mentioned above,
methanogens grow in anaerobic environments by the reduction of one carbon (C1)
compounds including carbon dioxide and carbon monoxide, methanol, methylamines,
and methyl sulfides as well as acetate [17-19]. It has also been demonstrated that coal can
be utilized as a methanogenic substrate [20]. To grow on these energy poor substrates
methanogens have adopted a highly efficient central respiratory pathway known as the
Wolfe Cycle [21] (Figure 1). In the five characterized versions of this pathway substrates
are reduced to methane while formate, primary alcohols/amines/thiols, or H2 are oxidized
to CO2 [17, 22]. In most methanogens, redox cofactors associated with the Wolfe cycle
are regenerated through formation of a transmembrane ion gradient which is coupled to
ATP synthesis via ATP synthase [23, 24]. These reactions yield a very small amount of
energy for the methanogen only amounting to between 0.5 and 2 moles of ATP per mole
of substrate [17]. A result of this low energy yield is a high relative flux through
respiration with over 99% of the chemistry within the cell being directly tied to the Wolfe
Cycle. This focus on central respiration makes methanogens an ideal organism for the
production of renewable biofuels as the vast majority of feed substrate is converted
efficiently to methane.
Methanogens are involved in more than just the degradation of terminal
fermentation products. In nature methanogens form syntrophic partnerships with other
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microorganisms such as hydrocarbon-degrading bacteria facilitating the reintroduction of
crude oil carbon into a bioavailable state [25-27]. It has recently been discovered from
ecological methane accumulation and the abundance of single cell cultures attached to oil
droplets in deep-sea oil seeps that methanogens are be capable of alkane oxidation
independent of any other archaeal or bacterial partner [28, 29]. These alkane utilizing
methanogens are not limited to short-chain alkanes; amongst these alkane degrading
methanogens is Candidatus methanoliparum which has been shown to incorporate the
degradation of long-chain hydrocarbons with methanogenesis [30]. The methanogens
associated are found widely distributed [26, 28, 30], indicating that methanogens are
involved in the bioconversion of crude oil to methane on a large scale and may serve a
benefit to bioremediation efforts in anaerobic environments such as deep-sea sediments.
It should be noted, however, that while the Wolfe Cycle is highly conserved and
exceedingly efficient, it can also be modified to better serve biotechnological goals
without undermining the proficiency of methanogenic growth. By overexpressing the
cytoplasmic enzyme complex heterodisulfide reductase (HdrABC), methane production
in methanogens grown on methanol has been shown to produce 30% extra methane
without a detectable change in growth rate compared with a non-modified strain [31].
Additionally, it is possible that the regeneration of methanogenic cofactors may be more
promiscuous than initially thought [32]. If a methanogen were engineered to produce a
non-native metabolite where the formation of which allows for the regeneration of
ferredoxin, F420, coenzyme M or coenzyme B then production of that metabolite has the
potential to increase the rate of methanogenesis while also producing the desired product
[32]. Due to the tight energetic restrictions central methanogenesis is a highly streamlined
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and is proposed to rely heavily on substrate channeling to minimize entropic effects [31].
This substrate channeling allows for the Wolfe Cycle to function efficiently but presents
challenges for metabolic engineers as the metabolite pools for central methanogenesis
have limited availability outside of the channeled enzyme complexes. To overcome this
metabolic obstacle metabolic engineers must choose products which draw from
metabolites which are not directly channeled or incorporate the production of their
products within the existing exchange of carbon and electrons within the Wolfe Cycle.
There are ways of making methanogens more amenable to modification and we have
complied a list of starting points for those eager to expand methanogen utilization under
novel conditions or applications (Table 1).

Anaerobic oxidation of methane and reverse methanogenesis
Given the efficiency of methanogenesis and the abundance of anaerobic
environments around the world, methanogens are distributed across every continent. Yet
of the approximately 1 billion tons of methane produced by methanogens in the wild each
year in anaerobic and microanaerobic environments, roughly half escapes into the aerobic
space of the carbon cycle [33]. The remainder of this methane is either trapped within this
anaerobic space (as gas or methane gas hydrates) or oxidized by methanotrophic archaea
and sulfate-reducing bacteria [34, 35]. Previously it was believed that the anaerobic
oxidation of methane (AOM) was possible through the symbiotic exchange of
metabolites and electrons between the methanotrophic archaea and the sulfate reducers
[36, 37]. Within this process anaerobic methane-oxidizing archaea (ANME) consisting of
methanomicrobiales (ANME-1) and methanosarcinales (ANME-2 and ANME-3) form
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granular aggregates with delta-proteobacteria in which electrons are transferred from the
via multi-haem cytrochromes [38]. Metabolic modeling has suggested that iron and
sulfate can be co-substrates in AOM [39] and 16S rRNA gene-sequences for Candidadus
Methanoperedens correlated with increased AOM in sulfate-rich anoxic sediments
suggesting the occurrence of AOM independent of a bacterial partner[40]. In laboratory
conditions it was found that trace amounts of AOM was observed in
Methanothermobacter marburgenis [41] and Methanosarcina acetivorans [42] though it
was not observed that these strains were able to use methane as the major source of
carbon and energy for growth. However, by scouring the metagenomes of unculturable
ANME-1 samples from aquatic regions with high amounts of AOM, a novel gene for
methyl-coenzyme M reductase (Mcr) was discovered which facilitated AOM without the
need for a syntrophic sulfate-reducing partner [43, 44]. As every step of methanogenesis
is reversible, reverse methanogenesis is theoretically possible for any methanogen though
under most conditions these reactions are non-energy yielding [21]. When the novel
ANME-1 Mcr was introduced into M. acetivorans it was found that isotope labeled
methane was converted into acetate while also facilitating growth [45]. Furthermore,
methanogen strains containing this ANME-1 Mcr gene can be utilized along with a
consortia of microbes including Geobacter sulfurreducens to produce electricity in a
microbial fuel cell utilizing only methane as a substrate [46]. These observations indicate
that the bidirectionality of the Wolfe Cycle, particularly in Methanosarcina spp. enables
the potential for an alternative utilization of methanogens: the bioconversion of C1
substrates into stable to transport fuels and high-value chemicals. For example: a
Methanosarcina culture which has been engineered to produce a high-value terpenoid
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product is grown using methyl compounds until stationary phase is achieved and biomass
accumulation is no longer necessary; this culture could then be induced to produce the
terpenoids utilizing potentially any C1 compound or mixtures of compounds including
CO, CO2, or CH4 based on substrate availability. This potential extends beyond the
production of secreted products, as the biomass of methanogens itself can be utilized as a
source of valuable lipids.

Potential for engineering the lipid membrane biosynthesis pathway as a valorization
strategy
Methanogen membranes, like those found in all archaea, are distinct from those
found in bacteria and eukarya. In bacterial and eukaryotic organisms lipid membrane
structures are composed of fatty acid chains ester liked to glycerol-3-phosphate (G3P)
[47]. Archaeal lipids membranes instead utilize isoprenoid alkyl chains ether linked to
glycerol-1-phosphate (G1P) (Figure 2) [47, 48]. This fundamental differentiation in
membrane composition is the basis of the so called ‘lipid divide’ separating archaea from
the other two domains of life [49]. Given the high quantity and the molecular uniformity
of lipid membranes by weight, comprising on average 5% of total methanogen dry weight
[16], and the relatively high metabolic flux through the pathway, isoprenoid lipid
biosynthesis pathway is an attractive target to engineer for producing high-value
chemicals. The isoprenoid lipids used by archaea are highly adaptable and allow for
archaea to tolerate a wide range of environmental stressors. The most abundant of
archaeal lipid structures are archeol, consisting of a pair of phytanyl chains ether linked
to G1P and caldarcheol, a cyclic dimer of archeol. Caldarcheol is of particular
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biotechnological interest as the cyclized tetraether lipids maintain cellular homeostasis in
the presence of extreme pH and thermal stress [50, 51]. Archaeal ether linked lipids are
more stable than ester linked membranes when exposed to extremes of pH and thermal
conditions, and the unique monolayer structure of tetraether linked lipids imparts
resistance to degradation to phospholipases [52]. These stable properties and the intrinsic
monolayer formed by caldarcheol represents an enticing alternative to traditional
phospholipids in liposome-based commercial applications. One such application is in the
delivery of chemotherapeutic compounds via archaeal derived liposomes. It has been
found that tetraether linked artificial liposomes reduce leakage of chemotherapeutic
compounds by 9-fold compared to conventional eukaryotic derived liposomes, which
results in a lower dose required for therapeutic effects [53]. The archaeal liposomes
themselves also contribute therapeutic effects as archaeal liposomes utilized to transport
vaccine components induce robust antigen specific humoral and cellular immune
responses exceeding those found from traditional delivery mechanisms [54-57].
In addition to the direct application of archaeal lipids, the high metabolic flux
through isoprenoid producing pathways in methanogens presents an opportunity for lowcost production of terpene compounds. Terpenes are the largest class of natural
compounds and have a wide range of commercial applications. Odorant terpenes such as
limonene, eucalyptol, and linalool are cornerstones for the $29B flavor and fragrance
industry [58]. In addition to odorants, terpenes are often the active compound in
pharmaceuticals including the anti-cancer drug paclitaxel and the antimalarial
artemisinin. Hundreds of natural terpenes have shown promising bioactivity [59-63] yet
are limited in application due to their availability. Many of these terpenes are currently
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harvested from their native plant, fungal, and marine producers which are limited by the
endogenous expression levels which are prohibitively low [64-66] or non-renewably
synthesized from petroleum precursors. Organically produced terpenes are primarily
produced via compounds derived from one of two isoprenoid synthesis pathways, the
mevalonate (MVA) pathway and the deoxyxylose 5-phosphate (DXP) pathway [67].
These pathways in non-archaeal organisms suffer low carbon flux and depletion of
precursors towards non-target compounds [68-70]. Archaea, however, synthesize the
majority of their lipid compounds through the mevalonate pathway, accounting for a
much higher flux through that pathway [71-73]. As such there is a higher abundance of
metabolic precursors available for the synthesis of isoprenoid and terpene products
without the need to preoptimize engineered strains for substrate availability. Concerns
over the depletion of these membrane precursors have been alleviated by the synthesis of
mono-isoprene from engineered strains of Methanosarcina acetivorans and
Methanosarcina barkeri [32, 74]. These strains demonstrated that methanogens are able
to handle the metabolic burden of membrane substrate depletion without a decrease in
growth rate or final carrying capacity, opening the door for further isoprenoid products to
be produced (Table 2. Possible terpenoids to be produced by methanogens based on
category) The expression of genes associated with terpenoid production can also be
associated with inducible promoters to activate new pathways when cells hit stationary
phase, so that expression doesn’t interfere with populating the bioreactor. One challenge
is that some terpenes require molecular oxygen for complete biosynthesis and this might
be difficult for anaerobic organisms to achieve. However, Methanosarcina acetivorans is
remarkably oxygen-tolerant and it is possible to further enhance through engineering or
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adaptation [75, 76]. These papers indicate it is feasible to use O2 availability as a
biosynthetic inducer during the terpene fermentation process with oxygen-tolerant
methanogens.

Benefits and challenges of methanogen biotechnologies
The use of methanogens in bioproduction is beneficial in a myriad of ways
including ease of selection, low cost of media, and flexibility of products. Methanogens
have been shown to be an excellent source of metabolically active compounds such as the
Coenzyme M (CoM) which acts as a potent chemotherapy adjuvant as the drug mesna
[77]. As methanogens grown in environments lacking in O2, they are able to produce
novel precursors with chirality which could later be utilized by chemists with custom
oxidation steps and subsequent functionalization. In large scale industrial fermentations
pure aseptic environments are difficult to maintain, and often media and growth
conditions are utilized to ensure continuous selection during the fermentation [78, 79].
Methanogens circumvent this issue by growing in selective environments free of oxygen
using substrates that cannot be used for the majority of common contaminating factors
such as lactic acid bacteria and fungi [80, 81]. Methanogens are prototrophic organisms,
able to synthesize all vitamins and cofactors required for growth from inorganic material,
allowing for additional selection by limiting available vitamins and nutrients required for
contaminating growth by exclusion [17, 21, 82]. While viral predation on methanogens
has been observed [83] there is little evidence that these methanophage particles have a
substantial effect on methanogenic digestor performance as viral titers did not correlate
with a significant decrease in methane output and methanogen carrying capacity. Another
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major challenge in industrial fermentations is the large amounts of fresh water required
for E. coli or yeast [84]. Methanogens however thrive in environments with high salt
concentrations, allowing for the utilization of seawater in fermentations. Non-sterile
hypersaline environments such ocean water and hydraulic fracking fluids have been
demonstrated to select for methylotrophic methanogens such as Methanohalophilus,
Methanohalobium, and Methanosarcina spp. while also presenting a high concentration
of non-competitive substrates such as methylamines [85, 86]. Methanogens are utilized
worldwide for the production of renewable biogas in non-selective environments with
high degrees of contamination such as municipal and agricultural wastewater treatment.
In these environments methanogens are exposed to a wide variety of stressors including
dramatic shifts in ammonia, osmotic shifts, and exposure to heavy metals [90]. Many
methanogens are natively capable of withstanding these stressors [87] though as stated
above, using genetic tools it is possible to stack these traits onto a single methanogen
strain to gain the maximum benefit from a single organism.

Conclusions
Methanogens are biologically important organisms with a wide-reaching impact
both in ecological and biotechnological applications. Their extremely efficient central
metabolism makes them an ideal source of renewable biofuels that can be captured
through anaerobic digestion or fermentation processes. They are able to grow
prototrophically with inexpensive feedstocks and can produce endotoxin-free protein,
carbohydrates, and valuable isoprenoid lipids. Their unique membrane composition can
be used to expand the biotechnological toolbox for the delivery of chemotherapeutics as
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well as source for novel terpene compounds previously not available via conventional
extraction means. By continuing to investigate the molecular, genetic, and synthetic
biology potential of these unique organisms, researchers may unlock a wide range of
applications from environmental and ecological management, renewable energy,
agriculture, chemical manufacturing, and pharmaceutic industries.

23
Figures and legends:

Figure 1: The Wolfe Cycle of methanogenesis[17]
The direction of arrows represents the direction of biochemical reactions.
Reactions which are utilized in every methanogenic pathway are represented in black.
Hydrogenotrophic methanogenesis is represented in red. Methyl respiration is represented
in orange. Methylotrophic methanogenesis is represented in green. Acetoclastic
methanogenesis is represented in fuchsia. Degradation of polyaromatic hydrocarbons is
represented in dark blue [88]. Ethylene and long chain alkane reduction is represented in
purple [89]. Carboxydotrophic methanogenesis is represented in cyan. CoB-SH,
coenzyme B thiol; CoM-SH, Coenzyme M thiol; CoM-S-S-CoB, coenzyme M-coenzyme
B heterodisulfide; Fd, ferredoxin; Fdred, reduced ferredoxin; H4MPT,
tetrahydromethanopterin; MFR, methanofuran; MPh, methanophenazine; MPhH2,
reduced methanophenazine. Enzymes involved in the Wolfe Cycle: a) Formylmethanofuran dehydrogenase (Fmd), b) Formyl-methanofuran:H4MPT formyl transferase
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(Ftr), c) Methenyl-H4MPT cyclohydrolase (Mch), d) F420-dependent Methylene-H4MPT
dehydrogenase (Mtd), e) F420-dependent Methylene-H4MPT reductase (Mer), f) MethylH4MPT:coenzyme M methyltransferase (Mtr), g) Methyl-coenzyme M reductase (Mcr),
g*) Atypical methyl-coenzyme M reductase (Mcr) [90], h) Electron-bifurcating
hydrogenase:heterodisulfide reductase complex (Mvh:HdrABC), i) F420-reducing
hydrogenase (Frh), j) Energy-converting sodium pumping ferredoxin hydrogenase, k)
Ferredoxin reducing hydrogenase (Eha/Ech), l) Proton-translocating
methanophenazine:heterodisulfide reductase (HdrED), m) Sodium–proton antiporter
(MrpA), n) F420 proton-pumping methanophenazine reductase (Fpo).
Table 1. Expanding the metabolic potential of the Wolfe Cycle
Desired Trait

Potential mechanism

Increased methanogenesis

Overexpression of genes associated with the Wolfe Cycle.

and methane production.

Research has shown that overexpression of redox-active
cofactors such as methanophenazine relieves the metabolic
bottleneck caused by cofactor regeneration and increases
the production of methane [31].

Increased substrate uptake

In methylotrophic methanogenesis entry point the Wolfe

rates.

Cycle is limited by the substrate-specific methyltransferase
whereas hydrogenotrophic methanogens rely upon
membrane bound methyltransferase to conserve energy and
maintain the methanogens sodium motive force[91]. By
overexpressing endogenous methyltransferases and
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hydrogenases more substrate carbon can enter
methanogenesis.

Increased substrate

Substrate entry into the Wolfe Cycle is limited by substrate

diversity.

specific methyltransferases and whether the methanogen
can directly utilize H2 as an electron source. By introducing
methyltransferase from different methanogens Introduction
of methyltransferase genes from multiple methanogens one
can expand the substrates usable to the methanogen.
Additionally, the introduction of EcH hydrogenase should
allow for organisms incapable of hydrogenotrophic
methanogenesis to utilize H2 and CO2 as a carbon and
energy source. By stacking these traits it is possible to
maximize methanogenic efficiency in mixed substrate
environments such as the treatment of waste biomass.

Increased stress resistance

All methanogens are strict anaerobes, though it has been
found that Methanosarcina spp. are the most oxidanttolerant [76]. Increased oxygen tolerance was observed in
Methanosarcina acetivorans when gradually passaged with
increased O2 concentrations over a course of 6 months [75].
Transcripts from adapted Methanosarcina suggest the over
expression of superoxide dismutase, catalase, and
peroxidase will confer increased aerotolerance to other
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methanogens. Cocultivation with sulfate reducing bacteria
has shown to mitigate heavy metal stress in methanogenic
cultures [92]. The introduction or overexpression of the
betaine transporter from Methanosarcina thermophila TM-1
increases internal ionic balance conferring protection
against osmotic stress [87]. Additionally, it has been noted
that under high ammonia conditions which inhibits
aceticlastic methanogenesis, the addition of magnetite
reduces inhibition [93].

Table 2. Possible terpenoids to be produced by methanogens based on category.

Terpene name

Terpene class

Isoprene

Hemiterpene

Synthesis Enzyme

Substrate

Isoprene synthase

Dimethylallyl

(4.2.3.27)

pyrophosphate

(2E,6E)-farnesyl

Dimethylallyl

pyrophosphate

diphosphate

pyrophosphate

(GPP)

synthase

Geranyl

Monoterpene

Structure

(2.5.1.10)
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Geraniol

Linalool

Ocimene

Monoterpene

Monoterpene

Monoterpene

Geraniol synthase

Geranyl

(3.1.7.11)

diphosphate

S-linalool synthase Geranyl
(4.2.3.25)

diphosphate

(E)-beta-ocimene

Geranyl

synthase

diphosphate

(4.2.3.106)
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Myrcene

Sabinene

Monoterpene

Myrcene synthase

Geranyl

(4.2.3.15)

diphosphate

Bicyclic

(+)-sabinene

Geranyl

Monoterpenoid

synthase

diphosphate

(4.2.3.110)

Pinene

Bicyclic

Pinene synthase

Geranyl

Monoterpenoid

(4.2.3.14)

diphosphate
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Farnesyl

Acyclic

Farnesyl

Dimethylallyl

diphosphate

Sesquiterpenoid

diphosphate

diphosphate and

synthase (2.5.1.1)

isopentenyl
diphosphate
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Farnesol

Acyclic

Farnesyl

Farnesyl

Sesquiterpenoid

diphosphatase

diphosphate

(3.1.7.6)

Nerolidol

Acyclic

(3S,6E)-nerolidol

Farnesyl

Sesquiterpenoid

synthase (4.2.3.48)

diphosphate
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Farnesene

Acyclic

Alpha-farnesene

Farnesyl

Sesquiterpenoid

synthase (4.2.3.46)

diphosphate

and beta-farnesene
synthase (4.2.3.47)

Humulene

Monocyclic

Alpha-humulene

Farnesyl

Sesquiterpenoid

synthase

diphosphate

(4.2.3.104)
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Bisabolene

Zingiberene

Monocyclic

Alpha-bisbolene

Farnesyl

Sesquiterpenoid

synthase (4.2.3.38)

diphosphate

Monocyclic

Zingiberene

Farnesyl

Sesquiterpenoid

synthase (4.2.3.65)

diphosphate
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Curcumene

Monocyclic

Gamma-

Farnesyl

Sesquiterpenoid

curcumene

diphosphate

synthase (4.2.3.94)

Amorphadiene

Bicyclic

Amorpha-4,11-

Farnesyl

Sesquiterpenoid

diene synthase

diphosphate

(4.2.3.24)

Valencene

Bicyclic

Valencene

Farnesyl

Sesquiterpenoid

synthase (4.2.3.73)

diphosphate
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Figure 2: Comparison between lipid structures of bacterial and archaeal lipids.
Glycerol molecules are shaded in orange. Phosphate groups are shaded in cyan. The
isoprenoid subunits which make up the archaeal lipids are highlighted in green brackets.
Fully saturated lipids are shown; organisms may produce versions of unsaturated alkane
lipids with multiple double bonds.
Table 3. Benefits and Challenges of methanogen biotechnology
Benefits

Challenges

Methanogens are some of the fastest-

Strain differences in growth rate and

replicating organisms, particularly

carrying capacity. Growth is flux-

members of Methanococcus [94-96] and

controlled depending on substrate feed

Methanopyrus [97] genus.

rates. Gas-phase fermentation presents
similar problems as oxygenation in
traditional fermentations [5, 78, 84]
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Methanogens can grow on inexpensive

Process disfavors growth of aerobic

substrates including negative value

pathogens. Co-product can be water

substrates such as wastewater[1, 17, 18,

ready for discharge to aquifers and

23, 85, 98-100].

waterways.

Methanogens already scaled up worldwide
for water treatment and biogas production
Can be coupled directly or indirectly to

Surface-to-area, substrate solubility, and

electrodes for carbon capture by

other challenges commensurate with

electrosynthesis or for electricity

microbial fuel cell technologies.

generation from biomass [101].
Oxygenation not required. Can grow on

Methanogens require specialized culture

non-gas substrates. No contamination by

environments to maintain anaerobicity

aerobic organisms.

[17, 102, 103].

Mesophilic and thermophilic strains

Methanogen chassis organisms may need

available to tailor to the desired product

different optimization strategies

and process needs
Novel metabolic pathways being

Methanogen biochemistry less

constantly discovered [17, 20, 23, 30, 86,

characterized than other model

98, 99, 104]. Synthetic biology pathways

organisms.

often use methanogen genes to improve
yields and reduce feedback inhibition.
Bacterial synth bio and genetic strategies
work in methanogens.
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Methanogens have a high substrate to

High titers of intracellular products may

volume ratio with low accumulation of

be difficult to obtain unless accumulated

biomass relative to products [1, 17, 105].

into vacuoles or secreted extracellularly

Multiple validated genetic tools available

Variability in genome copy number can

including tools for Methanosarcina SPP.

present challenges when performing

[106-108], Methanococcus maripaludis

chromosomal modifications [32, 113].

[109, 110], Methanopyrus kandleri [111],
and Methanothermobacter
thermautotrophicus [112]
The lack of cell wall and envelope ensures
that products generated through
methanogen fermentations are not
contaminated with peptidoglycan or
endotoxin.
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Abstract
Isoprene is a valuable petrochemical used for a wide variety of consumer goods,
such as adhesives and synthetic rubber. We were able to achieve a high yield of
renewable isoprene by taking advantage of the naturally high-ﬂux mevalonate lipid
synthesis pathway in anaerobic methane-producing archaea (methanogens). Our study
illustrates that by genetically manipulating Methanosarcina species methanogens, it is
possible to create organisms that grow by producing the hemiterpene isoprene. Mass
balance measurements show that engineered methanogens direct up to 4% of total carbon
ﬂux to isoprene, demonstrating that methanogens produce higher isoprene yields than
engineered yeast, bacteria, or cyanobacteria, and from inexpensive feedstocks.
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Expression of isoprene synthase resulted in increased biomass and changes in gene
expression that indicate that isoprene synthesis depletes membrane precursors and
redirects electron ﬂux, enabling isoprene to be a major metabolic product. Our results
demonstrate that methanogens are a promising engineering chassis for renewable
isoprene synthesis.

Introduction
Isoprene (2-methyl-1,3-butadiene, C5H8) is a valuable chemical used to
synthesize synthetic rubber, styrene-isoprene-styrene (SIS block) copolymer
adhesives, ﬂavorings, cosmetics, and pharmaceuticals. Approximately 800,000 tons
of isoprene is reﬁned from petroleum annually, in which over 95% of it is used to
produce cis-1,4-polyisoprene (synthetic rubber) (1). The global market for isoprene,
including natural and synthetic polyisoprene rubber, is estimated at 1.3 metric tons per
year, at a value approaching $4.3 billion (2). Cost-effective, high-yield synthesis of
renewable isoprene from biomass feedstocks has the potential to supplant the need for
petroleum-derived isoprene and would contribute to reducing use of fossil fuels.
monomer or isoprenoid lipids can be naturally synthesized by various species of plants
and microbes (3–5). It is estimated some plant species channel up to 10% of total ﬁxed
carbon into isoprene, which transpires through photosynthetic tissues (6).
To obtain industrial quantities of renewable isoprene, synthetic biologists have
introduced the isoprene synthase ispS gene from plants into microbial host organisms
such as Escherichia coli (3, 7), Saccharomyces yeast (8, 9), and Synechocystis
cyanobacteria (10). Synthesis of isoprene by engineered microbes or algae is
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advantageous over natural plant isoprene synthesis because microbes can be grown in
enclosed bioreactors that facilitate isoprene recovery from the gas phase. Because the
isoprene monomer has a low vapor point (35°C) and evaporates rapidly at room
temperature, it can be easily captured from the gas phase of a microbial culture. While
efforts to engineer isoprene monomer synthesis using microbes have been successful at
small scales, there are remaining issues with cost of production and yield optimization
(11). Three factors limit industrial-scale renewable isoprene technologies: scale-up
development costs, production costs, and metabolic ﬂux of the chassis organism. We
hypothesized that using methane-producing archaea as a chassis could simultaneously
solve all three of these limiting factors.
Methane-producing archaea (methanogens) are strict anaerobes that use gaseous
or liquid C1 substrates or acetate to grow, converting 60 to 99% of C to pure methane gas
(12). Technologies for growing methanogens at industrial scale are already well
established (13). Methanogens are currently used in large-scale anaerobic digesters
worldwide, where waste biomass is used to produce methane-containing biogas that is
recovered, upgraded, and compressed to be used to generate electricity and transportation
fuel. Production costs for methanogen-based technologies are also very low. When
cultivated in anaerobic digesters at large scale, methanogens do not require light or
aeration, and substrates for methanogenesis (CO, CO2, methanol, acetate, etc.) are
inexpensive and abundant. Methanosarcina species have been coaxed to grow on other
substrates (14), to synthesize bioproducts such as lactate in the reverse methanotrophic
direction (15), and to increase tolerance to oxygen exposure (16, 17). Hydrogenotrophic
Methanococcus strains have also been engineered to produce geraniol, a monoterpene
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derived from the mevalonate pathway for use as a fragrance (Table 1). Combined with an
expanding list of available genetic tools, methanogens are emerging as viable chassis for
bio-product synthesis from inexpensive feedstocks. Due to the low feedstock cost, high
yield, and existing anaerobic digestion infrastructure, methanogens have the potential to
be an efﬁcient and adaptable platform for renewable isoprene synthesis.
The substrate for the isoprene synthase enzyme, IspS, is dimethylallyl
pyrophosphate (DMAPP), an isomer of isopentenyl diphosphate (IPP) (3). IPP/DMAPP is
synthesized by one of two known biochemical pathways, the 2-C-methyl-D-erythritol 4phosphate/1-deoxy-D-xylulose 5-phosphate (MEP/DOXP) pathway or the mevalonate
pathway (Fig. 1). The two pathways differ in starting substrates (the branch point from
central metabolism), enzyme steps, substrate intermediates, and energetic requirements,
particularly due to a variation in the conversion of mevalonate to IPP. The MEP/ DOXP
pathway is primarily used by bacteria, while the mevalonate pathway is used by
eukaryotes and archaea. The MEP/DOXP pathway uses 8 enzymes, 2 NADPH, 2 CTP,
ATP, and reduced ferredoxin (2 e–) to produce DMAPP from pyruvate. The mevalonate
pathway used by eukaryotes and archaea requires 2 or 3 ATP and 2 NADPH (18–21).
Using the MEP/DOXP pathway results in a substrate pool IPP:DMAPP ratio of 5:1, and
thus isoprene synthesis using this pathway also necessitates increased activity of
isopentenyl diphosphate isomerase idi (22). The mevalonate pathway uses seven or eight
enzymes to synthesize DMAPP from acetyl-CoA and results in a more favorable IPP:
DMAPP ratio of 3:7. It has been found in previous attempts to produce isoprenoids at an
industrial scale that the mevalonate pathway produces superior yields (23). The yeast
Saccharomyces cerevisiae has been engineered to synthesize isoprene; unfortunately,
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isoprene yields were low because eukaryote enzymes are feedback-inhibited (24, 25).
Thus, efforts to increase ﬂux through the mevalonate pathway to increase isoprene yields
by manipulating intracellular substrate pools are unsuccessful unless archaeal enzymes,
which are resistant to feedback inhibition, are used (26–28). Methanogens, in contrast,
already grow on inexpensive feedstocks (CO2, CO, C1 compounds, acetate) that are 3 to
20x less expensive than glucose, do not require illumination or aeration, and naturally
direct 5% of biomass to isoprenoid lipid synthesis (Table S1 in the supplemental material)
(29). We surmised that so long as they are still able to synthesize isoprenoid lipid
membranes for growth, methanogens may be able to produce renewable isoprene in high
yields due to their inherently high metabolic ﬂux through the archaeal mevalonate
pathway (Fig. 1). The purpose of our study was to test whether Methanosarcina can be
used to synthesize isoprene from C1 substrates and acetate.

Methods
Anaerobic techniques
Anaerobic procedures were performed in a custom B-type Coy anaerobic chamber
(Coy Labs, Grass Lake, MI). Internal environment of the chamber is maintained at 5%
H2/20% CO2/75% N2 (6 3%) (Matheson Gas, Lincoln, NE). Cells incubated outside the
anaerobic chamber are contained in glass Balch tubes secured with butyl rubber stoppers
(Belco Glass, Vineland, NJ) and aluminum crimps (Wheaton, Millville, NJ).
Methanogen cell culture
Cells listed in Table 4 were grown in anaerobic high-salt (HS) medium (200 mM
NaCl, 45 mM NaHCO3, 13 mM KCl, 54 mM MgCl2·6H2O, 2 mM CaCl2·2H2O, 2 mM

57

0.1% resazurin [w v21], 5 mM KH2PO4, 19 mM NH4Cl, 2.8 mM cysteine·HCl, 0.1 mM
Na2S·9H2O, trace elements, vitamin solution) (47) supplemented with a carbon and
energy source (methanol, 125 mM; trimethylamine, 50 mM; sodium acetate, 120 mM)
and 2 mg liter-1 puromycin as needed (48, 49). 3-(N-morpholino)propanesulfonic acid
(MOPS) high-salt medium (MHS) was created by substituting 45 mM NaHCO3 with 50
mM MOPs buffer (50). Cells in liquid medium were incubated at 35°C without shaking.
For growth on solid medium, 1.4% agar was added to HS medium. All chemicals and
reagents were sourced from Millipore Sigma (St. Louis, MO) or Thermo Fisher Scientiﬁc
(Waltham, MA).
Cloning and genetic techniques
Methods for genetic manipulation of M. acetivorans have been described
previously (51). All plasmids and primers shown in Table 4 were designed using
VectorNTI software (Thermo Fisher Scientiﬁc, Waltham MA). PCR primers were
synthesized by Integrated DNA Technologies (IDT, Coralville, IA). All plasmids were
veriﬁed by sequencing (Euroﬁns, Louisville, KY). Plasmid pNB730 was used as a parent
vector (31). Key features of pNB730 include: (i) pUC ori for highcopy replication in E.
coli; (ii) φC31 phage recombinase att site for chromosomal insertion of the vector into the
host genome; (iii) resistance to ampicillin for selection during ampliﬁcation in
Escherichia coli; and (iv) puromycin resistance for selection in Methanosarcina spp. The
cDNA sequence of ispS was obtained from NCBI (locus BAD98243, gi: 63108310) from
the isoprene-producing poplar plant, Populus alba (30). The P. alba ispS gene was codonoptimized for translation in archaea and inverted repeats were removed to create sNB19,
which was commercially synthesized by Life Technologies Corporation (Grand Island,

58

NY). PCR ampliﬁcation of synthetic genes designed with predicted chloroplast
localization signal intact or truncated (ispS and ispSΔ1-13) was achieved using the primers
listed in Table 4 with Phusion Flash PCR Master Mix as a proofreading DNA polymerase
(Thermo Fisher Scientiﬁc, Waltham, MA). DNA puriﬁcation was accomplished using
Promega Wizard SV Gel and PCR clean-up kits (Madison, WI). Fast Digest restriction
enzymes (BamHI and Ndel) were purchased from Thermo Fisher Scientiﬁc (Waltham,
MA). DNA fragments were assembled using the sequence and ligation-independent
cloning (SLIC) protocol previously described (52). The synthesized ispS genes were
expressed from the constitutive methyl-CoM reductase promoter (Pmcr) at the pNB730
multiple cloning site. Electroporated E. coli cells were plated on lysis broth (LB) agarose
plates with 100 mg liter-1 ampicillin and colonies were selected after overnight growth at
37°C (53). Plasmids were screened by PCR as described and sequenced (31). Plasmids
were transfected into Methanosarcina spp. cells according to established procedures using
Roche DOTAP liposomal transfection reagent (Roche Diagnostics Corporation,
Indianapolis, IN) (48, 51). Cells transfected with pNB730 lacking ispS were used as a
vector-only control.
Quantitative PCR (qPCR) was used to quantify integrated gene copies of ispS in
the population relative to the unique rpoA1 gene found on each chromosome. Cells were
grown in HS + MeOH medium until late exponential (optical density at 600 nm [OD600] =
0.8) and harvested by vacuum ﬁltration followed by lysis using TRI reagent (SigmaAldrich, St. Louis, MO) according to the manufacturer’s instructions. cDNA was
synthesized with random hexamers (Promega, Madison, WI) using GoTaq 2-step RTqPCR system (Promega, Madison, WI) and the ispS transcript was conﬁrmed by qPCR
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using primers oNB735 and oNB736, listed in Table 4.
Cellular growth measurements
Cell growth rate was determined by measuring culture optical density at 600 nm
using a Spectronic D spectrophotometer (Thermo Fisher Scientiﬁc, Waltham, MA).
Biomass measurements for each strain were obtained as previously described (37).
Pyrophosphate assay
M. acetivorans cell extracts were assayed for isopentenyl pyrophosphate
pyrophosphatase activity using EnzChek pyrophosphate assay kit (Molecular Probes,
Eugene, OR). Brieﬂy, cells were harvested at late exponential phase of growth from a 100
ml culture by centrifugation in a Thermo Fisher Scientiﬁc Sorvall Legend XTR centrifuge
using a TX-750 swinging bucket rotor with 50 ml conical tube adapters at 4,000 x g for 5
min at room temperature. Cell pellets were washed twice using 1 ml of 0.4 M NaCl to
remove spent culture medium. After resuspension, cells were lysed using 9 ml ddH2O and
centrifuged at 10,000 x g in a Thermo Fisher Scientiﬁc Sorvall Legend Micro21 rotor to
pellet cell debris. The resulting supernatant was transferred to a fresh microcentrifuge
tube and kept on ice. Cell lysate was used to test for enzymatic activity of IspS by
following the protocol described by the manufacturer using dimethylallyl diphosphate
purchased from Sigma-Aldrich (St. Louis, MO) as the substrate for the reaction. The
reaction was monitored spectrophotometrically at 360 nm on a Jenway 7305
spectrophotometer (Burlington, NJ).
Methane production assay
Methane in culture headspace was measured by gas chromatography using a ﬂame
ionization detector (GC-FID) as previously described (54). Brieﬂy, 10-ml cultures were
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grown to stationary phase. After growth, 100 μl of headspace was captured using a
gastight Hamilton syringe and transferred to an empty crimped 2 ml autosampler serum
vial (Wheaton, Millville, NJ). Vial contents were analyzed by ﬂame ionization using a
custom Agilent 7890A gas chromatography (GC) system. The GC is equipped with an
autosampler for consistent sample injection and utilized a GS CarbonPLOT column
(Agilent Technologies) at 145°C for separation of volatile metabolites. Quantiﬁcation of
methane was achieved by comparison to a methane standard curve (Matheson, Lincoln,
NE) run in parallel with experimental samples.
Isoprene production assay
The same GC-FID system as above was deployed to quantify isoprene (55). M.
acetivorans strains were grown in 10 ml cultures with a 1 ml parafﬁn oil overlay. Once
grown to stationary phase, the oil was harvested and transferred to a 2 ml stoppered and
crimped autosampler vial. The GC-FID method for isoprene quantiﬁcation was as
follows: 160°C for 35 min, ramp to 200°C at 75°C/min for 20 min, ramp to 275°C at
75°C/min for 20 min, 275°C for 5 min, and ramp to 160°C at 75°C/min to equilibrate the
system for the next run. Isoprene quantiﬁcation was achieved using a standard of known
volumes of isoprene injected into 1 ml of parafﬁn oil in a 2 ml autosampler vial.
Mass balance measurements
M. acetivorans was grown to early stationary phase in 100 ml cultures. Cultures
were centrifuged and concentrated to 10 ml in MHS medium. Cells were washed twice
with MHS and resuspended in 10 ml MHS. Then, 0.250 ml of resuspended cells was
transferred to sterile, anaerobic autosampler vials, after which 0.250 ml of 2x MeOH
MHS was added to the autosampler vials, which were then stoppered and crimped. The
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headspaces of the autosampler vials were ﬂushed with N2 to remove residual CO2.
Prepared samples were incubated for 36 h at 35°C. After incubation, remaining methanol
in spent medium was analyzed by GC-FID and the methanol peak area was compared to
standard curves generated by serial dilutions of HS MeOH medium. CO2 and CH4 in the
headspace were quantiﬁed using a thermal conductivity detector (GC-TCD). Peak areas
of headspace gases were compared to standard curves generated for each gas using
methane and CO2 reference standards (Airgas, Randor, PA, and Matheson Gas, Lincoln,
NE).
qRT-PCR methods
Cultures of att:ispS+ and control strains were grown anaerobically in triplicate in
HS 1 MeOH until exponential phase (OD600 of 0.56 to 0.74). Cells were anaerobically
concentrated in a clinical centrifuge (5,000 x g) and RNA isolation was performed using
TRI reagent (Invitrogen) as per the manufacturer’s protocol. DNase treatment was
performed using TURBO DNase (Invitrogen) and DNA digestion was conﬁrmed by lack
of PCR ampliﬁcation after 35 cycles using primers oNB733 and oNB734. The cDNA was
synthesized using GoTaq 2-step RT-qPCR system (Promega, Madison, WI) with random
hexamers and cDNA integrity was veriﬁed via agarose gel. qPCR was performed using
the primers in Table 4 and GoTaq qPCR Master Mix with SYBR Green I (Promega,
Madison, WI) on a Mastercycler RealPlex (2) thermocycler (Eppendorf). Data were
obtained from three biological replicates and ﬁve technical replicates each (n = 15).
Threshold cycle (CT) values from qPCR were normalized to the expression of rpoA1, the
DNA-dependent RNA polymerase found in a single copy in M. acetivorans (38) and
transcript abundance of each gene was compared using the 2^(-ΔΔCT) method as
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described (56, 57).
Data availability
Plasmids, strains, and growth and assay data that support the ﬁndings of this study
are available from the corresponding author (N.R.B.) upon reasonable request. The
sequence for sNB19 was submitted to GenBank (MW295460) but not released prior to
publication; it is expected to be released shortly. This sequence may also be found in the
supplemental material.

Results
Creation and characterization of Methanosarcina acetivorans ispS+ strains
In plants, the isoprene monomer is synthesized by cleavage of the C-O bond of
dimethylallyl pyrophosphate (DMAPP) to produce isoprene monomer and
pyrophosphate by the enzyme isoprene synthase (IspS) (3). To generate isoprenesynthesizing methanogens, we cloned the codon-optimized ispS gene from poplar
(Populus alba) into the Methanosarcina spp. overexpression suicide vector pNB730
(Figure 2a) (30, 31). Once transfected into cells, the resulting plasmid pJA2 integrates
into the chromosome, resulting in constitutive overexpression of synthetic ispS from the
methyl coenzyme M reductase (mcr) promoter, PmcrB (Figure 2a) (32). Integration of
pJA2 was conﬁrmed by PCR, and transcription of ispS mRNA was validated by reverse
transcriptase-PCR (RT- PCR) of an 88-bp fragment of the ispS cDNA transcript (Figure
2b). A vector-only control (att:pNB730) strain was also created by integrating pNB730
onto the M. acetivorans chromosome. These results indicate successful integration of
pJA2 onto the chromosome and transcription of ispS in M. acetivorans.
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Gene integration and transcription alone is not necessarily sufﬁcient to ensure an
enzyme will be translated, folded, and maintain stable biochemical activity in a new
host cell. P. alba IspS is most enzymatically active at 40°C and has a high Km for
DMAPP (30). To determine if the newly designed, synthetic ispS was translated and
maintained enzyme activity in methanogen cells grown at 35°C, the cell extract was
assayed for DMAPP pyrophosphatase activity (Figure 2c). Cells expressing ispS had a
2-fold higher release of PPi from DMAPP activity versus vector-only control
(att:pNB730) cells, suggesting IspS is enzymatically active in methanogen cells.
Isoprene synthesis by methanol-grown cells was conﬁrmed by gas chromatography
using ﬂame ionization and mass spectrometry (Figure 2d and e). These data suggest the
synthetic ispS gene was transcribed, translated, and folded into an active enzyme that
could access the intracellular DMAPP pool in growing M. acetivorans cells at 35°C to
yield the end product isoprene.
M. acetivorans att:ispS+ strains were cultured and physiologically characterized
to determine if ispS expression had an effect on growth of the organism (Table S2).
Because methanogens synthesize cell membrane lipids entirely from DMAPP (Figure
1d) (4, 29, 33), it was initially expected that high constitutive expression of ispS from
PmcrB could decrease viability or may even be lethal. However, when grown on
methanol, there was no detectable difference in methane produced (Figure 2e) or in
population doubling time (Figure 2g), thus demonstrating that ispS expression does not
result in decreased cell viability.
Some possible explanations for tolerance of high ispS expression by M.
acetivorans include substrate channeling (such that DMAPP is preferentially funneled
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to membrane synthesis and only excess intracellular DMAPP pools are available to
IspS), the high Km of IspS (34), or autotitration of gene copies. Previous work has
shown that methanogens vary the number of copies of the entire chromosome
determined by growth phase and type of growth substrate, with chromosomal copies
ranging from 3 to 18 (35). We hypothesized that this variance could possibly modulate
ispS gene copy number and therefore expression levels by homologous recombination at
the site of pJA2 integration. To test this hypothesis, the stability of the ispS gene in the
culture population was assessed by serial passaging of ispS+ strains with and without
puromycin antibiotic selection. If expression of ispS caused a decrease in reproductive
ﬁtness, serial passaging in the absence of antibiotic selection should have selected for
fewer copies of the ispS gene in the total population, which could be detected using
quantitative PCR (qPCR) of ispS versus an unlinked essential housekeeping gene, such
as rpoA1. The rpoA1 gene encodes the sole DNA-dependent RNA polymerase gene on
the chromosome and can be used as a reference gene in a qPCR assay. By comparing
ispS gene copy number to copies of the chromosomal reference gene rpoA1, we could
calculate the average number of ispS genes per chromosome and per cell. If expression
of ispS was neither beneﬁcial nor detrimental under the culturing conditions, we would
have expected no change in the ispS:rpoA1 ratio. With constant antibiotic pressure, M.
acetivorans strains transformed with pJA2 were found to have an average of 0.57 copies
of ispS per chromosome after 20 generations (Table 2). The ispS:rpoA1 ratio was
relatively unchanged at 0.56 after 140 generations. Without antibiotic selection, the
ispS:rpoA1 ratios were 0.59 at 20 generations and 0.53 at 140 generations. We next
tested whether we could drive an increase in ispS:rpoA1 ratio through homologous
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recombination by selecting for increased expression of the linked puromycin resistance
cassette; however, these efforts were unsuccessful and the ispS:rpoA1 ratio remained
unchanged. These data suggest pJA2 is stably integrated onto the chromosome.
Additional experiments are needed to further explore the effects of gene dosage and
gene expression on isoprene production.
Mass balance of isoprene synthesis from methanol
The primary metabolic products of methylotrophic methanogenesis by M.
acetivorans are methane, CO2, and biomass. Mass balance experiments were used to
measure the molar carbon partitioning between control and ispS+ strains to determine if
isoprene was derived from the methane, CO2, or biomass pools (Table S3). Mass
balance experiments showed both control and ispS+ strains consumed 100% of the
substrate methanol and produced nearly equivalent amounts of methane (73.0 ± 2.2 and
72.8 ± 3.8, P = 0.0191, respectively, for a 0.2% C ﬂux difference). However, the ispS+
strain shows 3.7% less CO2 ﬂux than the control strain (P = 0.0001) but 6.7% more
biomass C according to dry weight (P = 0.0041). The ispS+ strain directed 3.8% of total
C to isoprene. The yields of methane were not signiﬁcantly different for control or ispS+
strains on bicarbonate-buffered medium versus MOPS-buffered medium (Table S3).
These results show cells beneﬁt with increased biomass synthesis when carbon is
siphoned from the oxidative branch of the methylotrophic methanogenesis pathway to
produce isoprene (Figure 2h).
Isoprene synthesis affects transcription of Mcr, mevalonate, and TCA enzymes
Isoprene synthesis would be expected to reduce the intracellular pool of DMAPP
that normally feeds into membrane synthesis. Therefore, as a result of isoprene
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synthesis, we would expect the ispS+ strain to upregulate expression of mevalonate
pathway genes that supply DMAPP/IPP to the lipid synthesis pathway (Fig. S1). In
addition, if isoprene synthesis is affecting electron ﬂux through the electron transport
system, we would expect to observe downregulation of one or more genes in the
tricarboxylic acid (TCA) or methanogenesis cycles that are responsible for maintaining
redox balance in the cell (Fig. 1). Compared to the control strain, the M. acetivorans
att::ispS+ strain was found to have a slight decrease in 3-hydroxy-3-methylglutarylCoA (HMG-CoA) synthase transcripts (1.5-fold) compared to the control strain and
increased mRNA abundance for genes downstream of HMG-CoA synthase. These
changes in mRNA levels suggest the cell is reacting to a depletion of downstream
metabolite pools that includes DMAPP (Table 3). We also observed that methyl
coenzyme M reductase (mcrB), pyruvate carboxylase, and malate dehydrogenase were
upregulated, while fumarate hydratase was signiﬁcantly downregulated. These results
suggest the cell is sensing an imbalance between methanogenesis, biomass synthesis,
and redox-dependent reactions and supports the hypothesis that electron ﬂux is
decreased through the rate-limiting terminal electron acceptor CoM-CoB heterodisulﬁde
and the membrane electron carrier methanophenazine, which is critical for ATP
synthesis (36, 37). Together, these results suggest that isoprene synthesis may relieve
known kinetic bottlenecks in CoM-CoB and methanophenazine redox balance, thereby
contributing to increased biomass. Future experiments using mutant strains could
provide further evidence of this process.
Isoprene production utilizing other carbon sources
Isoprene production and ispS+ strain physiology were assessed on additional
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carbon sources trimethylamine (TMA) and acetate to determine if isoprene yields
changed depending on growth substrate (Fig. 3). When growing on methanol or TMA,
M. acetivorans uses the methylotrophic methanogenesis pathway, while when growing
on acetate uses the acetoclastic pathway. The methylotrophic and acetoclastic
methanogenesis pathways differ with respect to intracellular carbon and electron ﬂuxes,
which could have an impact on isoprene yields. Cells grown on TMA and acetate had
similar DMAPP pyrophosphatase activity and isoprene yields as methanol-grown cells
(Fig. 3, Table S2). Endpoint methane production by ispS+ strains was 10% lower than
control strains when grown on TMA, despite the fact that methanol and TMA are both
metabolized by the methylotrophic methanogenesis pathway (Table S2). Similar to
methanol-grown cells, TMA- and acetate-grown ispS+ strains had population doubling
times that were the same as control strains (Table S2). These data show engineered M.
acetivorans can produce high quantities of isoprene from a variety of inexpensive
carbon sources and production is independent of whether the methylotrophic or
acetoclastic methanogenesis pathway is used by the cell.
Isoprene synthesis by engineered Methanosarcina barkeri
Methanosarcina acetivorans is a versatile organism capable of growth on the
widest range of methanogenic substrates, including C1 chemicals (carbon monoxide,
methanol, methylamines, methylsulﬁdes, etc.) and acetate (38). Methanosarcina
barkeri, a related methanogen, can grow on C1 compounds and acetate similar to M.
acetivorans, except it has maintained the ability to use H2 as an electron donor via the
hydrogenotrophic (reducing carbon dioxide to methane) or methyl respiration (reducing
methanol or other C1 compounds to methane) methanogenesis pathways. To expand the
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possible feedstocks for isoprene synthesis and to determine whether the different
electron transport system conﬁguration found in M. barkeri affects isoprene yields, we
transformed M. barkeri with the pJA2 plasmid.
After conﬁrmation of successful integration of pJA2 onto the chromosome,
biochemical tests were used to conﬁrm isoprene production and its effect on growth of
the organism (Table S4). Similar to M. acetivorans, the methanol-grown M. barkeri
ispS+ strain had increased DMAPP pyrophosphatase levels (136% ± 0.4%) compared to
the parental strain (100% ± 0.2%), indicating the introduced ispS gene was translated
into active enzyme in methanogen whole-cell lysate. M. barkeri ispS+ strains had
identical growth rates as control strains; however, methane yields were 18% less on
methanol and 10% less on H2 + CO2 versus control strains, similar to what was
observed with TMA-grown M. acetivorans (Figure 4a). Isoprene yield with M. barkeri
was 3.8% of the isoprene produced by M. acetivorans during growth on methanol.
Isoprene yield on H2 + CO2 was 2.4% of the M. acetivorans yield on methanol (Figure
4b), and roughly equivalent to the reported yield of geraniol diterpene by
Methanococcus maripaludis (Table 1, Table S4) (39).
Differences in isoprene yield between these methanogens likely results from
expression of hydrogenases in M. barkeri and M. maripaludis. Hydrogenases are
essential in the hydrogenotrophic methanogenesis pathway (40) and are necessary for
conserving energy through hydrogen cycling in M. barkeri (41). As a result of
hydrogenase expression, redox balancing in M. barkeri kinetically favors hydrogen
synthesis rather than acetyl-CoA and DMAPP synthesis. M. acetivorans, which does
not use hydrogen cycling for energy conservation, is poised to donate electrons to CoM-
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CoB heterodisulﬁde reductase or to acetyl-CoA synthesis (42). Previous work has
shown that further decreasing ﬂux through the CoM-CoB terminal electron acceptor in
M. acetivorans results in increased biomass synthesis and increased metabolic
efﬁciency (37). The degree of similarity in substrate channeling and redox balance
mechanisms between M. acetivorans and M. barkeri is an ongoing area of research, but
it is clear that isoprene optimization will require tailored metabolic engineering
approaches depending on whether methanogens are capable of hydrogenotrophic
growth. Our results indicate that while M. acetivorans produces higher yields than
hydrogenotrophic methanogens, both M. acetivorans and M. bakeri can be engineered
to produce isoprene from various inexpensive feedstocks without signiﬁcantly
sacriﬁcing growth kinetics or biomass yields.

Discussion
Our results conﬁrm the hypothesis that archaea, and Methanosarcina spp. in
particular, can be engineered to synthesize high yields of isoprene. Under batch-growth
conditions using methanol as a substrate, M. acetivorans was able to produce 6 x 106
times more isoprene than the bacterium Clostridium ljungdahlii, and 179 times more
isoprene than the autotrophic cyanobacterium Synechocystis. The high carbon ﬂuxes we
measured (4% total C) and the observation of increased biomass (Figure 2h) suggest
that in M. acetivorans ispS+ strains, isoprene is an abundant metabolic product that
beneﬁts cells. Furthermore, the engineered strains showed no detectable changes in
population doubling rate, maximum culture optical density, and methane production
compared to a vector-only control strain. Mass balance data indicated a 16% decrease in

70

CO2 production, suggesting that C for isoprene was derived from the oxidative branch
of the methylotrophic methanogenesis pathway. The data support the conclusion that M.
acetivorans and M. barkeri ispS+ strains have become “isoprenogens,” i.e.,
methanogens capable of growing by synthesizing mixed products of isoprene and
methane. Importantly, the isoprene yields and 4% total C ﬂux we observed were
obtained by expression of a single terpene synthase without extensive pathway
optimization.
Can we push isoprene yields further? Other investigators using S. cerevisiae and
E. coli chassis were challenged by unstable expression and low activity of terpene
synthases, low substrate pathway ﬂuxes, and enzyme feedback inhibition that had to be
overcome through biochemical and metabolic engineering. Optimization of these
factors and use of inducible promoters has the potential to further increase isoprene
yield using Methanosarcina spp. The results of genetic selection experiments, shown in
Table 2, suggest that 4% ﬂux seems to be an upper limit that still provides enough
isoprenoid lipid synthesis for central metabolism and maintaining redox balance at wildtype growth rates. However, by identifying metabolic bottlenecks and addressing these
with additional mutations, such as using an engineered IspS enzyme with a lower Km
(43), it is possible that yields may be increased.
Methanogens survive on the very edge of thermodynamic favorability,
producing approximately 0.3 ATP per mole of carbon substrate utilized (44). This lean
metabolism creates a high ﬂux of carbon with an exceedingly small fraction of overall
carbon being utilized for biomass, all of which is coupled to the rate-limiting reactions
of methanogenesis. As such, the growth of methanogens can be predicted
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predominantly from the energetics of substrate utilization. In a steady-state culture,
methylotrophic methanogenesis can be modeled based on the mass balance equation:
4CH3OH  1CO2 + 3CH4 + 2H2O (ΔG° = -84.25 kJ Cmol-1). Assuming all mevalonate
pathway ﬂux is devoted to isoprene synthesis at the expense of CO2 or membrane lipid
synthesis in a nonreplicating culture, up to 75% of C could be directed to isoprene
synthesis from methylotrophic substrates according to the mass balance equation:
40CH3OH  9CH4 + 6C5H8 + 38H2O (ΔG°= -5.2 kJ Cmol-1). Based on current
understanding of metabolism in methanogens, up to 85.7% of substrate carbon could be
used to synthesize isoprene using hydrogenotrophic methanogens (35CO2 + 104H2 
5CH4 + 6C5H8 + 70H2O, ΔG° = -9.9 kJ Cmol-1) and up to 71.4% at near equilibrium
from acetoclastic methanogens (7CH3CO2H  2C5H8 + 4CO2 + 6H2O, ΔG° = -16.6 kJ
Cmol-1). While growing cells must divert some C ﬂux to lipid synthesis, as long as cells
can couple additional isoprene synthesis to generation of a transmembrane ion gradient,
they will be able to conserve energy via ATP synthesis. Recent studies have shown that
E. coli and S. cerevisiae strains were able to signiﬁcantly increase isoprene yields
utilizing nonreplicating cells in fed-batch fermentation (Table 1) (45, 46). The data
reported here for Methanosarcina spp. were obtained from batch-grown cultures to
facilitate mass balance measurements and likely represent an underestimate compared
to the isoprene yield that could be obtained from larger-scale fed-batch or chemostat
bioreactors.
The lack of change in growth rate of isoprene-producing Methanosarcina
species strains, as well as the decrease in CO2 production, are consistent with the
interpretation that isoprene synthesis does not negatively affect the cell’s ability to
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conserve energy. In methanogens, the methanogenesis pathway is linked to biosynthesis
by the carbon monoxide dehydrogenase/acetyl-CoA synthase (CODH/ACS) complex,
which facilitates growth and ATP generation by the regeneration of the cofactor
ferredoxin (Fdx) and the synthesis of acetyl-CoA (36). We speculate that by providing
the ability to synthesize an alternative metabolic by-product, isoprene, the cell can
overcome the kinetic bottleneck caused by reduced Fdx and high acetyl-CoA pools.
Further investigation is needed to test this hypothesis and to clarify how the introduction
of isoprene synthase may have altered metabolism in M. acetivorans and M. barkeri.
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Figure 1. Isoprenoid biosynthesis pathways and macromolecular compositions of representative
bacteria,

eukarya,

and

archaea.

(a)

Isoprene

is

synthesized

from

isopentenyl

pyrophosphate/dimethylallyl pyrophosphate (IPP/DMAPP) derived from glucose via the
methylerythritol phosphate/deoxy xylulose phosphate (MEP/DOXP) pathway in bacteria or
mevalonate (MVA) pathway in eukarya. (b and c) Relative amounts of macromolecules in E. coli
bacterium (58) and S. cerevisiae yeast (59), respectively. (d) Isoprenoid lipids are synthesized from
IPP/DMAPP by the archaeal MVA pathway in methanogens. (e) Isoprenoid lipids in methanogens
comprise 5% of biomass dry weight (29). Arrow sizes and line widths depict published carbon
fluxes through each pathway. One or more genes are required for most organisms to produce
isoprene monomer (red arrows). See Table S1 for macromolecular composition values shown in
panels b, c, and e.
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Figure 2. Strain construction and validation of isoprene production from methanol. (a) Plasmid
map of pJA2 for constitutive expression of isoprene synthase IspS in Methanosarcina spp. (b)
Validation of ispS transcription by RT-qPCR. Plasmid DNA from pJA2 was used as
a positive control, while genomic DNA from the parent strain NB34 was used as a negative
control. (c) Dimethylallyl pyrophosphate pyrophosphatase activity in cell extracts. (d) Isoprene
production measured by gas chromatography. (e) Validation of isoprene production by mass
spectrometry. (f) Endpoint methane production. (g) Growth curve of att:pNB730 and att:ispS
strains. (h) Mass balance of M. acetivorans att:pNB730 (blue) and att:ispS (red) strains showing
percent molar carbon fluxes. Standard deviations are shown in parentheses. Blue bars,
att:pNB730 strain; red bars, att:ispS strain. Data presented in panels c, d, f, and h were obtained
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from quadruplicate biological and triplicate technical replicates (n = 12). Data presented in panel
e were from a double-blinded experiment. Data from panel g were from five biological replicates.

Figure 3. Characterization of ispS1 strains grown on trimethylamine (TMA) or acetate substrates.
(a and e) Dimethylallyl pyrophosphate pyrophosphatase activity in cell extracts. (b and f)
Endpoint methane production. (c and g) Isoprene production measured by gas chromatography. (d
and h) Growth curves of att:pNB730 and att:ispS strains. Blue bars, att:pNB730 strain; red bars,
att:ispS strain. Data presented in panels a to c and e to g were obtained from quadruplicate
biological and triplicate technical replicates (n =12). Data in panels d and h were from five
biological replicates.
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Figure 4. Demonstration of isoprene production by Methanosarcina barkeri. (a) Endpoint
methane assays for M. barkeri att:pNB730 and att:ispS strains. (b) Isoprene production by M.
barkeri att:pNB730 and att:ispS strains as measured by gas chromatography. Blue, att:pNB730
strains; red, att:ispS strains. Data for panels a and b were obtained from quadruplicate biological
and triplicate technical replicates (n = 12).
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Table 1. Comparison of isoprene and terpenoid yields in engineered bacteria and archaea.
Organism
Yield
Condition
Citation
Batch culture yieldsa
60
Clostridium ljungdahliib
0.00001
MES-Fructose, batch
b
61
Synechocyctis
0.336
Light+CO2, batch
c
39
Methanococcus maripaludis
2.8
H2+CO2, batch (geraniol)
c
39
Methanococcus maripaludis
4.6
Formate, batch (geraniol)
This study
Methanosarcina acetivorans
67.2
Methanol, batch
d
Fed-batch yields
45
Escherichia coli
24.0
0.1-2% glucose, fed-batch
e
46
Saccharomyces cerevisiae
11.9
25g/L initial glucose, fed-batch
-1 -1
a. Batch culture yields in mg mol g dry weight.
b. Strains contain two or more mutations to enhance isoprene production.
c. Values are for the terpene geraniol.
d. Fed-batch fermentation yields in g/L.
e. The rate of feed solution and final concentration of glucose utilized were not reported.
Table 2. Gene copies per cell
Gene
rpoA1
IspS

Puromycina
-

ratio
rpoA1
IspS

+
+

20 (7)
16
9.39

Std Dev
0
0.10

Generation (days)
56 (19)
Std Dev
16
0
8.32
0.51

140 (47)
16
8.52

Std Dev
0
0.53

P-value
1
0.545

0.59
16
9.19

0
0.34

0.56
16
9.51

0.53
16
8.91

0
0.18

1
0.548

0
0.23

ratio
+
0.57
0.59
a. Without antibiotic selection (-), with constant antibiotic selection (+).
Values were obtained from biological and technical triplicates (n=9).

0.56

Table 3. Relative transcript abundance between att:ispS and att:pNB730 strains of M.
acetivorans.a
Pathway
Gene
Fold
p-value
Change
Mevalonate pathway HMG-CoA synthase
0.66
0.001271
HMG-CoA reductase
1.49
0.045242
Mevalonate kinase
1.31
0.004854
Isopentenyl phosphate kinase
1.88
0.117332
Isopentenyl diphosphate delta-isomerase
TCA Pathwayb

2.26

0.011509

Pyruvate synthase
0.80
0.211017
Pyruvate carboxylase
1.96
0.000206
Malate dehydrogenase
1.68
0.007657
Fumarate hydratase
0.21
1.53E-05
Methanogenesis
Methyl coenzyme M reductase B (mcrB) 1.55
0.000121
a. Values were obtained from triplicate biological and 5 technical replicates (n=15).
b. All annotated TCA cycle enzymes in M. acetivorans. Methanogens have an
incomplete TCA cycle.
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Table 4: Strains, plasmids, and primers used in this study
Strain,
Description
Plasmid,
or Primer
Methanosarcina acetivorans C2A

Purpose

Source

394

Dhpt::w C31 int, att:pJA2

Isoprene production (att:ispS)

This study

452

Dhpt::w C31 int, att:pNB730

Vector-only control (att:pNB730)

This study

Methanosarcina barkeri
396

Dhpt::w C31 int, att:pJA2

Isoprene production

This study

459

Dhpt::w C31 int, att:pNB730

Vector-only control (att:pNB730)

(31)

F9proA1B1 lacIq D(lacZ)M15 zzf::Tn10 (TetR)/fhuA2D(argFlacZ) U169 phoA glnV44 U80D(lacZ)M15 gyrA96 recA1
endA1 thi-1 hsdR17
F9 proA1B1 lacIq D(lacZ)M15 zzf::Tn10 (TetR)/fhuA2D(argFlacZ) U169 phoA glnV44 U80D(lacZ)M15 gyrA96 recA1
endA1 thi-1 hsdR17/ pNB730
F9 proA1B1 lacIq D(lacZ)M15 zzf::Tn10 (TetR)/fhuA2D(argFlacZ) U169 phoA glnV44 U80D(lacZ)M15 gyrA96 recA1
endA1 thi-1 hsdR17/ pJA2

Cloning and plasmid propagation
Production of pNB730 plasmid

New
England
Biolabs
(31)

Expression of ispS in M. acetivorans

(55)

pUC ori bla PmcrB pac(opt) w C31 attB

Methanosarcina spp. integration and
expression vector
Integration of ispS into genome for
constitutive expression of isoprene
synthase

(31)

GenBank accession no. MW295460 (see the supplemental
material)

Synthetic optimized Populus alba ispS
(isoprene synthase)

This study

ispSD1213 DNA string ampliﬁcation and
cloning, fwd
DNA string ampliﬁcation and cloning,
rev
RNA polymerase, rpoA1 qRT fwd
housekeeping gene

(55)

oNB729

ATTAAGGAGGAAATTCATATGTCCGTTTCCACCGAA
AATGT
CGAGGGCCCAAGCTTGGATCCTCATCTTTCAAAAGG
AAGAATAG
CATATGCCTGACGACCTCATTA

oNB730

GAATTTGATTTCGAGCTGTTCC

This study

oNB733

GTTTACAAAAGTAGCTGCAAGGGTA

oNB734

ATACAAATTCTACAAGGCAAACGAC

oNB735
oNB736
oNB930
oNB931
oNB932
oNB933
oNB934
oNB935
oNB936
oNB937
oNB938

GGATTCGATGCAGTTACCAAA
TGCTTCCTGGCTAACTTCAAA
CCGTGCCTGATGTCGACGAA
TGGAGGGATCTACGCCGCTT
GCCGGCCTTCTGAAAGTAAACG
TCCGCGGTTTACACTGGCAA
CCCGTGTGCGGGTGGAATTA
ACCACTGCGGAGATATAAGGATGT
GAGGCAGCGCCATTACCGAT
GCCTGAAACTTCCCGCGCAA
CAGCCAGAGAGCCGCAATCG

oNB939

CCGTAGACAAAGGCGTTCGGA

RNA polymerase, rpoA1 qRT rev
housekeeping gene
Methyl-coenzyme M reductase, mcrB
qRT fwd
Methyl-coenzyme M reductase, mcrB
qRT rev
ispS qPCR primer, fwd
ispS qPCR primer, rev
HMG-CoA synthase fwd
HMG-CoA synthase rev
HMGR fwd
HMGR rev
Mevalonate kinase fwd
Mevalonate kinase rev
Isopentenyl phosphate kinase fwd
Isopentenyl phosphate kinase rev
Isopentenyl-diphosphate d -isomerase
fwd
Isopentenyl-diphosphate d -isomerase
rev

Escherichia coli
3
134
453

Plasmids
pNB730
pJA2

pNB730 ispSD1213

(55)

Primers and DNA strings
sNB19

oNB568
oNB576

(55)
This study

This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
This study
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oNB940
oNB941
oNB942
oNB943
oNB944
oNB945
oNB946
oNB947

GCTCATGCACGAGGTGCTCT
GCACTGACTGCCCTGTTTGC
TCATGCGTGCCTGCAGAGAG
GCCTCATCGGCATACTTGGCA
CCGAACTGGAACCTGGCGAA
TGCCTGCATGAGGTCAAGGG
TCCTCGACCTGCCTATCGGT
GGTCGGCTGGAACCTCAACC

Pyruvate synthase fwd
Pyruvate synthase rev
Pyruvate carboxylase fwd
Pyruvate carboxylase rev
Malate dehydrogenase fwd
Malate dehydrogenase rev
Fumarate hydratase fwd
Fumarate hydratase rev

This study
This study
This study
This study
This study
This study
This study
This study

89

Figure S1: Relative transcript abundance in att:ispS+ strains. Genes in red were assayed by
RT-qPCR. Circles represent changes in gene expression as determined using the -ΔΔCt method
versus control strain. Green circles, upregulated genes; red circles, downregulated genes; gray
circles, not statistically significant (p>0.01). Numbers represent average fold change from three
biological replicates with five technical replicates each (n=15). Question marks represent
unknown mechanisms. ADP, adenosine diphosphate; AMPD, anhydromevalonate phosphate
decarboxylase; ATP, adenosine triphosphate; atoB, acetyl-CoA acetyltransferase; CoA,
coenzyme A; Fdx(ox), oxidized ferredoxin; Fdx(red), reduced ferredoxin; fumA, fumarate
hydratase; HMGR, hydroxymethylglutaryl-CoA reductase; HMGS; hydroxymethylglutaryl-CoA
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synthase; idi, isopentenyl diphosphate isomerase; ipk, isopenetyl phosphate kinase; ispS, isoprene
synthase mcrB, methyl-coenzyme M reductase; MDH, malate dehydrogenase; MK, mevalonate
kinase; MP, methanophenazine; MPH2, reduced methanophenazine; PMDh, phosphomevalonate
dehydratase; Pi, inorganic phosphate; PPi, pyrophosphate; porB, pyruvate synthase; pycA,
pyruvate carboxylase.
Table S1: Macromolecular composition by % dry weight.
Macromolecule class E. coli1
S. cerevisiae2
M. barkeri 3
Protein
50.90
44.90
Fatty acid lipid
8.33
12.29
Isoprenoid lipid
0.05
Not reported
Carbohydrate
11.11
29.58
Nucleic Acid
21.29
8.88
Metabolites
8.33
4.35

62.97
0.10
5.00
0.50
27.99
4.00

Table S2: M. acetivorans strains grown in HS medium.
MeOH
TMA
Acetate
Hours
Std dev
Hours
Std dev
Hours
Std dev
Doubling
timea
att:pNB730
9.57
0.36
11.8
0.31
44.0
2.80
att:ispS
9.01
0.42
13.0
1.92
46.6
2.64
p
0.770
0.472
1.00
-1
-1
mmoles
L
Std
dev
mmoles
L
Std
dev
mmoles
L-1
Std dev
b
CH4
att:pNB730
83.18
2.53
82.34
0.75
111.07
3.24
att:ispS
79.44
2.76
73.54
3.54
107.71
3.03
p
0.0610
0.0006
0.0593
Isopreneb
mmoles L-1
Std dev mmoles L-1
Std dev mmoles L-1
Std dev
att:pNB730
ND
ND
ND
att:ispS
0.954
0.236
1.020
0.239
0.933
0.271
a. Data were obtained from five biological replicates (n=5).
b. Data were obtained from quadruplicate biological replicates and triplicate technical
replicates (n=12).
ND, Not detected.
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Table S3: M. acetivorans mass balance on MOPS buffered MeOH medium.a
Isopreneb
Biomassc
CH4b
CO2b
Strain
mmoles
Std
mmoles
Std mmoles
Std
g/L
Std
L-1
dev
L-1
dev
L-1
dev (%C) d
dev
(%C)d
(%C) d
(%C) d
90
30
0
0.9
Theoretical
(74.4)
(24.8)
(0.7)
84.10
2.48
30.1
1.16
ND
0.904 0.040
att:pNB730
(73.0)
(2.2)
(26.2)
(1.0)
(0.7)
(0.0)
81.00
4.21
25.0
1.06
0.855 0.073 0.965 0.043
att:ispS
(72.8)
(3.8)
(22.5)
(1.0)
(3.8)
(0.3)
(0.9)
(0.0)
p
0.0191
0.0001
0.0041
a. Calculated from 125 mmoles MeOH.
b. Data were obtained from quadruplicate biological replicates and triplicate technical
replicates (n=12).
c. Data were obtained from ten biological replicates (n=10). Estimated as CHO (mwt=29).
d. Calculated using the equation %𝐶𝐶 = (𝐶𝐶/ ∑ 𝐶𝐶) ∙ 100
ND, Not detected.
Table S4: M. barkeri strains grown in HS medium.
MeOHa

H2+CO2b

Doubling timec
Strain
Hours
Std dev
Hours
Std dev
att:pNB730
8.95
0.232
NT
att:ispS
9.33
0.299
NT
p
0.061
CH4 production d
Strain
Std dev
Std dev
Δmoles L-1
Δmoles L-1
att:pNB730
715.13
22.067
289.53
12.54
att:ispS
583.98
32.20
263.67
20.39
p
0.0001
0.0011
Isoprene productiond
Strain
Δmoles L-1
Std dev
Δmoles L-1
Std dev
att:pNB730
ND
ND
att:ispS
36.0
2.02
23.2
3.56
a. Calculated from 125 mmoles MeOH.
b. H2:CO2 80%:20% every 12h at 15 psi.
c. Data were obtained from five biological replicates (n=5).
d. Data were obtained from quadruplicate biological replicates and triplicate technical
replicates (n=12).
ND, Not detected. NT, Not tested.
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Abstract
Wastewater biosolids are a promising feedstock for production of value-added
renewable chemicals. Methane-producing archaea (methanogens) are already used to
produce renewable biogas via the anaerobic treatment of wastewater. The ability of
methanogens to efficiently convert dissolved organic carbon into methane makes them an
appealing potential platform for biorefining using metabolic engineering. We have
engineered a strain of the methanogen Methanosarcina acetivorans to produce the volatile
hemiterpene isoprene in addition to methane. The engineered strain was adapted to grow
in municipal wastewater through cultivation in a synthetic wastewater medium. When
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introduced to municipal wastewater the engineered methanogens were able to compete
with the indigenous microorganisms and produce 0.97 mM of isoprene (65.9 ± 21.3 g per
m3 of effluent). The production of isoprene in wastewater appears to be dependent on the
quantity of available methanogenic substrate produced during upstream digestion by
heterotrophic fermenters. This shows that with minimal adaptation it is possible to dropin engineered methanogens to existing wastewater environments and attain value-added
products in addition to the processing of wastewater. This shows the potential for
utilizing methanogens as a platform for low-cost production of renewable materials
without expensive feedstocks or the need to build or adapt existing facilities.

Introduction
Methane-producing archaea (methanogens) are obligate anaerobes which inhabit a
keystone niche in the global carbon cycle, utilizing the endpoint degradation products of
complex organic material and liberating otherwise inaccessible carbon [1–4]. Their
unique metabolism and their potential to utilize a wide array of plentiful substrates make
methanogens a subject of particular interest in industrial applications such as wastewater
treatment [5–7], and the production of value-added products (Figure 1) [8,9].
Methanogens are used worldwide to reduce dissolved organic carbon in effluent as part
of the wastewater treatment process. Wastewater treatment is a multistage process which
is highly variant depending on the substrate being treated, though the end goal is largely
the same: the detoxification of water by degrading complex biomass and pollutants
before reintroducing the effluent into the water cycle. For the purpose of this study, we
focused on the anaerobic digestion of municipal wastewater which primarily aims to
remove dissolved carbon and suspended solids from a city’s water supply.
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Municipal wastewater treatment generally occurs in three distinct stages based
upon the aerobicity of the wastewater and the activity of microorganisms involved in the
multistage process. In the first stage, aerobic microorganisms breakdown complex
biomass into simpler organic material [10]. The deconvoluted material is further
anaerobically digested by a second consortia of microbes into one- or two-carbon
compounds and organic acids. These one- and two-carbon compounds are utilized by
methanogens to complete the decomposition process [6,11]. In addition to removing
polluting organic carbon from the water, anaerobic digestion has the added benefit of
producing methane which is often captured as renewable biogas [11–14]. Due to the low
energetic potential of methanogenic feedstocks, methanogens utilize a highly efficient
central metabolism which greatly favors the production of methane over biomass and
heat. Anaerobic treatment of wastewater results in 95% conversion of the initial substrate
into available biogas with 5% being utilized for microbial biomass [15,16]. We
hypothesized that the highly efficient metabolism of methanogens may have potential to
produce high yields of other value-added products in addition to methane.
Isoprene (2-methyl-1,3-butadiene) is the primary component of natural rubber and
an important chemical precursor utilized in the production of synthetic rubber as well as
adhesives, flavorings, cosmetics, and pharmaceuticals. Traditionally, isoprene is
harvested from natural rubber from tree sap or produced industrially through the thermal
cracking of petroleum. By producing renewable isoprene via engineered microbes, it
could be possible to reduce the need to rely on the harvesting of plant biomass or the
mining of fossil fuels. Recently our laboratory demonstrated that the methanogen
Methanosarcina acetivorans can be engineered to efficiently produce bioisoprene as a
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methane coproduct under laboratory conditions [9]. The gene for isoprene synthase, ispS,
was stably inserted into the chromosome of M. acetivorans (att::ispS) and the production
of isoprene as well as methane was confirmed via gas chromatography. The production of
isoprene showed no detrimental effect on growth rate or metabolic efficiency of the
engineered strains compared with a vector-only control. We surmised that without an
obvious decrease in fitness it may be possible to drop-in these engineered methanogens
into an existing anaerobic wastewater treatment consortium to produce bioisoprene.
However, any inoculated methanogens would have to compete for substrate with wild
methanogens in the mixed microbial community of the anaerobic digester. M. acetivorans
has the largest genome of any characterized methanogen as well as the widest range of
substrate utilization, allowing for growth from methanol, methyl-amines, carbon
monoxide, and acetate [17,18]. We postulated that this metabolic flexibility would allow
for our engineered strains to compete with the endogenous methanogens present in
municipal wastewater resulting in an increase in methane production as well as the
production of bioisoprene. The detection of isoprene in wastewater inoculated with our
engineered strains with and without the supplementation of additional feed substrate
supports our hypothesis.
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Materials and Methods
Anaerobic Techniques
Anaerobic procedures were performed in a custom B-type Coy anaerobic chamber
(Coy Labs, Grass Lake, MI, USA). The chamber was maintained at 35 °C with an
atmosphere of 5% H2/20% CO2/75% N2 (±3%) (Matheson Gas, Lincoln, NE, USA).
The Methanosarcina acetivorans strains used in this study are the isoprene-producing
strain NB394 (Δhpt::φC31 int, att:pJA2) and the vector-only control NB452 (Δhpt::φC31
int, att:pNB730) [9]. Strains were cultured in anaerobic high-salt (HS) medium (200 mM
NaCl, 45 mM NaHCO3, 13 mM KCl, 54 mM MgCl2·6H2O, 2 mM CaCl2·2H2O, 2 µM
0.1% resazurin (w v−1), 5 mM KH2PO4, 19 mM NH4Cl, 2.8 mM cysteine·HCl, 0.1 mM
Na2S·9H2O, trace elements, vitamin solution) [19] supplemented with a carbon and
energy source (methanol, 125 mM; trimethylamine, 50 mM; sodium acetate, 120 mM)
and 2 mg L−1 puromycin as needed [20,21]. Cells were incubated at 35 °C outside of
anaerobic chamber in glass Balch tubes secured with butyl rubber stoppers (Belco Glass,
Vineland, NJ, USA) and aluminum crimps (Wheaton, Millville, NJ, USA).
Synthetic Wastewater
Anaerobic synthetic wastewater (SWW) medium was developed to adapt cells
from laboratory conditions to growth on municipal wastewater [22]. Chemical
composition of SWW medium is based on OECD guidelines for testing of chemicals
[23]. SWW is composed from 28 mg L−1 peptone, 100 mg L−1 meat extract, 100 mg
L−1 urea, 161 µM KH2PO4, 120 µM NaCl, 27 µM CaCl2·2H2O, 8.7 µM MgCl2·6H2O,
0.23% agarose (w v−1), and 3% evaporated milk (w v−1), supplemented with a carbon
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and energy source: 125 mM of methanol, 50 mM of trimethylamine, or 120 mM of
sodium acetate.
Methane Production Assay
Methane in culture headspace was measured by gas chromatography using a
flame ionization detector (GC-FID) as previously described [24]. Briefly, 10 mL cultures
were grown to stationary phase. After growth, 100 µL of headspace was captured using a
gastight Hamilton syringe and transferred to an empty crimped 2 mL autosampler serum
vial (Wheaton, Millville, NJ, USA). Vial contents were analyzed by flame ionization
using a custom Agilent 7890A Gas Chromatography System (Agilent Technologies,
Santa Clara, CA, USA, 2010). The GC was equipped with an autosampler for consistent
sample injection and utilized a GS CarbonPLOT column (Agilent Technologies, Santa
Clara, CA, USA) at 145 °C for separation of volatile metabolites. Quantification of
methane was achieved by comparison to a methane standard curve (Matheson, Lincoln,
NE, USA) ran in parallel with experimental samples.
Isoprene Production Assay
The same GC-FID system as above was deployed to quantify isoprene [22]. M.
acetivorans strains were grown in 10 mL cultures with 1 mL paraffin oil overlay in Balch
tubes. Once grown to stationary phase, the oil was harvested and transferred to a 2 mL
stoppered and crimped autosampler vial. The GC-FID method for isoprene quantification
was as follows: 160 °C for 35 min, ramp to 200 °C at 75 °C/min for 20 min, ramp to 275
°C at 75 °C/min for 20 min, 275 °C for 5 min, ramp to 160 °C at 75 °C/min to equilibrate
the system for the next run. Isoprene quantification was achieved using a standard of
known volumes of isoprene injected into 1 mL of paraffin oil in a 2 mL autosampler vial.
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Municipal Wastewater Handling
Municipal wastewater sludge was collected from the City of Lincoln Teresa Street
Water Resource Recovery Facility (Lincoln, NE, USA) [22]. Two different sludges were
collected anaerobically: one after primary anaerobic digestion, and another after
secondary anaerobic digestion and settling (before dewatering, disinfection, and
discharge). Aliquots (~50 g) were transferred to serum bottles and methanol (5 µL g−1)
was added as appropriate. Sludge samples were inoculated with 10% (w/v) SWW starter
cultures and incubated at 35 °C without shaking. Methane and isoprene synthesis were
measured as described above except 10 mL paraffin oil overlay was added. Isoprene was
detectable but not accurately measurable in the headspace when paraffin oil was omitted.
Sludge was not autoclaved until experiments were completed.

Results
Adapting Methanosarcina acetivorans to Growth in Wastewater
A challenge when introducing a laboratory methanogen strain to a wastewater
environment is their sensitivity to changes in osmolarity. M. acetivorans was originally
isolated from marine sediment and grows best under high-salt conditions (400 mM
NaCl). When introduced directly to a comparatively low solute environment such as
wastewater M. acetivorans rapidly lyses. To counteract this phenomenon, strains had to
first be adapted to growth in synthetic wastewater (SWW), a complex growth medium
containing mixed carbohydrates, lipids, and proteins that mimics the composition of
wastewater digester solids [23]. Cultures of M. acetivorans were gradually adapted by
supplementing our high-salt (HS) media with 10% (v/v) of synthetic wastewater every 24
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h until the media reached a ratio of 50:50 HS:SWW (8 days; final NaCl concentration
was 100.06 mM). At this point the methanogens were passaged into SWW supplemented
with MeOH and confirmed to grow without lysis via autofluorescence (Figure 2).
Measurement of Methane and Isoprene Production on Wastewater
Once growth was achieved in SWW, cells were transferred to wastewater
biosolids pre- and postdigest effluent (before and after second-stage anaerobic digestion)
from the Teresa Street Water Resource Recovery Facility in Lincoln, NE (Figure 3).
Microcosms with and without methanol supplementation were incubated for 5 days at 35
°C, after which time methane and isoprene yields were quantified (Table 1). Methane was
detected from predigest effluent whether or not methanol was added, indicating that
substrates for methanogens (both wild and engineered strains) were present in the effluent
(Figure 4).
Methane yield was higher in the postdigest effluent than the predigest effluent,
which was anticipated because wild methanogens are enriched during the anaerobic
digestion treatment step. When methanol was added to SWW, pre- or postdigester
effluent the methane yields were comparable to methane yields when isolated strains are
grown in defined medium [9]. No methane was detected when samples were heat-killed
by autoclaving microcosms before inoculating with engineered M. acetivorans,
suggesting active fermentation by the digester microbial community is necessary to
produce substrate unless the microcosm is supplemented with methanol. Isoprene was not
detected from predigest effluent microcosms or when wastewater was heat-killed by
autoclaving. Isoprene production was observed in postdigest effluent microcosms with
and without addition of methanol (Figure 4). With methanol supplementation, isoprene
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yields were equivalent to SWW cultures, which was similar to the isoprene yield
achieved by isolated strains grown in defined medium [9]. Based on these data we
estimate up to 0.77 ± 0.25% of dissolved organic carbon in postdigest effluent was
recovered as isoprene (Table 1). These data suggest engineered M. acetivorans can
compete with wild methanogens in anaerobic digesters and isoprene can be detected in
biogas from municipal waste. In pure batch culture the M. acetivorans ispS+ strain
produces 0.89 mmol isoprene per mol methanol per gram of cells [9], which is 180× the
yield of engineered Synechocystis cyanobacteria growing on CO2 [25]. In comparison, E.
coli and Saccharomyces have been engineered to produce 352 and 175 mM isoprene,
respectively, from glucose under fed-batch conditions [26,27]. It is unknown whether any
of these engineered strains can synthesize isoprene from digester effluent as has been
demonstrated by M. acetivorans in this work. Additional studies are needed to develop a
commercially viable process that optimizes isoprene recovery from wastewater digester
biogas streams.

Discussion
Our results confirm the hypothesis that engineered Methanosarcina acetivorans
can survive in municipal wastewater and produce isoprene at detectable levels. Methane
production was greater in wastewater biosolids which had undergone anaerobic digestion
compared with those samples grown in preanaerobic digestion biosolids. While there is
an incidental enrichment process during fermentation over time, the majority of microbes
found in municipal wastewater are known bacterial gut symbionts such as Proteobacteria,
Firmicutes, and Bacteroides [28], as well as a diverse collection of methanogens
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including Methanomicrobiales, Methanosarcinales, Methanobacteriales, and
Methanobrevibacter spp. [29–31]. It has been well documented that these organisms
exchange nutrients via syntrophy both in the gut and during wastewater treatment [32–
35] and methanogen growth is dependent on metabolic byproducts of upstream microbial
metabolism. The increase in methane production observed in samples grown in
wastewater postanaerobic digestate suggests the engineered M. acetivorans ispS+ strains
may be capable of participating in syntrophic relationships with other microbes in the
digestate.
After four days of incubation at 35 °C methane was detected though no isoprene
production was identified in samples grown in preanaerobic digested effluent, indicating
that there may not be enough freely available methanogenic substrates for the engineered
strains to compete with the existing microbial population. However, the postdigester
effluent inoculated with our isoprene-producing M. acetivorans incubated under the same
culture conditions yielded detectable bioisoprene (0.144 ± 0.273 mM). When this
postdigest effluent was supplemented with 125 mM of MeOH the yield was increased to
0.968 ± 0.144 mM. This indicates that isoprene production from wastewater is primarily
determined by the available substrate rather than environmental stressors. These results
demonstrate that engineered methanogens are viable as a drop-in additive to wastewater
treatment, and that the rate limiting factor for isoprene production is the rate at which the
syntrophic microbial community can produce metabolites necessary for methanogen
growth. By stimulating the microbial community, higher titers of bioisoprene production
may be achieved.
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Methanogens are a compelling source of renewable bioproducts due to their high
substrate to product ratio efficiency. Here, we have demonstrated that with minor
adaptation, it is possible to drop-in engineered methanogens to existing wastewater
environments and attain value-added products in addition to the processing of
wastewater. Due to existing capabilities for methane capture, many wastewater treatment
facilities are already equipped with the infrastructure necessary for the capture of gaseous
products such as isoprene. Separation of isoprene from biogas would require additional
investment in biogas refining. However, isoprene separation from biogas streams is
expected to be compatible with existing biogas upgrading technologies that are used to
separate CO2 and enrich methane content to produce renewable natural gas. Our results
suggest there may be promising potential for utilizing methanogens as a platform for lowcost production of synthetic materials without expensive feedstocks or extensive
modification of existing renewable natural gas facilities.
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Figure 1. Schematic representation of anaerobic digestion of waste biomass at the
Theresa Street Water Resource Recovery facility in Lincoln, NE. After aerobic
incubation, waste biomass is anaerobically digested in a two-step process. First, the
complex biomolecules are degraded through heterotrophic fermentation to less complex
substrates for methanogenic growth in the second stage. In the methanogenic bioreactor
dissolved organic carbon is converted to biogas that can be recouped as a biofuel.
Introduction of isoprene-synthesizing methanogens (e.g., strain NB 394 in which plasmid
pJA2 expressing isoprene synthase is integrated onto the chromosome) to the second
stage digester has potential to produce renewable isoprene in the captured biogas.

(a)
(b)
Figure 2. Engineered methanogens adapted to synthetic wastewater. (a) Inoculated
synthetic wastewater (SWW) in anaerobic Balch tubes. (b) Confirmation of live
engineered methanogens in SWW under 400× optical magnification. Viable methanogens
are irregular cocci (0.5–1 µm diameter) that fluoresce blue through a DAPI filter when
UV illuminated.
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Figure 3. Municipal wastewater collected from the Theresa Street Water Resource
Recovery Facility in Lincoln, Nebraska. (Left) Organic solids before anaerobic digestion.
(Right) Organic solids after anaerobic digestion.
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Table 1. Methane and isoprene production on wastewater biosolids.
Synthetic Waste Water
Predigest Effluent
Postdigest Effluent
CH4a Production
Substrate Strain b
mmol L−1
Std Dev
mmol L−1
Std Dev
mmol L−1
Std Dev
att:VOC
84.64
6.19
80.98
7.34
89.87
2.94
c
MeOH
att:ispS
83.89
8.32
80.22
9.42
87.63
6.98
att:VOC
NT
33.85
1.64
31.36
12.30
None
att:ispS
NT
26.36
2.74
54.82
4.57
att:VOC
ND
ND
ND
Heat killed
att:ispS
ND
ND
ND
Isoprenea Production
Substrate
Strain
mmol L−1
Std Dev
mmol L−1
Std Dev
mmol L−1
Std Dev
att:VOC
ND
ND
ND
c
MeOH
att:ispS
0.972
0.301
ND
0.968
0.312
att:VOC
NT
ND
ND
None
att:ispS
NT
ND
0.144
0.273
att:VOC
ND
ND
ND
Heat killed
att:ispS
ND
ND
ND
a Data were obtained from triplicate biological replicates and triplicate technical replicates (n = 9);
b att:VOC, parent strain in which vector only negative control (plasmid pNB730) was integrated onto the chromosome.
att:ispS, strain in which plasmid pJA2 expressing isoprene synthase was integrated onto the chromosome;
c calculated from 125 mmol MeOH (e.g., 250 µL 100% MeOH added to 50 g digester solids) as described in the
Materials and Methods (Section 2.5).
NT, Not tested. ND, Not detected.

(a)

(b)

Figure 4. Methane and isoprene production from waste biosolids. Endpoint methane
assays after M. acetivorans strains were added to unsterilized wastewater biosolids
digestate or synthetic wastewater (SWW) amended with methanol. (a) Methane
production by isoprene-producing M. acetivorans (att:ispS) and vector only control
(att:VOC) strains added to predigest effluent, postdigest effluent, or SWW with
(w/MeOH) and without (w/o MeOH) added methanol. (b) Isoprene production by M.
acetivorans att:VOC and att:ispS strains added to SWW or postdigest effluent
amended with methanol and postdigest effluent without added substrates. Blue,
att:VOC strain in which empty vector pNB730 is integrated onto the chromosome.
Red, att:ispS strain in which plasmid pJA2 expressing isoprene synthase is integrated
onto the chromosome. All data were obtained from triplicate biological and technical
replicates (n = 9).
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Chapter 5: Expression of isoprene synthase in Methanosarcina
acetivorans reveals energetic adaptations and links to amino
acid biosynthesis.
This chapter to be submitted for publication
Abstract
Methane-producing archaea (methanogens) are a promising platform for biorefining due
to their efficient central metabolism and use of inexpensive substrates. We engineered a strain of
the methanogen Methanosarcina acetivorans to produce the volatile hemiterpene isoprene in
addition to methane. Characterization of the engineered methanogen against a vector-only control
showed no significant variation in growth rate, carrying capacity, or methane production despite
the additional energetic burden and depletion of DMAPP, an essential lipid precursor. Differential
expression analysis of the isoprene producing methanogens showed shifts in genes associated
with membrane permeability and cellular energy conservation. A decrease was observed in genes
associated with the uptake of sodium as well as C1 transporting cofactors while the proteins
associated with the metabolic transition of purines between nucleotide and amino acid synthesis
was upregulated. We propose this shift supports our hypothesis that the production of isoprene in
Methanosarcina acetivorans is not treated as an increased burden but rather treated as a
respiratory byproduct.
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Introduction
Methanogens, anaerobic methane producing archaea, are key organisms in the global
carbon cycle and are predicted to play a major role in global carbon cycle and play a major role in
climate change[1-3]. One of the most defining features of methanogens beyond the production of
methane as a byproduct of their central respiration is their ability to efficiently grow utilizing low
energy substrates as their primary carbon and energy source[4, 5]. In order to subsist on these low
energy substrates, methanogens utilize a highly efficient central respiration strategy known as the
Wolfe Cycle [1, 5, 6]. In the Wolfe Cycle, methanogenic substrates are reduced to methane and
oxidized to carbon dioxide, driving the establishment of a chemiosmotic gradient through the
coupling of cofactor regeneration with the transportation of H+ and Na+ ions which is harnessed
for ATP synthesis (Figure 1) [1, 5, 7-9]. This cycle produces only a fraction of an ATP for each
substrate molecule entering the pathway, which results in respiration reactions making up over
99% of the biochemistry carried out within the methanogen[4]. From a biotechnical standpoint,
this is appealing as the emphasis on respiration over biomass accumulation drives a high
substrate:product ratio so long as the desired product does not interfere with methanogenic
homeostasis. Recently our laboratory examined the effects of introducing the gene for isoprene
synthase, IspS, to observe how Methanosarcina spp. reacted to the energetic burden of producing
a non-native metabolite [10, 11]. As isoprene is synthesized via the consumption of dimethylallyl
pyrophosphate (DMAPP), the precursor to archaeal membrane biosynthesis, it was assumed that
the production of isoprene would result in decreased growth rate or diminished biomass
accumulation. However, it was observed that the isoprene producing strains did not show any
significant decrease in growth rate, rather there was an increase in total biomass accumulation
and a ~20% decrease in CO2 production. This stoichiometric decrease in CO2 production related
to the 4% total substrate carbon being diverted towards isoprene production lead us to postulate
that the production of isoprene is being linked to methanogenesis as a respiratory byproduct
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rather than a secondary metabolite, fulfilling the metabolic purpose of CO2 respiration in the
regeneration of methanogenic cofactors, namely ferredoxin. To further understand how this
phenotype is achieved and how the cells react to this new pathway, we performed transcriptomic
analysis on the isoprene producing strains against a vector only control.

Methods
Strains and anaerobic culturing techniques. Anaerobic procedures were performed in a Btype Coy anaerobic chamber (Coy Labs, Grass Lake, MI). The internal gas composition of the
anaerobic chamber is maintained at 5% H2 / 20% CO2 / 75% N2 (± 3%). An isoprene producing
strain, NB394 (Δhpt::ϕC31 int, att:pJA2), and an isogenic vector only control strain, NB452
(Δhpt::ϕC31 int, att:pNB730) were grown in triplicate in high salt (HS) media supplemented with
methanol as a carbon and energy source [200 mM NaCl, 45 mM NaHCO3, 13 mM KCl, 54 mM
MgCl2•6H2O, 2 mM CaCl2•2H2O, 2 µM 0.1% resazurin (w v-1), 5 mM KH2PO4, 19 mM NH4Cl,
2.8 mM cysteine•HCl, 0.1 mM Na2S•9H2O, trace elements, vitamin solution, 125mM methanol]
as previously described [12]. Cells were inoculated in the anaerobic chamber and incubated
outside of the chamber in glass Balch tubes sealed with butyl rubber stoppers (Belco Glass,
Vinelane, NJ) at 35° until late exponential phase (OD600 7.0-8.0).
RNA Sequencing
The cells were harvested with TRI Reagent™ (Invitrogen™) according to the
manufacturers’ protocol. RNA quantity and purity were measured via Nanodrop before
transportation to GeneWiz for sequencing (Table 1). RNA integrity was assayed via agarose gel
and revealed no significant degradation or contamination (Figure 2). The RNA was treated with
DNase before ribosomal RNA depletion using Ribo-Zero Plus rRNA Depletion kit (Illumina)
according to the standard protocol. The treated RNA was sequenced on an Illumina HiSeq
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providing paired-end 2x150bp sequencing (Azenta Life Sciences, South Plainfield, NJ). The
samples produced 396,282,199 reads with a mean quality score of 38.3 and 92% of the reads
being ≥30. With help from the UNL Bioinformatics core facility, reads were mapped against the
canonical genome of Methanosarcina acetivorans C2A (GCA_000007345) using Bowtie2 as
described by Owens et al. [13] resulting in a coverage of 97.32%. It should be noted that the
genome of C2A contains slight variations from the parental strain used to create these strains
(NB34) including the addition of a phage integration (φC31) site and recombinase expression
cassette where the plasmids integrated [14]. Differential expression analysis was carried out using
DESeq2 with a significance cutoff of <P=0.05 [15].

Results
The RNA sequences mapped against the M. acetivorans C2A genome revealed 4914
protein coding genes. Differential expression analysis was performed using DEseq2 revealing 55
significant differentially expressed genes (Figure 3, Table 2) and 73 significantly differentially
expressed non-coding RNAs. The most highly upregulated genes were those associated with the
tryptophan biosynthesis pathway (Figure 4).
Filtering out any genes with a differential expression of less than 2-fold and factoring a
5% false discovery rate, the pool of differentially expressed genes were narrowed down to the top
14 most significantly expressed (Figure 5, Table 3). Many of the genes previously identified as
differentially expressed via qRT-PCR previous [10] did not meet the significance cutoff. This
could have been a result of variations in preparation or a biproduct of selecting only a handful of
select genes rather than surveying the entire transcriptome. Among the most downregulated genes
in isoprene producing methanogens were the genes encoding for an aldolase associated with the
production of methanopterin (figure 6), an important methanogenic cofactor which facilitates the
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C1 transportation from substrates through the reduction to a methyl group as well as genes
associated with the import of sodium and a Zn2+/Mn2+ permease. The Zn2+/Mn2+ permease is part
of a larger metal transport operon promoted by a metal dependent transcriptional regulator. A
decrease in the production of these enzymes would result in a less permeable cellular membrane
and restrict the flow of the Na+ ions to import through the membrane bound ATPase. Additionally
downregulated was an uncharacterized MA1715-like protein which contains domains required for
optimum growth in methanogens with sulfide as the sole sulfur source.
Genes upregulated in isoprene producing M. acetivorans included several proteins of unknown
function. An inorganic pyrophosphatase was upregulated not as part of any known operon as well
as a molybdopterin synthase associated with molybdenum cofactor biosynthesis. An operon
containing the initiation factor IF-2 as well a DNA binding protein and 5-formaminoimidazole-4carboxamide-1-(beta)-D-ribofuranosyl 5'-monophosphate synthetase was upregulated indicating
an increase in ribosomal recruitment for the translation of mRNA. The upregulation of PurP
(GeneID 1475582) is of particular interest as this gene is considered a signature gene of archaea
[16]. Increased expression of PurP is significant as it is responsible for the branching point in
purine biosynthesis between amino acid biosynthesis and the IMP and subsequently AMP, ADP,
and ATP. Increased expression of PurP would correlate with increased energetic flexibility,
allowing for the diverting of carbon and nitrogen from amino acid biosynthesis to energy as
required by the cell. It would be worthwhile to assay whether this increase in expression
correlates to increased enzymatic activity utilizing the Bratton-Marshall assay [17] in isoprene
producing cells as an increase in metabolic flexibility could be relevant for future trait stacking
experiments.
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Discussion
Central methanogenesis is a highly efficient respiratory pathway with very little energetic
latitude for change. Of the 4914 protein coding genes identified only a small percentage of these
were found to be differentially expressed in Methanosarcina acetivorans strains producing
bioisoprene. This indicates that isoprene biosynthesis does not have a major impact in the overall
functioning of the organism, elicit a stress response, or interfere with central methanogenesis.
With the expression of IspS and the production of isoprene we expected either a decrease in
growth rate as a response to the depletion of dimethylallyl pyrophosphate (DMAPP) the precursor
to isoprenoid lipid formation in archaea or a diminished final carrying capacity as a result of
carbon destined for cellular division was diverted towards a non-usable volatile compound.
However, phenotyping and metabolic flux analysis revealed no significant variation in growth
rate or carrying capacity [10]. Flux balance analysis revealed 4% of substrate carbon being
allocated towards the production of isoprene and a 20% decrease in CO2 production. This
stoichiometric shift in flux indicates the carbon which would otherwise be directed towards the
oxidation of methyl substrates towards CO2 is instead being diverted towards isoprene
production. The energetic limitations and highly consistent nature of methanogenesis suggest that
without the reducing equivalents generated through the oxidation of methyl substrates the
generation of methane would not be possible [6, 18]. However, no decrease in methane
production was observed in methane producing Methanosarcina acetivorans. This left us with the
hypothesis that the production of isoprene was serving the metabolic function of the oxidation of
methyl substrates to CO2.
Given the energetic limitations of methanogenesis, when analyzing the differential
expression of genes between isoprene producing M. acetivorans and a vector only control we
were cognizant of the expression of stress response genes. The response of methanogenic archaea
towards various stressors has been documented including those in response to heat, oxygen, pH,
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osmotic shift, nutritional variation, heavy metals, and antibiotic stressors [19, 20]. If the
expression of isoprene synthase and the production of isoprene depleted metabolite pools we
would have seen an increase in expression of the genes associated upstream of those metabolites
to increase their abundance and to relieve the metabolic bottleneck. No genes associated with
either the mevalonate pathway or lipid biosynthesis was observed. In bacteria which have been
engineered express a heterologous mevalonate pathway toxicity was observed as a result of the
accumulation of diphosphates [21]. The generation of excess PPi did not seem to generate any
cytotoxic response though the increased expression of the inorganic diphosphatase does reflect
the cell utilizing the available free diphosphate generated as a result of the conversion of DMAPP
to isoprene. There was no detected protein stress response such as an increase in the expression of
chaperone proteins including Hsp70, Hsp60, or Hsp40 as well as no increase in genes associated
general stress reduction [22, 23], or most importantly starvation [24]. If the synthesis of isoprene
is an energetic burden to the cell we would expect to see an increase in genes associated with the
ATP synthesis to make up for the deficit. This response would have elicited an increase in genes
associated with the incomplete TCA cycle found in methanogens [25, 26] or have facilitated an
upregulation of genes associated with central methanogenesis to generate the required reducing
equivalents to stimulate the required to generate ATP through membrane found ATPases [5, 6].
We did not observe any significant upregulation in any of those genes. We did observe a
significant decrease in the expression of an aldolase associated with the biosynthesis of
methanopterin [27] and the sodium symporter PutP. The decrease in expression of genes
associated with the chemiosmotic gradient responsible for the regeneration of methanogenic
cofactors as well as ATP biosynthesis further supports our previous assessment that the
production of isoprene is treated by the cell as an alternative respiratory pathway. Both
methanopterin and PutP are involved in the utilization of ferredoxin (Fd) whose regeneration
drives the methanogen’s membrane bound ATPase.
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The change in expression for redox carriers and an increase in genes associated with
purine and amino acid biosynthesis as a result of a product of the Mevalonate pathway is
interesting. All chemistry in a methanogen is tied back to methanogenesis via either redox
carriers or ATP generation[4]. A key component in this pathway is the regeneration of redox
carrier ferredoxin from its reduced to its oxidated state through the utilization of the enzyme
complex Rnf [6, 18, 28]. The energy required for the reaction is driven by the export of Na+ ions
which would have been affected by the downregulation of PutP, reducing Na+ concentration in
the cell. We have theorized that the synthesis of isoprene is able to fulfil the role of regenerating
ferredoxin during the Mg2+ assisted phosphatase reaction which forms isoprene (Figure 7). This
would also explain the decrease the expression of the Zn2+ and Mn2+ permease found in M.
acetivorans which would decrease the metallic ions cell-wide.
The increase in expression of genes associated with the metabolic routing of purine
backbones between nucleotide and amino acid synthesis is interesting as it could allow for more
flexibility between energy production and amino acid biosynthesis. Of all of the genes associated
with amino acid synthesis, the increase in tryptophan biosynthesis is curious as the TRP pathway
is an important regulator in nitrogen utilization in the cell and indicates the potential for further
genetic engineering in that pathway. Tryptophan is the most energetically costly of the amino
acids to produce and is tightly regulated in most organisms, often with regulation imposed upon
multiple levels [29-31]. In methanogens, the biosynthesis of tryptophan appears to be regulated
both from a transcriptional level but also through the interactions with small RNAs [32, 33]. That
these engineered methanogens appear to be enhancing expression of tryptophan biosynthetic
genes could indicate the pushing of carbon towards this branch of metabolism. Although
methanogens do not natively produce terpenes, this indicates that further engineering could be
utilized to produce higher ordered terpenes while sidestepping the sequestration of metabolic
precursors necessary for membrane biosynthesis. This is promising as an increase in flux through
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the tryptophan biosynthetic pathway could lead to higher metabolite pools for (3-indolyl)glycerol phosphate, opening the door to the biosynthesis of indole diterpene alkaloids alongside
terpenoid backbones generated through a modified mevalonate pathway.
It should be noted that changes in abundance of transcripts most likely corresponds to
changes in protein levels, the magnitude of the correlation is often variable and difficult to predict
[34, 35]. Further investigations into the direct shift in protein abundance is required to validate
these results as well as an in-depth analysis of the small non-coding RNAs found to be
significantly varied in isoprene producing methanogens.
Conclusions: Isoprene production in the engineered methanogen M. acetivorans showed
unexpected variation in genes associated with membrane permeability and energy conservation.
The lack of change in growth-phenotype as well as no significant increase in genes associated
with stress response indicates the cell is not treating the production of isoprene as a burden. Shifts
in energy conservation mechanisms such as an increase in the metabolic router between amino
acid and nucleotide biosynthesis indicate an increased flexibility between energy production and
biomass accumulation. The limitation of multiple ion channels suggests a restriction of sodium
uptake to the energy producing ATPase which could denote an alternative method for increasing
energetic efficiency. The varied response from multiple, seemingly distantly related pathways
further emphasizes the importance of systems level analysis in organisms with novel introduced
metabolic pathways.
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Figures and tables

Figure 1: The Wolfe Cycle of methanogenesis[4]
The direction of arrows represents the direction of biochemical reactions. Reactions which are
utilized in every methanogenic pathway are represented in black. Hydrogenotrophic
methanogenesis is represented in red. Methyl respiration is represented in orange. Methylotrophic
methanogenesis is represented in green. Acetoclastic methanogenesis is represented in fuchsia.
Degradation of polyaromatic hydrocarbons is represented in dark blue [36]. Ethylene and long
chain alkane reduction is represented in purple [37]. Carboxydotrophic methanogenesis is
represented in cyan. CoB-SH, coenzyme B thiol; CoM-SH, Coenzyme M thiol; CoM-S-S-CoB,
coenzyme M-coenzyme B heterodisulfide; Fd, ferredoxin; Fdred, reduced ferredoxin; H4MPT,
tetrahydromethanopterin; MFR, methanofuran; MPh, methanophenazine; MPhH2, reduced
methanophenazine. Enzymes involved in the Wolfe Cycle: a) Formyl-methanofuran
dehydrogenase (Fmd), b) Formyl-methanofuran:H4MPT formyl transferase (Ftr), c) MethenylH4MPT cyclohydrolase (Mch), d) F420-dependent Methylene-H4MPT dehydrogenase (Mtd), e)
F420-dependent Methylene-H4MPT reductase (Mer), f) Methyl-H4MPT:coenzyme M
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methyltransferase (Mtr), g) Methyl-coenzyme M reductase (Mcr), g*) Atypical methyl-coenzyme
M reductase (Mcr) [38], h) Electron-bifurcating hydrogenase:heterodisulfide reductase complex
(Mvh:HdrABC), i) F420-reducing hydrogenase (Frh), j) Energy-converting sodium pumping
ferredoxin hydrogenase, k) Ferredoxin reducing hydrogenase (Eha/Ech), l) Proton-translocating
methanophenazine:heterodisulfide reductase (HdrED), m) Sodium–proton antiporter (MrpA), n)
F420 proton-pumping methanophenazine reductase (Fpo).

Table 1. Yield and purity of RNA samples assessed via NanoDrop spectrophotometer.
Sample Name

Harvest Yield

260/280

260/230

(NG/uL)
Iso1

2861.42

2.01

2.18

Iso2

678.99

2.04

1.98

Iso3

2357.49

2.02

2.20

Voc1

3241.45

2.03

2.14

Voc2

3406.78

2.01

2.08

Voc3

2744.50

2.16

2.16
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Figure 2. Confirmation of RNA integrity prior to cDNA synthesis. Total RNA from isoprene
producing strains (att:ispS) and a vector only control (VOC) strains were harvested via TRI
Reagent and run on an agarose gel. The presence of defined 23s, 16s, and 5s bands without
smearing indicates high quality RNA without any significant degradation.
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Figure 3. Heatmap of significantly expressed genes in isoprene producing methanogens
compared against a vector only control. The first three columns on the left (coral) indicate M.
acetivorans containing only the vector backbone (VOC) whereas the three columns on the right
(teal) indicate isoprene producing M. acetivorans (ISO). Genes shaded blue represent a decrease
in expression compared with the vector only control whereas genes shaded red indicate increased
expression in isoprene producing M. acetivorans.
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Table 2. Differentially expressed genes in isoprene producing methanogens.
GeneID

Gene MA_RS#

1474886

MA_RS15690

1473305

1473306

MA_RS07355
MA_RS15680
MA_RS15685
MA_RS07360

1473307
1473574

1474884
1474885

1474119
1472842
43446072
1474295
1472767
1472768
1474112
24782598
43446071
43446070
1474113
43446067
1473139
1474802
1474121
1474123
43446068
1475849
1472766
1474116
1474021
43446085
1474122
1476509
1475732
1472545
43446210

log2
Fold
Change
4.57

pvalue

padj

Annotation

5.64E-14

6.92E-11

4.32

2.54E-06

0.000541

indole-3-glycerol-phosphate
synthase
hypothetical protein

3.89

0.000127

0.013862

tryptophan synthase subunit alpha

3.81

1.94E-09

9.53E-07

tryptophan synthase subunit beta

3.66

1.10E-11

7.73E-09

MA_RS07365

3.33

5.36E-10

2.92E-07

MA_RS08745
MA_RS11565
MA_RS04950

2.18

5.44E-05

0.007026

ABC transporter ATP-binding
protein
energy-coupling factor transporter
transmembrane protein EcfT
metallophosphoesterase

2.14

5.82E-09

2.38E-06

tyrosine-type recombinase/integrase

2.12

1.34E-05

0.002271

MA_RS26935
MA_RS12485

2.03

0.000146

0.015289

iron ABC transporter substratebinding protein
hypothetical protein

2.00

6.11E-20

1.50E-16

MA_RS04555
MA_RS04560
MA_RS11535
MA_RS00485
MA_RS26930
MA_RS26925
MA_RS11540
MA_RS26910
MA_RS06495

1.98

3.67E-05

0.005006

ISL3-like element ISMac21 family
transposase
hypothetical protein

1.95

9.20E-06

0.001736

hypothetical protein

1.90

4.81E-06

0.000984

tyrosine-type recombinase/integrase

1.80

3.33E-07

0.000102

hypothetical protein

1.79

4.07E-07

0.000117

hypothetical protein

1.77

0.000196

0.019276

hypothetical protein

1.77

2.36E-09

1.05E-06

hypothetical protein

1.74

1.58E-12

1.29E-09

hypothetical protein

1.73

3.67E-05

0.005006

MA_RS15235
MA_RS11575
MA_RS11585
MA_RS26915
MA_RS20635
MA_RS04550

1.70

1.32E-05

0.002271

methyltransferase domaincontaining protein
SAM-dependent methyltransferase

1.65

6.73E-05

0.00846

1.65

8.16E-11

5.01E-08

DUF927 domain-containing protein

1.64

1.16E-12

1.14E-09

hypothetical protein

1.62

8.82E-05

0.010558

sodium/proline symporter PutP

1.54

0.00012

0.013656

MA_RS11550
MA_RS11085
MA_RS27000
MA_RS11580
MA_RS24085
MA_RS20025
MA_RS03435
MA_RS27625

1.54

9.04E-06

0.001736

PQQ-binding-like beta-propeller
repeat protein
hypothetical protein

1.53

1.06E-05

0.001929

Fic family protein

1.44

0.000616

0.045767

hypothetical protein

1.44

1.73E-05

0.002835

hypothetical protein

1.41

9.07E-07

0.000234

2-isopropylmalate synthase

1.34

1.98E-05

0.003138

hypothetical protein

1.30

5.27E-07

0.000144

hypothetical protein

1.25

0.000298

0.025173

hypothetical protein

hypothetical protein

126
MA_RS11570
MA_RS20285
MA_RS01155
MA_RS14560

1.25

2.38E-06

0.000532

AAA family ATPase

1.23

0.000266

0.024171

sodium/proline symporter PutP

1.20

0.00041

0.032439

sodium/proline symporter PutP

1.19

0.000308

0.025451

MA_RS25400
MA_RS00010
MA_RS13595
MA_RS20290
MA_RS09070

1.17

2.31E-07

7.55E-05

class I SAM-dependent
methyltransferase
translation initiation factor eIF-1A

1.14

4.81E-05

0.006372

sodium/proline symporter PutP

1.13

1.21E-07

4.42E-05

tetratricopeptide repeat protein

1.11

0.000202

0.01944

sodium/proline symporter PutP

1.11

1.26E-07

4.42E-05

MA_RS16660
MA_RS09160

1.09

1.91E-06

0.000447

ABC transporter ATP-binding
protein
sodium/proline symporter PutP

1.04

0.000445

0.03414

MA_RS09425
MA_RS16655

1.04

2.32E-05

0.003562

1475082

1.01

0.000244

0.022976

1476274

MA_RS22905

-1.29

3.00E-05

0.004332

1476102

-1.36

0.000158

0.016116

-1.53

2.90E-05

0.004319

hypothetical protein

-1.65

0.000283

0.024788

ammonium transporter

-2.19

4.40E-18

7.20E-15

hypothetical protein

1471916

MA_RS21965
MA_RS15590
MA_RS21960
MA_RS07530
MA_RS00120

MarR family transcriptional
regulator
methylamine methyltransferase
corrinoid protein reductive activase
P-II family nitrogen regulator

-2.29

0.000146

0.015289

1474111

MA_RS11530

-2.71

2.99E-30

1.47E-26

ABC transporter ATP-binding
protein
sodium/proline symporter PutP

1474120
3362158
3362133
1474675
32154456
1471895
1474498
3362159
1473635
1475083
1473651
3362146

24782985
1476101
24782745

nickel-responsive transcriptional
regulator NikR
sodium/proline symporter PutP
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Figure 4. Upregulated genes associated with tryptophan biosynthesis in isoprene producing
Methanosarcina acetivorans. The genes involved in tryptophan biosynthesis are indicated in red,
Phosphoribosyl-anthranilate isomerase (trp1), tryptophan biosynthesis protein subunit A (trpA),
tryptophan biosynthesis protein subunit B (trpB), tryptophan biosynthesis protein subunit C
(trpC). The green circles indicate the fold change increase in expression of the genes.
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Figure 5. Most significantly differentially expressed genes in isoprene producing M. acetivorans.
The X-axis indicates log-fold change with genes downregulated in isoprene producing M.
acetivorans on the left and upregulated genes on the right. The Y-axis indicated the magnitude of
significance of the of the differential expression. Genes significantly downregulated are colored
blue whereas genes significantly upregulated are represented in red. Genes either below 2-fold
change in expression or below a significance of p=0.05 are shaded grey.
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Table 3. Most significantly differentially expressed genes in isoprene producing M. acetivorans
in figure 5. A blue dot indicates which were downregulated in isoprene producing M. acetivorans
whereas a red dot indicates genes which were upregulated.
Gene ID

P Value

Log

Gene Name

Function

Genome Context

Aldolase

Sugar

Monocistronic

Fold
Change
1474555● 2.99E-30

-2.71

metabolism,
methanopterin
synthesis.
Methanopterin is
a primary
coenzyme
responsible for
C1 transport
during
methanogenesis.
1473603● 4.40E-18

-2.19

Uncharacterized

Required for

MA1715-like protein

optimum growth

Monocistronic

with sufide as
the sole sulfur
source.
1471917● 0.000146 -2.29

Metal ABC

Mn2+/Zn2+

Part of a potential

transporter permease

transport system

metal transport
operon promoted by
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permease

a GeneID 1471914, a

component.

metal-depented
transcriptional
regulator.

1474813● 6.11E-20

2.00

1474576● 0.000146 2.03

Hypothetical

Unknown.

Monocistronic

SDR family

Short chain

Part of an operon

oxidoreductase

NAD-/NADP-

otherwise filled with

dependent

Domains of

oxidoreductase.

Unknown Function.
Unknown regulator.

1473006● 1.34E-05

2.12

ABC transporter

Contains SalY

Part of an operon

permease

domain which in

regulated by GeneID

other organisms

1473010, a MarR

functions as an

family transcriptional

antimicrobial

regulator.

peptide transport
system.
1474565● 5.82E-09

2.15

Inorganic

Pyrophosphatase

Monocistronic
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Figure 6. Structure of methanopterin. Methanopterin is an essential coenzyme in methanogenesis
responsible for the transfer of methyl groups during the reduction into methane or oxidation into
CO2.

Figure 7. Effect of isoprene production on metabolite and redox flux M. acetivorans. The
blue ring represents the methanogen cell membrane. Proteins encoded by genes which
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showed decreased expression in isoprene producing M. acetivorans are represented in
red. Proteins encoded by genes which showed increased expression in isoprene producing
M. acetivorans are shown in green. MVA; mevaolate pathway. Fd; ferredoxin.
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Abstract
Microbial metabolism and trophic interactions between microbes give rise to
complex multispecies communities in microbe-host systems. Bacteroides
thetaiotaomicron (B. theta) is a human gut symbiont thought to play an important role in
maintaining host health. Untargeted nuclear magnetic resonance metabolomics revealed
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B. theta secretes speciﬁc organic acids and amino acids in deﬁned minimal medium.
Physiological concentrations of acetate and formate found in the human intestinal tract
were shown to cause dose-dependent changes in secretion of metabolites known to play
roles in host nutrition and pathogenesis. While secretion ﬂuxes varied, biomass yield was
unchanged, suggesting feedback inhibition does not affect metabolic bioenergetics but
instead redirects carbon and energy to CO2 and H2. Flux balance analysis modeling
showed increased ﬂux through CO2-producing reactions under glucose-limiting growth
conditions. The metabolic dynamics observed for B. theta, a keystone symbiont
organism, underscores the need for metabolic modeling to complement genomic
predictions of microbial metabolism to infer mechanisms of microbe- microbe and
microbe-host interactions.

Introduction
Microbes, whether in the environment or associated with host organisms, form
complex multispecies communities that cooperate and compete to metabolize nutrients.
The host gut ecosystem is a constantly changing landscape where symbiont organisms
manage to establish long-term colonization despite the fact that the host regularly ingests
and eliminates nutrients and transient microbes. This results in a constantly ﬂuctuating
environment where diverse microbes are secreting metabolic fermentation products and
other secondary metabolic chemicals that may inhibit or stimulate neighboring organisms
as they compete for nutrients. While there is recognition that microbes play important
roles in host nutrition, health, and disease (1), it is difﬁcult to conceptualize how diverse
microbes interact with each other and the host in such a way as to be able to develop
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treatments or recommendations that preserve host-symbiont and beneﬁcial microbemicrobe interactions while disfavoring pathogens.
Considering that bacterial virulence factors are often triggered by nutritional
limitation (carbon, nitrogen, phosphorous, iron, etc.) (2–4) or physical stress
(temperature, oxidative burst, etc.) (5, 6) and, at the molecular level, cause changes in
intracellular metabolic ﬂux and redox state/energy charge (7), the availability of nutrients
and the physical factors that inﬂuence metabolism are at the crux of whether microbes
induce virulence factors. Virulence factors such as cell invasion, chemotaxis, and
siderophore and antibiotic synthesis, among others, can be recast as “nutrient searching”
behaviors that are triggered by changes in the environment that result in decreased
intracellular metabolic ﬂuxes (8). Quorum sensing, in which bacteria secrete a small
molecule that triggers expression of community-level behavior (sporulation, adherence,
virulence, etc.) when it reaches a critical concentration (9), can also be “eavesdropped”
by neighboring organisms in anticipation of intensiﬁcation of competition for nutrients
(10).
Symbionts have evolved to cooperate with hosts to establish long-term
colonization strategies that do not result in disease and even protect the host from
pathogens. It has been shown that establishing host-symbiont trophic relationships
protects hosts from virulent interlopers by physically and nutritionally limiting the ability
of pathogens to establish infections (11, 12), stimulating gut epithelial growth (13), and
also modulating local immune response to maintain a healthy state (14, 15). It is
hypothesized that perturbations of symbiont bacterial metabolism, such as through diet or
antibiotic use, can disrupt this natural defensive relationship and predispose the host to
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disease by allowing pathogens to gain a metabolic foothold (16). By this reasoning, the
dynamic interplay of nutrition and metabolism of colonizing symbiont bacteria (17) is
crucial as they form the foundation of the host microbiome community with which
transient and pathogenic microbes must compete for survival.
Bacteroides species are Gram-negative bacteria that are especially adept at
metabolizing complex carbohydrates (18) and are often the dominant bacterial phylum in
the digestive systems of many herbivorous and omnivorous animals, including humans
(19). Bacteroides thetaiotaomicron (B. theta) is a nonpathogenic human gut symbiont
that colonizes infants within a day of normal birth (20, 21). While B. theta is classiﬁed as
nonpathogenic and has been shown to protect the host from Salmonella infection (22), it
was shown to exacerbate infection by Citrobacter rodentium in a mouse model of
enterohemorrhagic Escherichia coli (EHEC) disease (23), underscoring the complicated
contributions of symbiont microbes to human health and disease. B. theta is closely
related to sister species (24) that are implicated in irritable bowel disease (25) and
periodontal disease (26) and has also been shown to carry and transmit antibiotic
resistance genes through proﬂigate conjugation with other bacteria (27, 28).
It was previously shown that B. theta secretes acetate, formate, propionate, and
succinate into culture medium (29–31). Bacteroides species have been shown to produce
low-molecular-weight heat-stable compounds that impair host defense by inhibiting
migration and killing polymorphonuclear leukocyte (PMN) phagocytes (32, 33).
Succinate and propionate, as low-molecular-weight heat-stable metabolites, have been
hypothesized to ﬁt the description and were shown to irreversibly inhibit superoxide and
hydrogen peroxide production by neutrophils by lowering cytoplasmic pH (34).
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Propionate-secreting B. theta have also been shown to protect mice from colonization by
Salmonella, presumably due to the same membrane-permeable pH-lowering property that
is inherent to short-chain fatty acids (22). Acetate is also a membrane permeable (35)
“switch” that reduces ATP synthesis in E. coli and regulates expression of virulence
genes in many bacteria (36). Secretion of acetate, formate, propionate, and succinate by
B. theta is therefore proposed to reduce the effectiveness of host response to pathogens
and to have species-speciﬁc effects (enhancing or abrogating) bacterial colonization and
virulence.
B. theta secretes metabolites as a result of starch, extracellular matrix, or glucose
metabolism (18). B. theta catabolizes glucose via the Embden-Meyerhof-Parnas (EMP)
pathway (glycolysis) to pyruvate, which is a major intracellular metabolite used as the
substrate in gluconeogenesis, the tricarboxylic acid cycle (TCA cycle), and for
biosynthesis of acetyl coenzyme A (acetyl-CoA), enzyme cofactors, and amino acids.
Acetate, the major secreted product, can be synthesized with ATP using two metabolic
pathways: (i) by hydrolysis of the CoA thioether bond by acetyl-CoA synthase (Acs) in
the acetyl-CoA pathway, or (ii) by phosphotransacetylase (Pta) and acetate kinase (Ack)
enzymes in the Ack/Pta pathway (see Table S1 in the supplemental material). The high
concentration of secreted acetate suggests acetate is the primary energy-conserving
overﬂow (37) by-product of B. theta. The second most abundant secreted product is
succinate, which is produced by hydrolysis of succinyl-CoA by succinyl-CoA synthetase
with generation of ATP in the TCA cycle. In the forward TCA cycle direction, succinate
is funneled to succinate dehydrogenase, which oxidizes succinate to fumarate with the
generation of reduced ubiquinone for generating a transmembrane proton gradient for
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ATP synthesis. These data suggest rapidly growing B. theta cells are limited in the
turnover rate of reduced/oxidized quinone and secrete succinate as an intermediate
product to maintain rates of glycolysis and glucose consumption (38). In the reverse TCA
direction, succinate synthesis requires ATP and HCO3 – (pyruvate carboxylase), NADH
(malate dehydrogenase), and reduced quinone (succinate dehydrogenase), and though
enzyme steps are reversible, succinate synthesis by reverse TCA can only occur when
there is a surplus of ATP generated as a result of forward TCA pathway ﬂux.
The next most abundant secreted products are formate and propionate. Formate is
synthesized by pyruvate formate-lyase, which uses pyruvate and coenzyme A as the
substrates to produce formate and acetyl-CoA. Formate is therefore an energy neutral
overﬂow metabolite that nevertheless increases the enzymatic routes to acetyl-CoA.
Propionate is synthesized from succinyl-CoA to propionyl-CoA by methylmalonyl-CoA
mutase, methylmalonyl-CoA epimerase, and propionyl-CoA carboxylase enzymes, with
subsequent thioesterase activity by the same Acs or Ack/Pta pathways used to synthesize
acetate. Ultimately, propionate synthesis yields 2 ATP, but the pathway requires multiple
enzyme steps and cofactors, suggesting this overﬂow pathway could be kinetically
limited (39). A small amount of lactate is secreted. Lactate is synthesized by lactate
dehydrogenase from pyruvate, NADH, and a proton and is therefore energy consuming
for the cell.
These original data were obtained using liquid chromatography technology, but
since then, our ability to collect high-resolution untargeted one-dimensional proton
nuclear magnetic resonance (1D 1H NMR) data and the statistical methods to deconvolute
complicated spectra has evolved considerably, making untargeted NMR metabolomics of
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B. theta cultures feasible (40–42). Our study aimed to use untargeted metabolomics,
systems biology, and biological modeling techniques to revisit the metabolism of this
important human symbiont to account for nutrient inputs and outputs and to gain insight
into how B. theta responds to physiological concentrations of metabolic fermentation
products that are encountered in the gut ecosystem.

Methods
Strains and culture conditions
Bacteroides thetaiotaomicron vpi-5482 (ATCC 29148, Buan lab strain collection
number NB203) was grown in minimal deﬁned medium as described but with minor
modiﬁcations (64–66). Cultures were grown under strict anaerobic conditions at 37°C in
18-mm by 150-mm Balch tubes in either tryptone and yeast extract (TYG) growth
medium (vitamin K omitted) or a deﬁned medium (vitamin K omitted). Media were
supplemented with glucose to 0.05% (wt/vol) (2.78 mM) under a 5% H2, 20% CO2, N2
atmosphere with the following additions as appropriate: sodium acetate (10 mM), sodium
formate (10 mM), or a combination of both 10 mM sodium acetate and 10 mM sodium
formate. Growth was measured using optical density at 600 nm using a Spectronic D
spectrophotometer (Thermo Fisher Scientiﬁc) ﬁtted with a Balch tube (18 mm) sample
chamber. Biomass and optical density were found correlate linearly with 0.54 ± 0.056 g
dry weight OD-1 liter-1 in deﬁned medium.
NMR sample preparation. Five replicates of B. theta cultures were grown to late
exponential stage in 10 ml deﬁned medium with 0.05% glucose and one of the following
concentrations of acetate: 0.5 mM, 1 mM, 5 mM, 10 mM, or a 10 mM formate and 10
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mM acetate control. Cells were separated from medium with 0.2-µm ﬁlters by vacuum.
Samples of ﬁltered medium were ﬂash frozen in liquid nitrogen and then lyophilized
overnight.
NMR data collection and analysis
One-dimensional (1D) 1H NMR data collection and analysis were completed as
described previously (40–42, 67–69). Brieﬂy, samples from each class were prepared for
NMR analysis by dissolving the lyophilized culture medium into 600 µl of 50 mM
phosphate buffer (pH 7.2, uncorrected) in 99.8% D2O with 50 µM 3(tetramethylsilane)propionic acid-2,2,3,3-d4 (TMSP). NMR spectra were recorded at 298
K on a Bruker Avance III-HD 700 MHz spectrometer equipped with a 5-mm inverse
quadruple-resonance (1H, 13C, 15N, and 31P) cryoprobe with cooled 1H and 13C channels
and a z-axis gradient. A SampleJet automated sample changer with Bruker ICON-NMR
software was used to automate the NMR data collection. 1D 1H spectra were collected
using excitation sculpting to remove the solvent signal and avoid any need for baseline
corrections (70). A total of 16,000 data points with a spectral width of 5482.5 Hz, 8
dummy scans, and 128 scans were used to obtain each spectrum.
The 1D 1H NMR spectra were processed and analyzed using our MVAPACK
metabolomics toolkit (http://bionmr.unl.edu/mvapack.php) (71). The 1D 1H NMR spectra
were Fourier transformed and phased prior to normalization using phase scatter
correction (72). Residual solvent peaks and noise regions were removed, and the spectra
were referenced to TMSP at 0.0 ppm. The spectra were then binned using an intelligent
adaptive binning algorithm (73) or aligned with the icoshift algorithm (74). The data were
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scaled using the Pareto method prior to principal-component analysis (PCA) or
orthogonal projections to latent structures (OPLS) analysis (69).
Binned data were used for the PCA model, whereas the full spectral data were
utilized for the OPLS models. OPLS model results were validated using analysis of
variance of the cross-validated residuals (CV-ANOVA) signiﬁcance testing (75).
Fractions of explained variation (R2x and R2y) were computed during the OPLS model
training. The OPLS models were also internally cross-validated using 7-fold Monte Carlo
cross-validation to compute Q2 values (76, 77).
The validated OPLS models enabled the generation of back-scaled loading plots
to identify the spectral features (NMR peaks) that primarily contributed to the observed
group separation. The relative peak intensities in these “pseudospectra” highlight the
magnitude of the metabolite’s contribution to the group separation in the OPLS scores
plot. Similarly, the relative sign of the peak indicates if the metabolite’s concentration
increases or decreases due to the effects of the growth medium. All nonoverlapping 1H
NMR peaks identiﬁed by the back-scaled loading plots as a major contributor to group
separation in the OPLS scores plot were assigned to a metabolite using the Chenomx
NMR suite
7.0 (Chenomx Inc., Edmonton, AB, Canada). 1H NMR peaks with signiﬁcant
overlap and multiple metabolite assignments were excluded from further analysis.
Empirical modeling of metabolomics data
Secretion ﬂux maps were generated using the following equation:
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where the secretion ﬂux (F) of any metabolite (x [mM]) is expressed as a % C mol fraction
(molCx) of the total carbon secreted.
Feedback inhibition was estimated using the following equation:

where metabolite secretion (xsec) is determined by subtracting the amount of each
metabolite in the 0 mM control treatment (xinit) from the amount of the metabolite
observed (xobs) following the addition of acetate.
The fold variance in metabolite secretion was estimated by:

where xobs in the observed concentration of each metabolite, Asup indicated the
concentration of acetate supplemented, and xvar is the magnitude of each “missing”
metabolite.
In silico modeling and software
In silico experimentation is conducted using the Department of Energy’s Systems
Biology Knowledgebase (KBase) (78). A public narrative with all experiments recreated
can be found in KBase (https://narrative.kbase.us/narrative/ws.53087.obj.1). Applications
used are part of the fba_tools module version 1.7.6 (78). Model creation begins with the
genome Bacteroides thetaiotaomicron VPI-5482 uploaded through KBase’s public NCBI
RefSeq genome database. Using the “build metabolic model” application, the draft
metabolic models were created from an annotated genome. The fba_tools default
parameters were used. The in silico experimentation process with KBase consists of four
steps: (i) creating a draft metabolic model from the B. theta genome, (ii) deﬁning the
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medium composition, (iii) gap ﬁlling the draft model to add in missing reactions, and (iv)
running a ﬂux balance analysis (FBA). FBA provides a measurement of growth resulting
from ﬂux through the biomass reaction (grams of dry weight of biomass)
(https://kbase.us/metabolic-modeling-faq/).
It is critical to note that the draft B. theta model we employed may have missing
reactions (gaps) due to incorrect or incomplete functional genome annotations. We used
the “gapﬁll metabolic model” application on the draft model to identify a minimal set of
biochemical reactions that, when added to the draft model, allow it to achieve biomass on
the speciﬁed media (https://kbase.us/metabolic-modeling-faq/) (79). Gap ﬁlling uses
linear programming to ﬁnd the optimized metabolic model that uses the fewest added
reactions to satisfy the biomass reaction and to balance the ﬂux balance equation. We gap
ﬁlled once for each of the eight media in our experimentation, creating eight metabolic
models. Then, starting with a base medium ﬁle containing 25 substrate compounds (full
medium compositions can be found in supplemental material), we added glucose,
formate, and acetate at their desired maximum uptake concentrations.
The “run ﬂux balance analysis” (FBA) application was used to run the simulation.
The FBA algorithm is a constraint-based approach that estimates growth-optimal ﬂuxes
through all the reactions speciﬁed by the metabolic network constructed in the previous
step (https://kbase.us/metabolic-modeling-faq/). This resulted in a rate of biomass
production as a measure of growth. For each FBA, we used the gap-ﬁlled model on the
medium of interest and used each medium as input to the FBA algorithm to maximize
biomass (bio1). From the output of the FBA application, the objective value was used as
a measurement of growth and to capture the reaction and exchange ﬂuxes, which were
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used to ﬁnd ﬂux values of interest. All data and results are presented in our public KBase
narrative (https://narrative.kbase.us/narrative/ws.53087.obj.1).
The FBA models were created with either high or low levels of glucose, which
were combined with either the absence or presence of acetate and/or formate. This
resulted in eight experiments: high glucose, high glucose with acetate, high glucose with
formate, high glucose with acetate and formate, low glucose, low glucose with acetate,
low glucose with formate, and low glucose with acetate and formate. The amount of each
compound used in the model is speciﬁed in the medium ﬁle, which deﬁnes maximum
uptake as measured in millimoles per gram cell dry weight per hour. Low glucose was
deﬁned as 0.1 maximum uptake, high glucose was deﬁned as 2.78 maximum uptake, and
the presence of formate or acetate was set to 10 maximum uptake. The absence of
formate or acetate was set to 0 maximum uptake.

Results
Untargeted metabolomics reveals B. theta secretes a subset of amino acids in
addition to organic acid fermentation products
B. theta was grown in minimal deﬁned medium on glucose as sole carbon and
energy sources, and spent culture medium was analyzed using 1D 1H NMR to detect the
secreted metabolome and to identify any new secreted metabolites (see Fig. S1 in the
supplemental material). We conﬁrmed previous observations that the major secreted
metabolic products were acetate, succinate, formate, and propionate, with small amounts
of lactate. In addition, we were able to detect histidine, cysteine, cystine (Cys-Cys
disulﬁde), glutathione, asparagine, and alanine (Fig. 1). These endpoint metabolic
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products were then used to build a secretion ﬂux map (Fig. 2). Notably, relatively few
metabolites of similar size, chemical composition, reactivity, or metabolic importance to
the cell were detected. Accordingly, these results suggest the secreted metabolites were
products of speciﬁc cellular processes rather than through nonspeciﬁc leaky transporters.
The secretion of amino acids is signiﬁcantly lower than the major organic acid
fermentation products (excluding lactate) but also suggests these metabolites are
overﬂows for purine metabolism (histidine), the TCA cycle (alanine, asparagine, and
glutathione), and the serine cycle (cysteine/cystine and glutathione) (Fig. 2). Notably, the
amino acid secretions were generally lower than those of lactate, suggesting amino acid
secretion is less favorable, likely reﬂecting the fact that amino acid synthesis is
energetically costly and requires multiple enzymatic steps in contrast to a single enzyme
for lactate synthesis. The network map illustrates that in minimal deﬁned medium,
secreted products can be easily derived from pyruvate, acetyl-CoA, and succinate after
minor biochemical transformation. This suggests the secreted metabolites are “overﬂow”
from the EMP pathway.
B. theta growth is inhibited by acetate and formate
Acetate and formate are major metabolic products of many organisms (43), and it
is thought that both acetate and formate may inhibit cell growth by feedback inhibition
and/or by transporting protons across the cell membrane and collapsing the
transmembrane ion gradient necessary for ATP synthesis (44, 45). This suggests that the
acetate and formate produced by competing organisms in the gut may also have a strong
inhibitory effect on B. theta metabolism. We tested these hypotheses by growing B. theta
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with increasing acetate, formate, or a combination of both in a culture medium at
physiological concentrations (46).
When B. theta is grown in minimal deﬁned medium with increasing
concentrations of acetate or formate, population doubling time increased by
approximately 25% (Fig. 3a and b; Table 1). Conversely, the ﬁnal optical density of the
culture was not affected by supplementation with acetate and/or formate (Fig. 3c), and
because optical density (OD) and biomass are correlated, it suggests that biomass yield is
also not affected (47). These data suggest ATP synthesis and metabolic efﬁciency have
not been altered. Instead, a direct or indirect kinetic biochemical feedback inhibition is
the primary factor in acetate- and formate-dependent inhibition of B. theta growth. The
stationary-phase cultures were observed to exhibit a modest statistically signiﬁcant
decrease in pH from 7.14 ± 0.064 to 7.03 ± 0.051 (P = 0.03) with the addition of acetate
despite the medium being buffered at pH 7.2 with 1 M potassium phosphate (Table 2).
The total amount of secreted organic acids and supplemental acetate cannot account for
the observed pH change. Thus, the drop in pH may be attributed to an increase in CO2
concentration, which is converted to carbonic acid (H2CO3) with a pKa of 3.6 in water.
An increase in the CO2 partial pressure produced by cells in sealed anaerobic culture
tubes is known to decrease the pH of culture medium (48).
Feedback inhibition by acetate causes suppression of metabolite secretion
The concentration for each of the metabolites in the culture medium changed
independently as a function of the amount of supplemental acetate (Fig. 3d). The effect of
supplemental acetate on metabolite secretion (xsec) was unmasked (Fig. 4a) by
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subtracting the amount of each metabolite in the 0 mM control treatment (xinit) from the
amount of the metabolite observed (xobs) after acetate supplementation.
The observed concentration for each metabolite should be the same as in the
initial 0 mM treatment condition if the supplemental acetate had no effect on metabolite
secretion. The xsec should also be equal to zero if the metabolite is neither a substrate nor
product of acetate metabolism (null hypothesis). Instead, the concentration for each
secreted metabolite changed as a result of the additional acetate in the culture
medium. For instance, acetate only increased by 4.21 (± 0.55) mM in the culture
medium after the 10 mM acetate treatment (Fig. 4a). This is signiﬁcantly less than
expected if no feedback inhibition occurred and the acetate concentrations were simply
additive. The acetate concentration detected in the culture medium should have been the
sum of the total amount of acetate derived from glucose (6.6 ± 0.5 mM) (Fig. 3d) plus the
10 mM acetate supplemented for a ﬁnal concentration of 16.60 mM.
Similar decreases in secretion were observed for formate (0.18 ± 0.02), propionate
(0.47 ± 0.02), and amino acids, while succinate (0.83 ± 0.13 mM) secretion increased.
These results suggest supplemented acetate was taken up by cells and altered metabolic
ﬂuxes such that secretion of acetate, formate, propionate, and amino acids are suppressed,
while a portion of the acetate is secreted as succinate.
Next, the fold variance (xvar) between the observed and the null model was
calculated assuming the secretions of acetate and the other metabolites are correlated
(Fig. 4b). The observed concentration of each metabolite indicated a negative variance
from the null model. As acetate supplementation increased, the magnitude of the variance
also increased, indicating “missing” metabolites. The increasing negative correlation as a
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function of supplemental acetate suggests these missing metabolites are a result of an
unknown inhibitory mechanism or process.
The slope of the linear regression Δxvar is the relative molar acetate suppression
coefﬁcient (Table 3). Accordingly, alanine and the amino acids have the highest molar
acetate suppression coefﬁcient despite acetate secretion having a higher magnitude of
inhibition. Relative molar ﬂux suppression was mapped onto a metabolic network as
shown in Fig. 4c. The ﬂux analysis shows that acetate supplementation has the highest
inhibitory effect on alanine secretion, an intermediate effect on amino acid secretion, and
the smallest inhibitory effect on the major fermentation products: acetate, succinate,
formate, and propionate.
Feedback inhibition is the primary driver of acetate inhibition effects
In addition to a direct competitive feedback inhibition (e.g., carbonic anhydrase)
(49), supplemental acetate and formate may also induce a noncompetitive inhibition
through posttranslational modiﬁcation (formylation) (50). A direct or indirect effect on
gene expression may occur as growing cells adapt to the stress. To determine the relative
contribution of feedback inhibition and gene expression changes to secretion ﬂuxes, the
following hypotheses were modeled with the assumption that secreted metabolites mirror
intracellular metabolic ﬂuxes: (a) secretion is additive with no destruction and no
regulation (see Fig. S2a); (b) secretion ﬂuxes are constant with balanced secretion and
absorption (Fig. S2b); (c) there is feedback inhibition with no regulation (Fig. S2c); (d)
there is synergistic negative feedback inhibition with compensatory gene regulation (Fig.
S2d); and (e) there is positive upregulation in response to increasing acetate (Fig. S2e).
The modeling results (Fig. 4b versus Fig. S2d) indicate that the experimental data most
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closely match a feedback inhibition model with no gene regulation. The only exception is
for acetate and succinate, which were discussed previously. B. theta appears to respond to
low concentrations of exogenous acetate (<0.5 mM) by adjusting gene expression to
decrease metabolic ﬂux, but at acetate levels up to 10 mM, no further changes in gene
expression or other metabolic rerouting occur.
Formate causes synergistic feedback inhibition of acetate, propionate, succinate,
histidine, cysteine, and glutathione
Formate is a major fermentation by- product encountered in anaerobic
environments. Like acetate, formate is produced from the Embden-Meyerhof-Parnas
fermentation pathway; however, formate can be used as either an energy sink or an
energy source depending on the levels of CO2 and H2 or the redox state of ferredoxin.
Thus, high formate concentrations may be synergistic, additive, or have independent
effects on secretion ﬂuxes compared to those for acetate alone. To differentiate between
these possibilities, cultures were supplemented with 10 mM both acetate and formate.
NMR metabolomics was then used to characterize the secreted metabolome. Growth
experiments demonstrated that formate had a synergistic effect on population doubling
time (Table 1). Supplemented acetate and formate appeared to be taken up from the
culture medium, but the additional acetate and/or formate did not affect biomass yield or
pH. No new secreted metabolites were observed in the culture medium, but a subset of
organic acids (Fig. 5a) and amino acids (Fig. 5b) did exhibit concentration changes
relative to those in treatments with only 10 mM acetate. Notably, lactate, alanine, and
asparagine secretion levels were unchanged. These data suggest those biosynthetic
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reactions are unaffected by acetate or formate, while other reactions are either directly
affected by enzyme inhibition or indirectly affected by changes in metabolic ﬂux.
Visualization of dynamic metabolite secretion and effects of feedback inhibition.
Animations of the dynamics of metabolic secretion (Movie S1), acetate inhibition (Movie
S2), and the modulation of acetate inhibition by formate supplementation (Movie S3) are
presented in the supplemental material. The animated models assume linear secretion
ﬂuxes and illustrate the accumulation of secreted products in the culture medium as a
function of time and acetate and/or formate supplementation.
High-glucose models do not predict feedback inhibition by acetate or formate
Empirical modeling suggested that the bioenergetics of glucose metabolism does
not change when acetate and/or formate accumulates in the culture medium. Therefore,
the observed changes in secreted metabolites must be due to increased CO2 and/or H2
secretion ﬂuxes. To determine if in silico B. theta metabolic models can reproduce the
observed growth phenotypes, we conducted a series of in silico experiments to obtain ﬂux
values for all reactions in the metabolic model and exchange ﬂuxes for all substrate
compounds and product metabolites.
A limited effect on the key reaction ﬂuxes (deﬁned in millimoles per gram cell
dry weight per hour) was observed under high-glucose (0.02% [wt/vol]) conditions. In
the high-glucose ﬂux balance analysis (FBA) models, there were no changes in predicted
biomass, which remained constant at 0.39 in all four experiments (Fig. 6a), or in
exchange ﬂuxes with either acetate and/or formate supplementation (Fig. 6b). There was
only one discrepancy in a predicted reaction ﬂux. The model shifts from using asparagine
synthetase (aspartate + glutamine + ATP + H2O ↔ asparagine + glutamate + AMP + PPi)
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to using aspartate ammonium ligase (aspartate + NH3 + ATP ¡ asparagine + AMP + PPi)
when either acetate and/or formate is included in the culture medium (see Data Set S1).
However, the glutamate, glutamine, asparagine, and aspartate exchange ﬂuxes were not
altered in the model despite the changes in reaction ﬂux. We conﬁrmed that either
pathway can be deleted in the model and results in the same exchange ﬂuxes regardless
of whether acetate or formate is supplemented. Thus, the simulations show either
metabolic pathway for asparagine synthesis can occur interchangeably in B. theta under
the culture conditions we modeled.
Modeling suggests acetate and formate affect metabolism when glucose
concentrations are low
The presence of acetate under low-glucose conditions (0.002% [wt/vol]) results in
an abundance of metabolic changes. When acetate was added, whether in the presence or
absence of formate, biomass decreased to 0.14 (Fig. 6a). Exchange ﬂux values for several
metabolites were also affected (Fig. 6c and Data Set S1). Some pathways, such as malate
dehydrogenase, serine ammonia-lyase, and formate-tetrahydrofuran (THF) ligase show a
net ﬂux of zero. Other reaction ﬂuxes, such as those corresponding to enzymes lactate
dehydrogenase, succinyl-CoA synthetase, and aspartate aminotransferase, incurred a
change in directionality. The reaction for aspartate oxidase had a zero-net ﬂux under
glucose-only or glucose and formate conditions; however, the reaction had a ﬂux of
0.0009 when acetate was present. Other reactions retained their directionality, but the net
ﬂux exhibited a change in magnitude. In the forward direction, examples of reactions that
increased exchange ﬂux in the presence of added acetate included pyruvate kinase and
aspartate aminotransferase, while pyruvate carboxylase, pyruvate synthase, pyruvate
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dehydrogenase, and acetate kinase had decreased ﬂux. In the reverse reaction direction,
pyruvate phosphate dikinase had increased exchange ﬂux and phosphotransacetylase had
decreased ﬂux. No additional effect was observed when formate was combined with
acetate.
The interchangeability of asparagine synthetase and aspartate ammonia ligase
pathways for asparagine synthesis was also observed under low-glucose conditions,
similar to what was seen under high glucose conditions (Fig. 6d). In addition, when
formate was added under low glucose conditions, the net ﬂux of the pyruvate formatelyase reaction (formate + acetyl-CoA ↔ CoA + pyruvate) decreased from ˗3.74 to
˗0.122, where a negative ﬂux value indicates the reaction was being executed from right
to left. Under this condition, biomass decreased to a value of 0.27 (Fig. 6a).
The low-glucose model also predicts increased uptake of acetate and decreased
uptake of CO2 and cysteine when acetate is supplemented into the culture medium, which
is consistent with metabolomics data and the observed pH decrease. None of the
simulations resulted in changes in the secretion of organic acids or amino acids to the
culture medium. Modeling instead showed decreased production of a small amount of
molecular oxygen, lack of nitrite secretion, and increased secretion of xanthine under
low-glucose conditions with addition of acetate.

Discussion
Feedback inhibition reveals metabolic plasticity and resiliency of B. theta
B. theta is a ubiquitous and abundant member of the human gut microbiome.
Accordingly, B. theta is an attractive organism for investigating the interaction between
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genes, environment, and system-level behaviors. B. theta is a strict anaerobe grown in
sealed culture tubes. Thus, by the law of conservation of mass, all mass inputs (culture
medium ingredients) and outputs (biomass and secreted metabolites) are accounted for in
the cell culture. Secreted metabolites, especially organic acids and amino acids, are
important mediators in microbial food webs and may play simultaneous roles as
nutrients, stimulators, and inhibitors. In this manner, secreted metabolites may affect
overall system behavior.
Metabolomics and cell growth data suggest fermentation products, acetate and
formate, cause large metabolic changes even when biomass yield is unaffected. B. theta
has two bidirectional acetate enzyme systems, Ack/Pta and acetyl-CoA pathways, and the
metabolomics and modeling data are consistent with B. theta using both of these
pathways to secrete acetate as an “overﬂow” of acetyl-CoA biosynthesis. Overﬂow
metabolism has been studied extensively in E. coli (37), where it is thought that excess
carbon from glucose is secreted as acetate due to metabolic bottleneck at pyruvate and
acetyl-CoA as a result of redox imbalance (38). In E. coli and Salmonella, secreted
acetate is recouped by the Ack and Pta enzymes during late stationary phase (51), where
the glyoxylate shunt is used to incorporate acetyl-CoA into biomass (52). While the
enzymes involved in acetate secretion and uptake are conserved between E. coli and B.
theta, B. theta lacks the glyoxylate shunt and is an anaerobe that cannot carry out
oxidative respiration. The addition of acetate to the culture medium caused the inhibition
of acetate, formate, and propionate secretion by B. theta, but increased succinate
secretion as the next available “overﬂow valve.” This result may be explained by
feedback inhibition of acetyl-CoA hydrolysis and increased succinyl-CoA hydrolysis
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later in the TCA cycle. Consequently, there was a decrease in the secretion of other
metabolic products (cysteine and other amino acids) downstream of succinate
biosynthesis. B. theta biomass yield was unaffected by supplemented acetate, as expected
by the lack of a glyoxylate shunt. The biomass yield did not increase despite a decrease in
the secretion of amino acids, indicating intracellular amino acid biosynthesis was
sufﬁcient for maximum growth.
The addition of formate to the culture medium caused an inhibition in the
secretion of acetate and a subset of amino acids, while metabolites derived from
oxaloacetate and aspartate (lactate, asparagine, and alanine) were not affected. Formate
and acetate are both synthesized from pyruvate but have different effects on downstream
“over- ﬂow” metabolites. One possible explanation for this difference is the fact that
formate is a substrate for C1 metabolism (ultimately for glycine, serine, cysteine, and
methyl transfer reactions). Thus, the addition of formate increases the synthesis of amino
acids, lactate, and pyruvate (through serine ammonia-lyase), which may compensate for
the inhibition of acetate, succinate, and propionate.
Unexpectedly, not all metabolites were secreted and no new metabolites were
detected in culture medium as a result of acetate and/or formate inhibition. Several
central metabolites are simply too large to be nonspeciﬁcally secreted (phosphosugars
and CoA-oxoacids), but many nonsecreted TCA and amino acid biosynthetic
intermediates are chemically similar to secreted metabolites. This suggests that
metabolite secretion is highly discriminated by transporters. B. theta also seems unable to
relax transporter speciﬁcity or to produce new transporters through changes in gene
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expression. In effect, B. theta did not relieve acetate or formate inhibition by secreting
other biosynthetic intermediates.
Another surprise was the observation that biomass yield was unaffected by the
physiological concentrations of acetate and/or formate. Accordingly, net bioenergetics
(ATP moles synthesized per mole substrate consumed) were also likely unaffected, even
though the rate of growth was signiﬁcantly lower and there were large changes in
secretion proﬁles. The FBA model was able to accurately predict that acetate and formate
supplementation does not affect biomass (Fig. 3c versus Fig. 6a) under high-glucose
conditions. This leads to the question of where the unaccounted carbon could have gone.
A likely explanation is that the missing carbon mass was released as CO2. Increased CO2
synthesis would manifest as a decrease in pH but would not necessarily affect CO2yielding decarboxylation reactions. At the partial pressures tested here, decarboxylation
reactions are virtually irreversible unidirectional reactions. Malate dehydrogenase
reversibly catalyzes the decarboxylation of oxaloacetate to produce pyruvate and CO2.
Malate dehydrogenase also reversibly oxidizes malate to produce pyruvate, CO2, and
NADPH. Our results can be explained if the forward malate dehydrogenase reaction is
favored, with increased pyruvate being secreted as acetate and formate. The low-glucose
FBA models support this hypothesis and show that addition of acetate results in nearly a
50% decrease in CO2 uptake from the culture medium (see Data Set S1 in the
supplemental material).
The FBA models for B. theta were unable to model secretion of organic acids and
amino acids (Fig. 2 versus Data Set S1), and though lowering the glucose concentration
in the growth medium caused some metabolic network changes, they did not completely
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predict the effect of acetate and formate on exchange ﬂuxes (compare Fig. 4c versus Fig.
6c and Fig. 5c versus Fig. 6d). One possibility is that the carbon predicted to be secreted
as xanthine (which was not detected experimentally) is instead used to synthesize organic
acids and amino acids. Under both the high-glucose and low- glucose conditions, there
were also unexpected results with respect to nitrite and ammonia ﬂuxes, suggesting
unexplored C/N metabolic or regulatory relationships in B. theta. Another possibility is
that transporters (either speciﬁcally or nonspeciﬁcally) secrete accumulated metabolite
pools as part of “overﬂow metabolism.” These discrepancies likely reﬂect technological
limitations of in silico modeling, such as an inability to predict allosteric or competitive
inhibition, gene expression changes that might result in speciﬁc or nonspeciﬁc activity of
transmembrane transporters, or perhaps the activity of poorly characterized enzymes or
nonspeciﬁc aminotransferases and decarboxylases (or other enzymes) that may affect
exchange ﬂuxes in unknown ways. By using untargeted NMR metabolomics, we were
able to detect and quantify metabolites in culture medium with minimal sample
processing in a relatively “agnostic” approach. NMR data sets can be used to produce
secretion ﬂux maps that describe metabolic behaviors without requiring genomic,
biochemical, or transcriptomic information or, in the reverse direction, may be used to
infer the existence of unknown biochemical pathways. We suggest that untargeted NMR
metabolomics may be a useful tool to inexpensively curate genome-scale metabolic
models and could be essential for developing accurate dynamic FBA models.
Are B. theta secretion signals of relevance to a host-microbiome system?
It has been hypothesized that amino acids can function as a “shared good” in
microbe-host ecosystems in which secreted “overﬂow” amino acids can be taken up by
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the host or neighboring community members (commensalism). In this regard, a cell can
dispose of its excess amino acids while also beneﬁtting near neighbors (mutualism). It is
also possible that these secreted amino acids are used in mutually beneﬁcial metabolite
exchange (syntrophy) (53–55), for example, when metabolite secretion causes metabolic
feedback inhibition that can be relieved by a consumer partner. Detection of amino acid
products in B. theta culture supernatants supports the postulation that B. theta is primed
to participate in such cross-feeding interactions in the gut (56). Humans are known to
require branched-chain amino acids (leucine, isoleucine, and valine) and conditionally
essential amino acids (arginine, proline, cysteine, and glycine) as well as lysine,
threonine, methionine, tryptophan, phenylalanine, and histidine (57). The essential amino
acid histidine and the conditionally essential amino acids cysteine and glycine (as
glutathione) were observed to be secreted by B. theta.
Besides nutrition, amino acids also have a wide range of roles in gut epithelial
metabolism and gut immune/neurological function. In fact, several amino acids are
secreted at high concentrations by B. theta. In gut epithelial cells, glutamate, aspartate,
and glutamine are substrates for ATP synthesis, glutamine, glycine, and aspartate are
used for nucleic acid synthesis, and threonine, cysteine, and proline are used for mucin
synthesis. Thus, a symbiotic relationship may exist between B. theta and gut epithelium,
where B. theta may provide essential amino acids critical for gut epithelial metabolism.
Glutathione is a tripeptide of cysteine, glutamate, and glycine, which also has an
important role in epithelial cell viability. It can provide a source of amino acids, it can
protect against toxic xenobiotics, and it is important for cell signaling. Glutathione also
serves as a redox buffer and can protect cells from reactive oxygen species (ROS) or
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oxidative stress (58). Thus, it is notable that B. theta was observed to secrete 121 ± 16
µM glutathione into the culture medium. Since lactic acid bacteria produce H2O2 in the
gut to compete with anaerobes such as B. theta for glycan nutrients (59, 60), the secretion
of glutathione by B. theta may protect B. theta from these competing microbes. Secreted
glutathione may also protect B. theta from oxidative stress generated by host epithelia at
the microbe-host interface (61–63). The amino acid components of glutathione,
glutamine, and glycine may act as neurotransmitters between gut epithelia and the nerve
cells that innervate the intestinal tract.
Cysteine (242 ± 22 µM) and cystine (209 ± 47 µM) were also secreted by B.
theta. Cysteine and cystine, like glutathione, can abiotically react with ROS or xenobiotic
compounds to protect cells from oxidative damage. Histidine was also secreted at high
levels (101 ± 12 µM), which was nearly equivalent to that of lactate (120 ± 25 µM).
Histidine is an essential amino acid and is a precursor to the immunological effector
histamine. Secretion of amino acids and glutathione by B. theta could potentially play an
important role in host nutrition, oxidative stress, neurological function, and immunology.
Our metabolomics, theoretical modeling, and cell viability results support the
hypothesis that microbes in complex communities modulate B. theta’s metabolic
efﬁciency, which leads to changes in secreted metabolites that, in turn, are sensed as
chemical messages by the microbial community and host (54). Metabolic feedback
inhibition by fermentation products such as acetate and formate would be expected to
function through generalized cellular processes rather than through speciﬁc quorum
sensing. However, because acetate and formate are highly conserved major metabolic end
products synthesized by anaerobic microbes in the millimolar and high micromolar
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concentration ranges, the local concentration achieved in gut microenvironments could be
sufﬁciently high to profoundly affect metabolism of neighboring microbes and thus
metabolism of the gut community as a whole.
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Figure 1: Metabolites secreted by B. theta. Concentrations of secreted metabolites detected after
batch growth in deﬁned minimal glucose medium (mean of 5 biological and 5 technical
replicates, n = 25).

Figure 2: Secretion ﬂuxes of organic acids and amino acids in deﬁned minimal medium.
Numbers represent percent mole carbon ﬂuxes (not shown, CO2 inferred, 4.6%). Gray outlined
circles represent undetected intracellular metabolic nodes. Black outlined circles indicate secreted
metabolites. Shading is proportional to concentration in culture medium.
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Figure 3: Effect of metabolic feedback inhibition on growth. (a) Population doubling time of
cultures on deﬁned minimal medium supplemented with acetate (n = 8 biological replicates, P <
0.01 versus 0 mM, r2 = 0.94). (b) Population doubling time of cultures on deﬁned minimal
medium supplemented with formate (n = 5 biological replicates, P < 0.01 versus 0 mM). (c) Final
optical densities of cultures with and without supplementation of 10 mM acetate (Ac) and 10 mM
formate (Fo) (n = 5 biological replicates, P > 0.05 versus 0 mM). (d) Concentrations of secreted
metabolites with increasing acetate supplementation (means from 5 biological and 5 technical
replicates, n = 25). P values are shown in Table S1 in the supplemental material. Curves were ﬁt
according to parabolic functions (a) or least-squares regression (b and d). Error bars may be
obscured by symbols.

Figure 4: Effect of acetate feedback inhibition on secretion ﬂuxes. (a) Concentrations of secreted
metabolites with increasing acetate supplementation (means from 5 biological and 5 technical
replicates, n = 25). P values are shown in Table S2. Error bars may be obscured by symbols. (b)
Change in secretion ﬂuxes with increasing acetate supplementation (means from 5 biological and
5 technical replicates, n = 25). P values are shown in Table S3. (c) Effect of acetate feedback
inhibition (10 mM) mapped onto a metabolic network. Red, decreased secretion. Shading is
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proportional to ﬂux magnitude. Gray outlined circles represent undetected intracellular metabolic
nodes. asp, aspartate.

Figure 5: Effect of formate supplementation on acetate feedback inhibition. (a) Change in
organic acid secretion with and without supplementation of 10 mM acetate or a combination of
10 mM acetate (Ac) and 10 mM formate (Fo). (b) Change in secreted amino acids with and
without supplementation. (c) Effect of 10 mM formate supplementation on 10 mM acetate
feedback inhibition mapped to the metabolic network. Green, increased secretion; red, decreased
secretion; gray, no signiﬁcant difference between 10 mM acetate versus 10 mM acetate and 10
mM formate conditions. Shading is proportional to ﬂux magnitude. Gray outlined circles
represent undetected intracellular metabolic nodes. asp, aspartate. P-values for data in panels a
and b are shown in Table S4. Error bars may be too small to see.
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Figure 6: Simulation of the effect of feedback inhibition on metabolism. (a) Predicted biomass in
high-glucose (HG) and low-glucose (LG) medium as acetate (Ac) and formate (Fo)
concentrations were varied from 0 mM to 10 mM. (b) Predicted effect of acetate and/or formate
on exchange ﬂuxes in HG medium. (c) Predicted effect of acetate on exchange ﬂuxes in LG
medium. (d) Predicted effect of formate on exchange ﬂuxes in LG medium. Green, increased
exchange ﬂux; red, decreased exchange ﬂux; gray, no net change in exchange ﬂux due to
metabolic rerouting; white, no change predicted.
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Table 1: Effect of formate and acetate on B. theta growth rate in deﬁned medium
P-value
Treatmenta

Doubling
Time (h)

SD

vs 10 mM Ac + 10 mM
vs 0mM Fo

0 mM

1.322

0.047

1

0.5 mM Ac

1.516

0.052

0.000

0.000

1 mM Ac

1.452

0.034

0.000

0.000

5 mM Ac

1.929

0.037

0.000

0.000

10 mM Ac

1.562

0.028

0.000

0.000

0.5 mM Fo

1.474

0.042

0.000

0.000

1 mM Fo

1.718

0.078

0.000

0.704b

5 mM Fo

1.561

0.034

0.000

0.000

10 mM Fo

1.521

0.034

0.000

0.000

10 mM Ac+10 mM
Fo

1.734

0.05

0.000

1

a Ac, acetate; Fo, formate. Data were obtained from six biological replicates (n = 6).
b Not statistically signiﬁcant (P > 0.05).

Table 2: pH of stationary-phase cultures in buffered medium
Treatmenta

pH

SD

P value vs 0 mM

0 mM control

7.14

0.064

1

0.5 mM Ac

7.07

0.079

0.196b

1 mM Ac

7.03

0.077

0.059b

5 mM Ac

7.06

0.034

0.064b

10 mM Ac

7.03

0.051

0.030

10 mM Ac+10 mM Fo 7.06

0.046

0.083b

a Ac, acetate; Fo, formate. Data were obtained from six biological replicates (n = 6).
b Not statistically signiﬁcant (P > 0.05).
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Table 3: Acetate suppression coefﬁcients of secreted metabolites
Metabolite

Fold suppression coefﬁcient (.:ixvar)

Pearson correlation (R2)

Acetate

-0.00535

0.93736

Formate

-0.05783

0.99941

Succinate

-0.01478

0.94946

Propionate

-0.07022

0.99859

Cysteine

-0.28908

0.99990

Cystine

-0.33741

0.99955

Glutathione

-0.57522

0.99995

Lactate

-0.57985

0.99998

Histidine

-0.68781

0.99997

Asparagine

-0.78083

0.99999

Alanine

-1.00662

1.00000
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Abstract
Trophic interactions between microbes are postulated to determine whether a
host microbiome is healthy or causes predisposition to disease. Two abundant taxa,
the Gram negative heterotrophic bacterium Bacteroides thetaiotaomicron (B. theta)
and the methanogenic archaean Methanobrevibacter smithii, are proposed to have a
synergistic metabolic relationship. Both organisms play vital roles in human gut
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health; B. theta assists the host by fermenting dietary polysaccharides whereas M.
smithii consumes end-stage fermentation products and is hypothesized to relieve
feedback inhibition of upstream microbes such as B. theta. To study their metabolic
interactions, we defined and optimized a co-culture system and used software testing
techniques to analyze growth under a range of conditions representing the nutrient
environment of the host. We verify that B. theta fermentation products are sufficient
for M. smithii growth, and accumulation of fermentation products alters secretion of
metabolites by B. theta to benefit M. smithii. Studies suggest B. theta metabolic
efficiency is greater in the absence of fermentation products or in the presence of M.
smithii. Under certain conditions B. theta and M. smithii form interspecies granules
consistent with behavior observed for syntrophic partnerships between microbes in
soil or sediment enrichments and anaerobic digesters. Furthermore, when vitamin
B12, hematin, and hydrogen gas are abundant, coculture growth is greater than the
sum of growth observed for monocultures, suggesting both organisms benefit from a
synergistic mutual metabolic relationship.

Importance
The human gut functions through a complex system of interactions between the
host human tissue and the microbes which inhabit it. These diverse interactions are
difficult to model or examine under controlled laboratory conditions and is necessary to
simplify the system in order to test mechanistic hypotheses. We studied the interactions
between two dominant human gut microbes B. theta and M. smithii using a sevencomponent culturing approach that allows the systematic examination of the metabolic
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complexity of this binary microbial system. We then use decision trees to identify
cooperative, neutral, and competitive interactions between nutrients, metabolites, and
organisms that are otherwise missed in community-level microbiome studies. By
combining high throughput methods with machine learning techniques, we were able to
investigate the interactions between two dominant genera of the gut microbiome in a
wide variety of environmental conditions. Our approach can be broadly applied to
studying microbial interactions and may be extended to evaluate and curate
computational metabolic models. The software tools developed for this study are
available as user-friendly tutorials in the Department of Energy KBase.

Introduction
From birth, the human microbiome plays an important role in maintaining human
health.1-4 Newborns are colonized in their first days of life5-7 and the microbiome grows
and develops with the child into adulthood.5,8 Depending on the age, geographic location,
diet, and health of its host, 10-100 trillion microbial cells reside in the intestines alone.1,9
These organisms are part of a dynamic, closely interconnected ecosystem made up of
Bacteria, Archaea, and Eukarya.7,8,10 Interactions between host-associated microbes affect
many aspects of human health. A well-balanced, healthy microbiota offers protection
against infection,11,12 metabolizes nutritional compounds,13 provides essential vitamins
and nutrients, adds 15 - 30% of human caloric intake,14,15 manages weight gain,16 and
influences the human immune system and its development.17-19 However, an unbalanced
microbiome is linked to obesity, infections, asthma, allergies, Crohn’s disease, irritable
bowel disease, neurodegenerative disease, and cancer.1-4,12,17,19-34
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It has been proposed that mutualistic relationships within the gut microbiome
maintain a balance that is necessary for a healthy host digestive system.8,29,35 The
dynamic interactions between microbes in a multispecies gut community are difficult to
study both in the laboratory and using computational modeling and analysis due to the
sheer complexity of the system. This complexity is due to many factors including the
combinatorial genetic space, sampling heterogeneity, unknown environmental conditions
(e.g. local microvariation in temperature and pH, and nutrient availability), and unknown
relationships between interacting genetic and environmental variables that make it
difficult to confidently ascribe major (or minor) organism functions in a mixed
microbiome community. Fortunately, cutting-edge software systems research approaches
such as statistical sampling and decision trees can be used to develop tools for
management and analysis of complex microbial systems.36 To benchmark new
computational tools we constrain the gut microbiome system to studying the relationship
between two key human gut inhabitants: the fermenter Bacteroides thetaiotaomicron (B.
theta) and the methanogenic archaeon, Methanobrevibacter smithii (M. smithii).
B. theta is one of the most prominent fermenters in the human gut, making up
between 5 and 50% of the overall gut community.15 B. theta a generalist fermenter: it
consumes dietary plant polysaccharides such as starch as well as mucosal glycans such as
heparin and produces fermentation products such as hydrogen, carbon dioxide, formate,
acetate and succinate.15 It plays a crucial digestive role by partially breaking down
polysaccharides human cells are unable to degrade and produces short-chain fatty acids
for human and microbial consumption (acetate, succinate, propionate, lactate). In the
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process, it protects intestines against infection by activating host immune defenses,
through direct interactions, and by competition with other bacteria.12,37
M. smithii is the dominant methanogen in the human gut and makes up between
1% and 10% of the human gut community.38,39 It colonizes the human gut in infancy and
remains present in the majority of the population through adulthood6,38 and has been
detected in up to 95.7% of individuals.39-42 Imbalance in M. smithii gut communities has
been associated with obesity and malnutrition-related digestive diseases.30,41,43,44 M.
smithii is a hydrogenotrophic methanogen and can conserve energy through
methanogenesis using carbon dioxide and hydrogen gas or formate as substrates.39,45, 46
M. smithii has an incomplete reductive tricarboxylic acid (TCA) cycle and must
assimilate acetate as a carbon substrate. It is hypothesized that growth of M. smithii in the
gut could benefit B. theta and other fermenters by metabolizing fermentation products
that would inhibit further fermentation by feedback inhibition as they accumulate.
Moreover, the removal of hydrogen could allow B. theta to increase metabolic efficiency
and contribute to effective metabolism of dietary substrates, since high hydrogen partial
pressure inhibits bacterial NADH dehydrogenases, reducing the yield of ATP and causing
fermentation overall to become endergonic (unfavorable).35,47 The proposed nature of the
complementary metabolism between B. theta and M. smithii suggests a mutualistic
relationship in which M. smithii relies on the metabolic products of B. theta fermentation
to survive, while B. theta relies on M. smithii to remove products that would inhibit
fermentation, which would be an example of metabolic syntrophy.47
Syntrophy is a form of mutualism in which two organisms form a tightly coupled,
mutually beneficial metabolic relationship.47-50 Syntrophic relationships allow bacteria to
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overcome energy barriers and to break down substrates more efficiently.35,48,50,51
Methanogens have often been observed in syntrophic relationships with soil bacteria,
removing hydrogen gas and other fermentation inhibitors to benefit the bacteria.47,50,52 B.
theta and M. smithii have been previously proposed to form a syntrophic relationship
based on genomic evidence.46 Gnotobiotic mouse studies suggest that the presence of M.
smithii assists B. theta in the breakdown of polysaccharides and increases host digestive
efficiency,35 and our previous study showed that B. theta is feedback inhibited by acetate
and formate,53 suggesting that a partner organism that consumes these metabolic
byproducts, such as M. smithii, may benefit B. theta. However the relationship between
B. theta and M. smithii is not fully characterized. One of the greatest obstacles is the
difficulty in systematically identifying what conditions could lead to a synergistic
metabolic relationship, such as syntrophy, that benefits both organisms.
To examine the metabolic relationship between B. theta and M. smithii, we
established laboratory conditions in which both monocultures and co-cultures of B. theta
and M. smithii can be studied and characterized. We leverage an approach to test complex
software; partitioning the input space and systematically manipulating program inputs
and inferring interactions and relationships between the inputs. In the system we studied
here, we observed organism and coculture growth behaviors as outputs dependent on
culture nutrient inputs. We then devised an assay to compare monocultures and
cocultures in 128 different nutrient conditions and evaluated growth using decision trees
from machine learning to identify neutral, favorable, and unfavorable conditions for M.
smithii and B. theta growing in co-culture.
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Materials and Methods:
Strains and culturing conditions
B. thetaiotaomicron vpi-5482 (ATCC29148, NB203)54,55 and M. smithii
DSM0861 (ATCC35061, NB215)45 were used for the described studies. Strains were
grown at 37˚C in 18 mm x 150 mm Balch culture tubes under strict anaerobic conditions,
in either a rich tryptone and yeast extract growth medium (TYG) or a defined medium.
Previous work with B. theta utilized tryptone, yeast extract and glucose medium (TYG)
as a rich growth medium.15,35,56 Rich medium for M. smithii was also dependent on yeast
extract.57,58 Using TYG as a base, the recipes were combined to ensure growth for both
organisms. M. smithii was initially grown in DSMZ Methanobacterium Medium 11958
then passaged into the modified rich medium supplemented with 10 mM formate and
10mM acetate with 138 kPa 20% CO2 80% H2 headspace atmosphere. The defined
medium was designed through a comparison of recipes.45,46,59-62 Rich medium contained
tryptone peptone (10 g), Bacto yeast extract (5 g), 100 mM KPO4 pH 7.2, 40 ml TYG
salts (0.5 g MgSO4•7H2O, 10 g NAHCO3, 2 g NaCl per liter), 54.4 µM CaCl2, 1.4 µM
FeSO4, 4 µM resazurin, 2.8 mM cysteine•HCl, 25 µM Na2S, per liter. Defined medium
contained 7.5 mM NH4SO4, 11.9 mM Na2CO3, 100 mM KPO4 pH 7.2, 14 µM FeSO4, 50
mL mineral salts (18 g NaCl, 0.53 g CaCl2•2H2O, 0.40 g MgCl2•6H2O, 0.20 g
MnCl2•4H2O, 0.20 g CoCl2•6H2O per liter), 4 µM resazurin, 2.8 mM cysteine•HCl, 25
µM Na2S, per liter. When indicated, cultures were supplemented with 10 mM sodium
acetate, 10 mM formate, 20 µM histidine and 2 µM hematin, 3.7 nM vitamin B12
(cyanocobalamin), or 5.8 mM vitamin K3 (menadione). B. theta was supplemented with
glucose to 0.05% (2.78 mM). Culture headspace was either 20% CO2, 80% N2 or 5% H2,
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20% CO2, 75% N2 atmosphere at 138 kPa. M. smithii was grown on a rotary shaker
operating at 45 rpm. M. smithii culture tubes were pressurized to 138 kPa with a 20%
CO2 80% H2 gas mixture twice daily during growth curves or every three days for culture
maintenance. Preliminary data suggested that vitamin K3 may hinder M. smithii growth.
B. theta / M. smithii co-cultures were grown on or off the shaker under a 5% H2, 20%
CO2, 75% N2 atmosphere in rich or defined medium supplemented with glucose to 0.05%
(2.78 mM).
Growth Curves
B. theta and M. smithii were grown in 10ml TYG, then transferred to media
containing appropriate carbon sources and compounds. Growth in 18 mm x 150 mm
anaerobic culture tubes was assessed by measuring changes in optical density at 600 nm
using a Spec20D spectrophotometer modified with an 18mm tube adapter. Growth in 96
well plates was assessed by measuring change in optical density at 600 nm using a Tecan
Sunrise plate reader under a 5% H2 20% CO2, 75% N2 atmosphere.

Microscopy
Microscopy was performed using an EVOS FL Auto Cell Imaging System with
DAPI, Texas Red, and Green Florescent Protein LED light cubes in the University of
Nebraska Morrison Microscopy Core Facility. B. theta and M. smithii were grown in
medium containing an appropriate carbon source as above. Co-cultures were grown in
defined medium with only glucose as a carbon source. 500 μl samples were taken in an
anaerobic atmosphere and stained with a combination of 5 μl propidium iodide and 1 μl
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SYTO 9 Green per 500 μl cells while remaining in anaerobic conditions. M. smithii
coenzyme F420 auto-fluorescence was viewed using a DAPI light cube,6,38,45,63 propidium
iodide with a Texas Red light cube, and Syto 9 Green with a Green Florescent Protein
light cube.
Flow cytometry
Flow cytometry was performed using a BD Biosciences FACS Aria II Flow
Cytometer (BD Biosciences) in the Nebraska Center for Biotechnology Flow Cytometry
Core Facility. B. theta and M. smithii were grown anaerobically in rich medium
supplemented with variable concentrations of glucose and sodium acetate over 4 and 9
days. Cell concentrations were recorded via OD600 and cultures were concentrated
anaerobically via centrifugation at a 500 x g for 10 minutes in a ThermoScientific Sorvall
Legend Micro21 rotor, washed with phosphate-buffered saline (PBS; 137mM NaCl,
2.7mM KCl, 10mM Na2HPO4, 1.8mM KH2PO4) and resuspended to a concentration of
~1.0x106 cells per mL. Cells were dyed using LIVE/DEADTM Fixable Yellow Dead Cell
Stain Kit (Invitrogen) according to the protocol provided. Flow Cytometry was
performed exciting with a 405nm laser until 10,000 events were recorded. Flow
cytometry size standards were obtained from Fisher (1.0-15 µm diameter; catalog number
F13838). The gating control is shown in Supplementay Data Figure S1.
qPCR quantification
B. theta and M. smithii were grown in rich media supplemented with glucose.
Cultures were incubated at 37°C and 1ml samples were collected anaerobically on day 4
and 9 of growth. DNA was isolated from the cells using a phenol-chloroform extraction64
and qPCR was performed on a Mastercycler® RealPlex2 instrument (Eppendorf)
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detecting SYBR Green using probes for 16s regions of the B. theta (B theta 16S fwd:
5’GGGATGCGTTCCATTAGGC; B theta 16S rev: 5’GGGACCTTCCTCTCAGAACC )
and M. smithii (M smithii 16S fwd: 5’CGGCCGATTAGGTAGTTGGT; M smithii 16S
rev: 5’GTTCCATCTCCGGGCTCTT) genomes. Ct values were normalized to input
DNA, amplification efficiency, and the apparent number of genomes per cell. To account
for variability in chromosome copy number between the two organisms an apparent
genome count was calculated by counting cells using a hemocytometer and carefully
extracting the DNA from 1 ml of cells. The DNA quantity was measured via NanoDrop
Spectrophotometer (Thermo Scientific) and was divided by the genome size to calculate
average number of genomes per cell which would then be divided by the number of cells
harvested in 1mL.
Dropout media preparation and growth assays
For each biological replicate of the 7-component growth assay, dropout media
were prepared that contained all combinations of vitamin K3, vitamin B12, formate,
acetate, histidine-hematin, and glucose. Media were dispensed into 16 sterile 96-well
culture plates, with two plates for each layout. One plate of each layout was kept under a
5% H2, 0.1% H2S, 20%CO2, 74.9% N2 atmosphere, the other under 0.1% H2S, 20% CO2,
79.9% N2, resulting in 128 media combinations total.
B. theta and M. smithii were grown in 10ml rich medium and used to inoculate
prepared 96 well culture plates. For monocultures, 1:20 inocula (5 μl) of B. theta, 1:10
inocula (10 μl) of M. smithii, or a co-culture of both were added to sample wells. The
inoculum volumes for each strain were empirically determined to yield measurable
culture turbidity within the two-week experiment. One plate of each layout was placed in
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a 35˚C anaerobic incubator with either 5% H2, 0.1% H2S, 20%CO2, 74.9% N2 or 0.1%
H2S, 20% CO2, 79.9% N2 atmosphere. A Tecan Sunrise plate reader measured optical
density at 600nm after 7 days or 14 days under strict anaerobic conditions. The process
was repeated for a total of three biological replicates.
Growth data analysis
The plate reader data was expected to contain errors due to splashing during
handling, evaporation and the formation of bubbles or cell clumps. Because each set of 8
samples or blanks contained similar contents, cells, and medium components, a normal
distribution was assumed and Chauvenet’s criterion was applied to eliminate statistical
outliers in preparation for statistical and algorithmic analysis.65 Chauvenet’s criterion
specifies a probability band around the mean with a probability of 1 −

1

2𝑛𝑛

. Data within the

band is retained, while data outside the band are considered outliers. For 8 samples,
Chauvenet's criterion specifies a probability band that encompasses 93.8 % of the
population (Equation 1):
𝑃𝑃 = 1 −

1
= 0.937
2∙8

This corresponds to 1.863 standard deviations from the mean. Samples or blanks
outside the band with a standard deviation greater than 1.863 were eliminated as outliers.
After applying Chauvenet’s criterion, differences in medium color were minimized by the
subtraction of the mean value of the medium blanks from each sample. To allow data
comparison across experiments, all samples were divided by the mean of a universal
positive control grown in a H2 atmosphere and containing glucose, vitamin B12, hematin,
formate, and acetate. These samples were joined. To compare error across biological
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replicates, we assumed that the standard deviations should be approximately equal across
datasets and calculated pooled variance 𝑠𝑠𝑝𝑝2 according to (Equation 2):
𝑠𝑠𝑝𝑝2 =

∑𝑘𝑘𝑖𝑖=1(𝑛𝑛𝑖𝑖 − 1)𝑠𝑠𝑖𝑖2
∑𝑘𝑘𝑖𝑖=1(𝑛𝑛𝑖𝑖 − 1)

Where 𝑛𝑛; is the sample size of population i and 𝑠𝑠𝑖𝑖2 , is the sample variance for

population i, or square of the standard deviation. Pooled standard error can then be
calculated with (Equation 3):
𝑘𝑘

𝑆𝑆𝑆𝑆𝑝𝑝 = ��
𝑖𝑖=1

𝑠𝑠𝑝𝑝2
𝑛𝑛𝑖𝑖

Trees. Decision trees are a divide-and-conquer machine learning technique that
sorts data according to the data attributes that best divide the data. C4.5 decision trees
were generated by running the data sets into a J28 classifier as previously described and
drawn using Adobe Illustrator.36 BioSIMP software and tutorials can be found on the
U.S. Department of Energy’s Knowledge Base (KBase).66 For analysis of monoculture
data and co-culture time course, sample averages were sorted into 4 buckets relative to a
positive control containing glucose, hematin, vitamin B12, acetate, formate and grown
under a 5% H2 atmosphere. Buckets related the growth to the positive control as follows:
no growth (NONE < 0.25); low growth: (LOW ≥ 0.25, < 0.75); similar growth:
(SIMILAR ≥ 0.75, < 1.25); and high growth: (HIGH ≥ 1.25).
Synergistic Interaction Index Calculations
If all the cells in a co-culture or consortium grow entirely independently of each
other, with no interactions, the number of cells in the coculture (𝑛𝑛𝑐𝑐𝑐𝑐−𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 ) would be
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equivalent to the sum of the number of monoculture cells grown under the same
conditions, or in our case (Equation 4):
𝑛𝑛𝑐𝑐𝑐𝑐−𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 = 𝑛𝑛𝐵𝐵.𝑡𝑡ℎ𝑒𝑒𝑒𝑒𝑒𝑒 + 𝑛𝑛𝑀𝑀.𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠ℎ𝑖𝑖𝑖𝑖

Because the optical density of the culture is directly proportional to the number of
cells, we can compare the relative growth 𝑅𝑅𝑠𝑠,𝑖𝑖 of each culture of taxon 𝑠𝑠 under culture
condition 𝑖𝑖 (Equation 5):

𝑅𝑅𝑠𝑠,𝑖𝑖 =

𝑂𝑂𝑂𝑂𝑖𝑖
𝑂𝑂𝑂𝑂𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐

As long as each organism can grow independently in a positive control (𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐)
condition, an 𝑥𝑥 -component coculture of B. theta and M. smithii should have an overall

growth that is an average of the monocultures (Equation 6):
𝑅𝑅𝑐𝑐𝑐𝑐−𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑖𝑖

𝑥𝑥

𝑂𝑂𝐷𝐷𝑐𝑐𝑐𝑐−𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑖𝑖
1
=
= ∙ � 𝑅𝑅𝑠𝑠,𝑖𝑖
𝑂𝑂𝐷𝐷𝑐𝑐𝑐𝑐−𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐 𝑥𝑥
𝑠𝑠=1

Therefore, assuming independent growth within a co-culture of B. theta and M.
smithii, the relative growth 𝑅𝑅 of a co-culture will equal (Equation 7):
𝑅𝑅𝑐𝑐𝑐𝑐−𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑖𝑖 =

𝑅𝑅𝐵𝐵.𝑡𝑡ℎ𝑒𝑒𝑒𝑒𝑒𝑒,𝑖𝑖 + 𝑅𝑅𝑀𝑀.𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠ℎ𝑖𝑖𝑖𝑖,𝑖𝑖
2

This relationship will only be true if the growth of B. theta and M. smithii are
independent of each other (null hypothesis). If the cells are interacting in a positive,
syntrophic way, the co-culture will contain more cells than the sum of the monocultures.
If the cells are competitive, total growth will be inhibited and there will be fewer cells in
the co-cultures than expected. To express co-culture interactions as a numerical value, we
divide the observed co-culture growth by the sum of the independent cultures, creating a
Synergistic Interaction index for each culture condition, 𝐼𝐼𝑖𝑖 (Equation 8):
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𝐼𝐼𝑖𝑖 =

𝑅𝑅𝐵𝐵.𝑡𝑡ℎ𝑒𝑒𝑒𝑒𝑒𝑒,𝑖𝑖 + 𝑅𝑅𝑀𝑀.𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠ℎ𝑖𝑖𝑖𝑖,𝑖𝑖
2𝑅𝑅𝑐𝑐𝑐𝑐−𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐𝑐,𝑖𝑖

A few caveats to this method should be considered depending on the organisms
being studied. Under very high culture densities the linear relationship between optical
density and cell number is no longer valid as the culture becomes increasingly opaque. In
these situations, the index would be an underestimate of the coculture productivity.
Another issue to keep in mind is that flocculation or aggregate formation would
complicate experimental reproducibility. In spectrophotometric microplate readers,
aggregates may be indicated when biological replicates produce signal variability
depending on whether the beam hits an aggregate by chance. The result is high biological
and technical variability that confounds statistical analysis. In either case, the Index may
be adapted by substituting biomass or another proxy growth measurement in place of OD
variables in the above equations.

Results
B. theta and M. smithii grow independently in both rich and defined medium when
supplemented with appropriate carbon sources
Before we can examine the interactions between B. theta and M. smithii we
needed to understand how they grow separately in monocultures. The rich medium is
based on a standard tryptone yeast-extract recipe with high nutrient availability. In sealed
anaerobic culture tubes supplemented with 0.05% glucose (Figure 1a), B. theta doubled
every 1.48 hours (Table 1). Supplemented with 10mM acetate and 10mM formate under
an atmosphere of 80% H2, M. smithii grew at a much slower rate (Figure 1b) with a
doubling time of 8.8 hours (Table 1). The difference in growth rates means that if two
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cultures are started at the same time, B. theta has already reached the stationary stage of
growth when M. smithii is entering early log growth (Figure 1ab). In defined medium the
difference B. theta and M. smithii monoculture growth is more pronounced. B. theta
doubled every 1.4 hours while M. smithii doubled every 15.4 hours (Figure 1ab, Table
1).
The presence of B. theta is sufficient for M. smithii growth in co-cultures
In defined medium optical density of cocultures was very similar to B. theta
monocultures (Table 1) except culture density did not decrease after 50 hours during
stationary phase. A decrease in culture optical density may indicate a number of causes;
among these are cell lysis or a change in cell shape or volume. The observation that
cocultures did not show this decrease in optical density suggested that either M. smithii
protects B. theta from lysis, that it prevents a change in cell shape or volume, or that the
optical density reflected growth of M. smithii even though M. smithii monocultures do
not grow in medium lacking H2+CO2 or formate and acetate (Figure 1c). When
cocultures were grown in rich medium in anaerobic culture tubes supplemented with
0.05% glucose we observed aggregation of cells after one week of incubation (Figure
2a). We did not observe aggregation in B. theta monocultures of the same age (Figure
2b). Microscopy indicated aggregates were comprised of intact B. theta with associated
M. smithii (Figure 2cd) in addition to intact planktonic and extracellular matrix or dead
cells (Figure 2ef). The accumulation of M. smithii cells in coculture lacking
methanogenic substrates indicates that B. theta fermentation products are sufficient to
support M. smithii growth. It should be noted that while lysed B. theta may provide
metabolite precursors, M. smithii has an absolute requirement for acetate for acetyl-CoA
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biosynthesis and it is restricted to using H2+CO2 and possibly formate as carbon and
energy sources.
Quantification of B. theta and M. smithii in coculture
To determine if the interaction is solely a cross-feeding interaction or if B. theta
also benefits from coculture with M. smithii during long-term cultivation with glucose as
the sole carbon and energy source , the ratio of each organism in coculture populations
was quantified using qPCR and flow cytometry. We calculated cell ratios by qPCR by
probing for the 16S rRNA coding region of the genome. Between 4 and 9 days of
coculture there was no change in the coculture optical density and the ratio of B. theta to
M. smithii remained steady at 11.56 (+/- 3.03) on Day 4 to 14.25(+/- 4.72) on Day 9
(p=0.313). To confirm the qPCR results, we also developed a flow cytometry assay to
quantify changes in the population ratio according to cell wall staining and to measure
cell aggregation. We found that when grown in the presence M. smithii, B. theta (Figure
3 panels b-d and f-h) forms larger cells or aggregates which mimics the phenotype
observed when B. theta is grown in rich medium with 0.5x glucose (Figure 3 panels a
and e). When 0.5x glucose is provided, cultures deplete glucose carbon source and enter
stationary phase more rapidly. Consistent with the qPCR data, after 4 days the ratio of
planktonic B. theta to M. smithii cells was 10.97 (+/- 3.81). These results suggest that B.
theta and M. smithii reach balanced growth, in contrast to a purely crossfeeding
interaction in which we would expect the ratios to transition from B. theta-dominated to
M. smithii-dominated cultures over time._ENREF_53Culturing, microscopy, and
quantification experiments suggest that B. theta forms irregular aggregates under limiting
nutrient conditions that either passively “trap” or actively recruit M. smithii.
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Evidence for metabolic crossfeeding between B. theta and M. smithii
M. smithii growth may be supported by B. theta fermentation products acetate,
formate, and H2+CO2. We next assessed the effect of acetate on cocultures, as acetate is
required for M. smithii growth. Under these conditions, growth of M. smithii still requires
H2 and CO2 provided by B. theta, as M. smithii cannot grow on acetate as an energy
source. When cocultures were supplemented with 20 mM acetate, B. theta cells were
larger, formed aggregates, and the relative proportion of B. theta to M. smithii decreased
to 4.52 (+/- 1.56) (Figure 3 panels d and h). The decrease in the relative proportion of B.
theta to M. smithii with acetate supplementation is interpreted to suggest acetate is
growth-limiting for M. smithii in cocultures.
We hypothesized that if B. theta and M. smithii have a metabolic relationship,
whether it be crossfeeding or syntrophy, then one or both of them may secrete unknown
small molecules such as amino acids, bacteriocins, toxins, or quorum-sensing factors to
promote growth of the other organism. We tested whether preconditioned medium may
have a positive effect on growth of monocultures. In these experiments, media were
preconditioned by inoculating with either B. theta or M. smithii monocultures and
allowing the monoculture to grow to stationary phase before filter sterilizing with a 0.2
µm filter to remove intact cells. When B. theta was grown on rich medium that had been
preconditioned by B. theta monocultures, growth was slower and maximum optical
density was decreased (Figure 4a). When B. theta was grown on medium that had been
sequentially preconditioned first by B. theta, then by M. smithii, cultures grew faster to a
higher maximum optical density, however the growth enhancement was not significant
versus growth of B. theta on rich medium preconditioned by B. theta (Figure 4a). B.
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theta + M. smithii cocultures grown on defined medium that had been preconditioned by
M. smithii or B. theta monocultures grew similarly to B. theta cultures using medium that
had been preconditioned by sequential culturing of B. theta then M. smithii monocultures.
,. These results suggest that when grown sequentially B. theta depletes rich medium of
one or more nutrients that are provided at a low level by M. smithii. In an attempt to
identify nutrients that might improve growth of B. theta we supplemented rich and
defined medium with hematin, vitamin B12, vitamin K3, formate, and acetate. Growth
experiments indicate that the lysis observed in rich medium was reduced by addition of
hematin with vitamin K (Figure 4b). In defined medium, vitamin B12, hematin, formate
and acetate had no effect, but vitamin K improved growth (Figure 4b). We also tested
whether M. smithii growth is enhanced by rich medium preconditioned by B. theta. M.
smithii was able to grow solely on rich medium preconditioned by B. theta suggesting
molecules secreted by B. theta were responsible for stimulating M. smithii growth
(Figure 4c). M. smithii growth was further enhanced by adding hematin, acetate, and
formate. However, the growth stimulation observed using preconditioned media were not
as dramatic as the growth observed in cocultures (Figure 1c and Figure 2). Crossfeeding
data indicated a comprehensive systematic approach was needed to characterize the
complex metabolic relationship between B. theta and M. smithii in coculture.
B. theta growth is inhibited by the presence of hydrogen gas, formate, and acetate
To tease apart the metabolic interactions between B. theta, M. smithii, and the
culture environment we used a machine learning technique to analyze large-scale growth
culture phenotype data. We assessed the growth of each organism alone and in coculture
in 128 different combinations of culture media (27). The combinatorial media recipes
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included or omitted the following nutrient components: 0.05% glucose, 10 mM acetate,
10mM formate, 5.8 mM vitamin K3, 0.0037 μM vitamin B12, and a mixture of 0.2 mM
histidine and 0.02mM hematin in the presence or absence of 5% H2 headspace gas. The
optical densities of B. theta (Figure 5), M. smithii (Figure 6), and cocultures (Figure 8)
were measured after 1 day to capture maximal B. theta optical density, 7 days to capture
slow-growing B. theta and maximal M. smithii optical density, and 14 days to measure
culture stability after prolonged incubation. The same time points were observed to allow
comparisons between monocultures and cocultures for every growth condition. To
analyze and visualize these data we utilized C4.5 decision trees to identify the
relationships between nutrient factors in the culture medium.36 Decision trees draw
branch nodes depending on whether the presence or absence of the factors (in this case,
the provided nutrients) affects growth of the culture.
In defined medium glucose was the only carbon source available to B. theta and
was the primary determinant of growth (Figure 5a). The structure of the decision tree
suggests that the presence of hydrogen gas alone inhibits growth (Figure 5b). Hydrogen
gas inhibited B. theta growth up to 37.6% (Figure 7a). When combined with acetate and
formate supplementation growth is decreased by 55% (Supplementary Data). Acetate
and formate alone do not have a significant effect on growth of B. theta (Figure 7a),
although the tree suggests the presence of acetate and formate in combination may
increase growth under certain conditions. Interestingly, the tree indicates the inhibition
caused by H2 is mitigated by the presence of vitamin K or a combination of vitamin B12
and hematin/histidine, (Figure 5b). Additional experiments are needed to understand
how this could be occurring, as inhibition of growth by hydrogen gas is not well
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understood in B. theta. M. smithii is unable to grow under conditions that favor B. theta
unless hydrogen, formate, and acetate are present (Figure 7c).
M. smithii grows best on a combination of glucose, vitamin B12, hematin, acetate,
formate, and H2 gas but depends on acetate for biomass
As expected, B. theta is incapable of growth (Figure 7b) under conditions that M.
smithii prefers (Figure 7d). M. smithii grew well in defined medium containing formate,
acetate, and hydrogen, even with the addition of glucose, vitamin B12, and hematin
(Figure 7c). Overall M. smithii was able to grow under a wider variety of conditions than
B. theta, albeit to a lower maximum optical density (Figure 6a). The decision tree for M.
smithii suggests that acetate is the primary determinant for the growth of M. smithii
(Figure 6b). The presence of hydrogen or formate are necessary, but not sufficient for
growth (Figure 7d). Both vitamin K3 (menadione) and vitamin B12 can inhibit M. smithii
growth, but under certain circumstances vitamin B12 rescues vitamin K inhibition and
hematin can rescue vitamin B12 inhibition (Figure 6b).

Dynamics of coculture phenotypes
To compare the growth of the co-cultures to the monocultures, growth was
normalized to the control treatment that contains the necessary additive requirements for
both organisms: glucose, hematin, vitamin B12, formate, acetate, and H2. Relative to the
control, co-culture growth closely resembles the B. theta monoculture tree after one day,
(Figure 8a) but increasingly resembles M. smithii by day 7 through day 14 (Figure 8bc).
On day one, glucose is the primary growth factor (Figure 8a). By day 7, biomass is
primarily linked to glucose catabolism, but acetate and hydrogen gas also influence
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coculture growth (Figure 8b). By day 14, growth is less dependent on glucose and more
on acetate, indicating increased importance of M. smithii in the coculture. However, the
decision trees for the coculture do not directly mimic the monoculture trees. These data
indicate that the metabolic relationship between B. theta and M. smithii is dynamic over a
two-week period and that coculture growth is not a simple additive relationship that can
be easily predicted from monoculture data. This is consistent with observations made by
others in which metabolism of diverse microbes are shaped by other members in a
consortium.67,68
The Synergistic Interaction index uncovers nutrient-dependent trophic interactions
The complex growth patterns we observed suggested that under some conditions
B. theta and M. smithii could be growing independently, while in other culture medium
they may crossfeed each other and/or may compete for nutrients. We developed a
Synergistic Interaction index to analyze the growth time course data (Figure 10).
Because B. theta will not grow without glucose, only the cases where glucose was
supplemented were examined, and the synergistic interaction index (SI) was determined
at 7 and 14 days (Figure 9, Supplementary Data). The SI for the control condition was
1 on both days, indicating an additive mutualistic relationship between B. theta and M.
smithii growth as expected (Table 2). After 7 days, two co-cultures (glucose + vitamin
B12 + heme + H2 and glucose + vitamin B12 + H2) had a SI ≥ 1.5, indicating the relative
growth of the co-culture was at least 1.5x that of the two monocultures together
(Supplementary Data). One of these conditions (glucose + vitamin B12 + H2) had SI =
2.307, indicating co-culture growth 2 times that of the monocultures together (Table 2).
By 14 days 7 cocultures had SI ≥ 1.5 with a maximum value of 2.36 for the glucose +
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vitamin B12 + H2 condition (Table 2). Cultures showing the highest indexes on day 14
were supplemented with vitamin B12, which is surprising because B12 inhibited M. smithii
growth in monoculture (Figure 6b). One of the seven conditions with SI ≥ 1.5 included
two fermentation products, acetate and hydrogen, and four cultures supplemented with
acetate showed an increase of at least 0.5 SI units between days 7 and 14. Of the 11
cultures with day 14 SI > 1.25, 10 showed an increase from day 7 to day 14, likely
indicating the differences in growth rates between B. theta and M. smithii, and suggesting
that depletion of glucose (and starvation of B. theta) is required for synergistic growth
under these culture conditions. Measurement of SI after 7 days correlated very well with
SI measured at 14 days with r2 = 0.7922 (Figure 10a). 24 cultures had SI < 0.75,
suggesting the possibility of antagonistic inhibition or competition between B. theta and
M. smithii. Of those 24 cultures, 20 saw a decrease in index from day 7 to day 14.
Overall, synergistic growth was dependent on the availability of heme, vitamin B12,
acetate, and hydrogen (Figure 9).
Synergistic growth is correlated with nutrient limitation and feedback inhibition
We noted that conditions indicating coculture synergy occurred when B. theta
monocultures grew poorly. When the Day 7 SI is compared to the growth of B. theta in
monocultures under the same conditions, we observed a strong inverse correlation with r2
= 0.6118 (Figure 10b). In contrast, the Day 7 SI was only very weakly correlated with M.
smithii growth with r2 = 0.0657 (Figure 10c). The decision tree analysis (Figure 8)
shows that highest growth occurs when the coculture is supplemented with acetate,
formate, and hematin. When cocultured, the data suggests both organisms compete for
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hematin (Figure 9, panels c and d), especially when M. smithii growth is stimulated by
added formate, acetate, and/or hydrogen (Supplementary Data).

Discussion
Our study highlights the benefit of using an interdisciplinary approach to discern
patterns of microbial growth as environmental conditions are varied. We have been able
to adapt the use of decision trees from machine learning to parse through large-scale
phenotype data to identify critical nutrient factors that contribute to growth. Machine
learning decision trees are an unbiased tool to search for patterns in large-scale data to
uncover hierarchy and interactions between variables. Here, we used optical density to
measure culture growth as an output dependent variable due to the ease of obtaining highthroughput data. However, decision trees can be adapted to use for any combination of
dependent and independent variables in biological systems. This approach allowed us to
ascertain patterns in growth phenotypes as well as emergent behaviors: in this case
competition and synergistic growth, when two species are cocultured. We then developed
a method to quantify these emergent behaviors in the form of a Synergistic Interaction
index. Our approaches apply well to studying the interactions between microbes as
diverse as the Gram negative bacterium B. theta and the archaeal methanogen M. smithii.
While we used end-point optical density as an output parameter, which may mask
phenotypes such as changes in cell size, shape, lysis and aggregation, other
complementary signals such as 16S sequence or metatranscriptomic abundance, biomass,
metabolites produced or consumed, or the rates of change of these signals could
theoretically be used instead with minimal adaptation. Likewise, while we constrained
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our study here to two organisms, with minor adjustment to account for number of species
in Equations 6-8 the approach could be retooled for more complex microbial
communities. A major consideration when studying complex microbial communities
would be to use statistical sampling techniques such as BioSIMP69 to develop technically
and logistically feasible experiments that still retain a suitable confidence interval for
observed responses. BioSIMP involves using statistical sampling techniques to reduce the
number of experiments required to uncover unexpected behavior/interactions in a
biological system. For instance, instead of testing a full-factorial array of environmental
conditions, statistical subsampling can be used to reduce the experiments by 50% or more
to find which culture conditions can be expected to produce a growth effect of a certain
magnitude. Precious resources in time, money, materials, and personnel can be devoted to
more detailed mechanistic experiments that require full-factorial experimentation once
“interesting” or “unexpected” results are identified for follow-up study.
The results of this study show that fermentation products secreted by B. theta are
sufficient to support growth of M. smithii (Figure 1c) and that M. smithii enhances
growth of B. theta (as determined by growth curve data (Figure 1c), microscopy (Figure
2e), and qPCR experiments). One explanation for this result could be that B. theta
becomes feedback inhibited by secreted metabolic byproducts but in the presence of M.
smithii the products are consumed thus reducing growth inhibition. We showed in a
previous study that the major fermentation products secreted by B. theta during growth
on glucose suppresses B. theta growth rates and alters metabolism resulting in increased
production of carbon dioxide and amino acids.53 M. smithii is capable of growing solely
on the metabolites secreted by B. theta (Figure 1c), and medium that has been

208

sequentially conditioned first by B. theta and then by M. smithii supports higher B. theta
biomass than medium that was preconditioned by B. theta alone (Figure 4a). It is
unknown what M. smithii might secrete besides methane, biomass, or intracellular
metabolites such as heme or corrinoids released by lysed cells. Heme iron is a wellstudied nutrient requirement and bacteria have many heme acquisition mechanisms such
as siderophores and pathogenesis factors that they synthesize to acquire iron for enzyme
cofactor synthesis from the environment, from neighboring microbes, or from the
host.70,71 Corrinoids have also been shown to play a key role in several interspecies
systems and competition for B12 is thought to be a significant factor that shapes human
gut microbial community ecology.72 Our results show that B. theta is capable of growth
in medium without supplemented heme or B12 when grown in coculture with M. smithii
presumably because B. theta can scavenge heme and corrinoids synthesized by M.
smithii.
It is formally possible that B. theta and M. smithii secrete one or more unknown
small molecules that are sensed as interspecies signals in addition to the central metabolic
interactions we tested in our treatments. Synergistic growth could be mediated by soluble
and insoluble signals that may be expressed when B. theta is undergoing the starvation
response. It is tempting to speculate that B. theta forms multicellular aggregates under
starvation conditions to attract M. smithii, which would benefit from physical association
with B. theta by allowing rapid mass transfer of hydrogen and acetate (Figure 2).
Intriguingly, these aggregates and the association of M. smithii with them statistically
decreased when acetate was supplemented into the culture medium (Figure 3),
suggesting that either acetate induces signaling molecules by B. theta, or that M. smithii,

209

which requires exogenous acetate for growth, secretes molecule(s) that promote
aggregate formation with B. theta. Whether the increase in B. theta growth is a result of
secreted product from M. smithii or by the protective effect of removing inhibitory
compounds is still to be decided. Additional experiments are needed to identify any
attractants secreted by B. theta and/or M. smithii under conditions that favor and disfavor
aggregate formation.
Finally, we developed a Synergistic Interaction index to score the likelihood that
two or more organisms are growing synergistically, independently, or are inhibiting each
other. The index scores suggest that in some situations, the coculture is metabolically
more efficient than expected from the biomass observed from independent monocultures.
While the index does not identify the molecular mechanism of synergy or inhibition, by
using a multi-component culturing strategy and decision trees, we are able to discern
patterns of coculture behavior that can lead to testable hypotheses. Our observations
suggest that B. theta and M. smithii have a mutually beneficial syntrophic relationship
when vitamin B12 and hydrogen gas are provided, and that they compete for hematin
when sufficient acetate, formate and/or hydrogen gas are available for M. smithii to grow.
Future experiments are needed to determine how B. theta and M. smithii compete for
heme. We speculate competition could proceed via passive mechanisms (autolysis,
diffusion, and ATP-dependent transport) or by active processes using small molecules
such as bacteriocins, toxins, quorum-sensing factors, or other mechanisms to obtain iron
that have been discovered in other microbes.73-75
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Table 1. Culture doubling times (hours).

M. smithii
Co-Culture
10mM acetate + 10mM
0.05% glucose
formate
Treatment Maxi Doubling p vs Maxim Doubli p vs Maxi Doublin p vs
p vs
mum time (std Rich um OD ng time Rich mum g time Bth Msm
OD
dev)
(std
OD (std dev)
dev)
Anaerobic
0.54
1.11 ±
1.48 ±
0.55 ± 8.84 ±
1.46 ±
culture tube
1
1
±
0.890 0.000
0.013
0.140
0.051 0.332
0.137
†
Rich
0.020
Anaerobic
0.52
0.55 ±
1.40 ± 0.69 0.15 ± 15.46 ±
1.44 ±
culture tube
0.000
±
0.872 0.000
0.017
0.092
9
0.007
1.803
0.05
Defined†
0.016
0.745
96-well
0.64 ±
1.62 ±
0.17 ± 7.93 ±
2.02 ±
1
1
±
0.001 0.000
‡
0.097
0.024 0.825
0.073
plates Rich 0.033
0.016
96-well
0.61
0.69 ±
2.04 ± 0.00 0.14 ± 318 ±
2.18 ±
plates
0.000
±
0.030 0.000
0.015
0.100
0
0.007
23.13
0.067
Defined‡
0.018
OD: culture optical density at 600 nm. NG: no growth. Data were collected from † n= 5 or ‡ n=
8 biological replicates. Significance p values determined by unpaired Student’s t-test. Bth: B.
theta. Msm: M. smithii.
B. theta
0.05% glucose

Figure 1. Growth phenotypes on rich and defined culture media. Panel a, Growth of
B. theta monocultures in anaerobic culture tubes in rich (black) or defined medium (gray)
compared to B. theta + M. smithii cocultures (red) grown on defined medium on 0.5%
glucose (n=5). Panel b, Growth of M. smithii monocultures in anaerobic culture tubes in
rich (black) or defined medium (gray) supplemented with 10mM acetate and 10mM
formate under an atmosphere of 80% H2 (n=5). Panel c, Growth of B. theta (gray), M.
smithii (blue) and B. theta + M. smithii cocultures (red) on defined medium with 0.5%
glucose as sole carbon and energy source in 96-well plates (n=8). Error bars have been
omitted for clarity. OD600, optical density at 600nm. G, 0.5% glucose; B, vitamin B12
(cyanocobalamin); H, hematin; F, 10mM formate; A, 10mM acetate; 2, 80% H2
atmosphere.

223

Figure 2. Microscopy of B. theta and M. smithii in cocultures grown in rich medium
for 8 days. Panel a, coculture of B. theta and M. smithii grown on rich medium for one
week showing visible aggregates. Panel b, monoculture of B. theta grown on rich
medium for one week. Panel c, Live/dead staining of a coculture aggregate appears to
show aggregates are comprised of live B. theta and M. smithii cells as well as what
appears to be extracellular matrix and/or lysed cell debris. In live/dead micrographs intact
B. theta cells are green, intact M. smithii cells are blue, and dead cells are stained red.
Yellow color results from colocalization of red and green channels. Methanogens autofluorescence due to oxidized co-enzyme F420 and appear blue when viewed under a DAPI
LED light filter. Panel d, transmission micrographs of Panel c. Panel e, Live/dead
staining of planktonic cells in coculture showing live B. theta (green), live M. smithii
(blue) and dead cells (red). Panel f, transmission micrograph of Panel d. Black bars
indicate scale.
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Figure 3. Quantification of B. theta and M. smithii in cocultures using flow
cytometry. Panels a-d, Cells were grown in defined medium for 9 days and counted by
flow cytometry. The X-axis reports forward scattering to quantify the size of the cell
populations. Blue histogram indicates B. theta staining. Green histogram indicates M.
smithii signal. Panels e-h, cells from the same experiments as in Panels a-d were
visualized by transmission electron microscopy and UV fluorescence with a DAPI filter
to detect M. smithii (arrow). Black bars indicate 5µm scale. Panel a and e, B. theta
grown alone in 0.5x glucose medium. Panels b and f, B. theta grown alone on glucose
defined medium. Panels c and g, B. theta grown in defined medium supplemented with
20mM acetate. Panels d and h, B. theta and M. smithii grown in coculture supplemented
with 20mM acetate.

Figure 4. Stimulation of B. theta and M. smithii growth by preconditioning or nutrient
supplementation. Panel a, Growth of B. theta monocultures (Bth) in rich medium is
enhanced by preconditioning with M. smithii, Msm (n=8). Bth G, B. theta monocultures
grown on control glucose medium; Bth sG, growth of B. theta monocultures on glucose
medium conditioned by B. theta; Bth+Msm sG, B. theta + M. smithii cocultures grown on
glucose medium conditioned by B. theta monoculture; Bth ssG, growth of B. theta
monocultures on glucose medium preconditioned first by B. theta monoculture, then by
M. smithii monoculture; Msm GFA, growth of M. smithii on rich medium control with
glucose, formate, and acetate supplementation. Panel b, Lysis of B. theta monocultures
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in defined medium is delayed by the addition of vitamin K3. Panel c, Growth of M.
smithii monocultures on rich medium with glucose (Rich) is enhanced when medium is
preconditioned by B. theta (sRich, n=8). Error bars have been omitted for clarity. OD600,
optical density at 600nm. G, 0.5% glucose; B, vitamin B12; H, hematin; K, vitamin K3; F,
10mM formate; A, 10mM acetate.

Figure 5. Effect of medium composition on B. theta growth. Triplicate B. theta
monocultures were grown in replicates of 8 on defined medium supplemented with 128
different combinations of glucose, vitamin B12, hematin, vitamin K3, acetate, formate,
and a 5% H2 atmosphere. Data across 3 experiments were compared to a positive control
(glucose, hematin, vitamin B12, acetate, formate and 5% H2) and combined. Panel a, B.
theta growth relative to a positive control. Panel b, Decision tree representation of
growth data relative to glucose, hematin, and vitamin B12 control condition. The decision
tree representation is read from left to right where each node represents one of the 7
nutrient conditions. The “-“ path means the nutrient was not included, the “+” path
means it was included. As the path is traversed, the nutrients are additive. The values in
parentheses represent how many total conditions are covered by that leaf, followed by
how many are incorrectly classified by the model. Growth relative to the positive control
is indicated as follows; open circles: no growth (NONE < 0.25), gray circles: low growth
(LOW ≥ 0.25, < 0.75); blue circles: similar growth (SIMILAR ≥ 0.75, < 1.25); and pink
circles: high growth (HIGH ≥ 1.25).
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Figure 6. Effect of medium composition on M. smithii growth. Triplicate M. smithii
monocultures were grown in replicates of 8 on defined medium supplemented with 128
different combinations of glucose, vitamin B12, hematin, vitamin K3, acetate, formate,
and a 5% H2 atmosphere. Data across 3 experiments were compared to a positive control
of acetate, formate and 5% H2 and combined. Panel a, M. smithii growth relative to a
positive control. Panel b, Decision tree representation of growth data relative to H2,
acetate control condition. Growth relative to the positive control is indicated as follows;
open circles: no growth (NONE < 0.25), gray circles: low growth (LOW ≥ 0.25, < 0.75);
blue circles: similar growth (SIMILAR ≥ 0.75, < 1.25); and pink circles: high growth
(HIGH ≥ 1.25).
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Figure 7. Identification of defined medium that supports independent growth.
Panels a and c, Growth of B. theta in dropout medium. Panels b and d, Growth of M.
smithii in dropout medium. Data for each panel was obtained from triplicate biological
and 8 technical replicates (n=24). Error bars represent standard deviation. G, 0.5%
glucose; B, vitamin B12; H, hematin; K, vitamin K3; F, 10mM formate; A, 10mM acetate;
2, 5% H2 atmosphere.
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Figure 8. Decision Trees of co-culture growth results. Triplicate B. theta + M. smithii
cocultures were grown in replicates of 8 on glucose defined medium supplemented with
64 different combinations of vitamin B12, hematin, vitamin K3, acetate, formate, and a 5%
H2 atmosphere. Panel a, Co-cultures after 1 day of growth Panel b, Co-cultures after 7
days of growth. Panel c, Cocultures after 14 days of growth. Data were obtained from
triplicate biological and eight technical replicates (n=24). Growth relative to the positive
control is indicated as follows; open circles: no growth (NONE < 0.25), gray circles: low
growth (LOW ≥ 0.25, < 0.75); blue circles: similar growth (SIMILAR ≥ 0.75, < 1.25);
and pink circles: high growth (HIGH ≥ 1.25).
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Figure 9. Metabolic Synergistic Interaction Index (SI). Panel a, Effect of nutrient
supplementation on growth. Panel b, Effect of nutrient combinations of on growth.
Panels c and d, SI of conditions shown in panels a and b, respectively. An index of 1
(dotted gray line) indicates the null hypothesis where organisms grow independently in
co-culture. An index greater than 1 indicates the relative growth of the co-culture is
greater than the sum of the monocultures, suggesting a syntrophic relationship. An index
of less than one indicates a competitive or inhibitory effect. Error bars represent standard
deviation from triplicate biological and eight technical replicates (n=24). G, 0.5%
glucose; B, vitamin B12; H, heme; K, vitamin K3; F, 10mM formate; A, 10mM acetate; 2,
5% H2 atmosphere.

Table 2. Synergistic Interaction Index
Statistics
Index range
Number of
treatments
(𝑰𝑰𝒊𝒊 =)
Day 7
Day 14
>1.5
2
7
>1.25
8
11
0.75 ≥ x ≥ 1.25
9
5
< 0.75
24
29
< 0.5
2
1
Extrema
Index Value (𝑰𝑰𝒊𝒊 =)
Day 7
Day 14
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Maximum
2.307
2.366
Minimum
0.376
0.397
a
Positive Control
0.928
0.950
a: Defined medium supplemented with
glucose, histidine and hematin, vitamin
B12, formate, acetate, and H2. In this
treatment B. theta and M. smithii are
provided nutrients for both to grow
independently.

Figure 10. Synergistic coculture growth is inversely related to B. theta growth. Panel
a, Metabolic relationships are established and stable between 7 and 14 days in culture.
Panel b, B. theta monoculture relative growth is inversely correlated to the 7-day
Synergistic Interaction index (SI). Panel c, M. smithii monoculture relative growth is not
correlated with the 7-day SI.
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Figure S1. Flow cytometry gating. Cells were harvested, washed in phosphate buffer,
and stained as described in the Materials and Methods. B. theta and M. smithii cells were
cultured anaerobically in rich medium until stationary phase (4 days for B. theta and 9
days for M. smithii) as determined by measuring optical density (OD) at 600nm. Cells
were mixed with an OD ratio of 10:1 B. theta:M. smithii and concentrated anaerobically
via centrifugation at a 500 x g for 10 minutes in a ThermoScientific Sorvall Legend
centrifuge fitted with a Micro21 rotor (ThermoFisher Scientific, Waltham, MA), washed
with phosphate-buffered saline (PBS; 137mM NaCl, 2.7mM KCl, 10mM Na2HPO4,
1.8mM KH2PO4) and resuspended to a concentration of approximately 1.0x106 cells per
mL. Cells were dyed using LIVE/DEADTM Fixable Yellow Dead Cell Stain Kit
(Invitrogen, Waltham, MA) according to the manufacturer instructions. Flow cytometry
was performed by exciting with a 405nm laser and 10,000 events were recorded. The
axes display the level of fluorescence detected at 510nm and 605nm. Blue dots indicate
B. theta cells. Green dots indicate M. smithii cells which fluoresce more strongly at
510nm due to the presence of cofactor F420 and due to staining with amine-reactive dye,
as M. smithii has a proteinaceous S-layer instead of a cell wall and has no outer
membrane. Red dots indicate signals which do not cluster strongly with either signal.

